activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
Not Active	1650063	CHEMBL860772	Average Binding Constant for CLK3; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL4226	Homo sapiens	Kd		
Not Active	1650063	CHEMBL860772	Average Binding Constant for CLK3; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL4226	Homo sapiens	Kd		
	1650064	CHEMBL860772	Average Binding Constant for CLK3; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	2100.0	CHEMBL4226	Homo sapiens	Kd	uM	2.1
Not Active	1650065	CHEMBL860772	Average Binding Constant for CLK3; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL4226	Homo sapiens	Kd		
Not Active	1650066	CHEMBL860772	Average Binding Constant for CLK3; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Kd			CHEMBL4226	Homo sapiens	Kd		
	1650067	CHEMBL860772	Average Binding Constant for CLK3; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	9000.0	CHEMBL4226	Homo sapiens	Kd	uM	9.0
Not Active	1650068	CHEMBL860772	Average Binding Constant for CLK3; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL4226	Homo sapiens	Kd		
Not Active	1650069	CHEMBL860772	Average Binding Constant for CLK3; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL4226	Homo sapiens	Kd		
Not Active	1650070	CHEMBL860772	Average Binding Constant for CLK3; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL4226	Homo sapiens	Kd		
	1650071	CHEMBL860772	Average Binding Constant for CLK3; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	1000.0	CHEMBL4226	Homo sapiens	Kd	uM	1.0
	1652072	CHEMBL860772	Average Binding Constant for CLK3; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	3500.0	CHEMBL4226	Homo sapiens	Kd	uM	3.5
Not Active	1652073	CHEMBL860772	Average Binding Constant for CLK3; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL4226	Homo sapiens	Kd		
Not Active	1652074	CHEMBL860772	Average Binding Constant for CLK3; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL4226	Homo sapiens	Kd		
Not Active	1652075	CHEMBL860772	Average Binding Constant for CLK3; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL4226	Homo sapiens	Kd		
Not Active	1652076	CHEMBL860772	Average Binding Constant for CLK3; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL4226	Homo sapiens	Kd		
Not Active	1652077	CHEMBL860772	Average Binding Constant for CLK3; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL4226	Homo sapiens	Kd		
Not Active	1652078	CHEMBL860772	Average Binding Constant for CLK3; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL4226	Homo sapiens	Kd		
Not Active	1652079	CHEMBL860772	Average Binding Constant for CLK3; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL4226	Homo sapiens	Kd		
Not Active	1652080	CHEMBL860772	Average Binding Constant for CLK3; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL4226	Homo sapiens	Kd		
Not Active	1652081	CHEMBL860772	Average Binding Constant for CLK3; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828		Kd			CHEMBL4226	Homo sapiens	Kd		
Not Active	1652082	CHEMBL860772	Average Binding Constant for CLK3; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL4226	Homo sapiens	Kd		
	1735031	CHEMBL854489	Activity against CLK3 at 10 uM in the presence of 100 uM ATP relative to control	B	COc1cc(/C=C2\C(=O)NN(c3ccc(Cl)c(Cl)c3)C2=O)ccc1O		CHEMBL380093	=	Activity	%	36.0	CHEMBL4226	Homo sapiens	Activity	%	36.0
	1735050	CHEMBL854489	Activity against CLK3 at 10 uM in the presence of 100 uM ATP relative to control	B	COc1cccc(NC(=O)Nc2nnc(-c3ccncc3)s2)c1		CHEMBL377430	=	Activity	%	11.0	CHEMBL4226	Homo sapiens	Activity	%	11.0
	2147226	CHEMBL929105	Activity of human CLK3 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	81.0	CHEMBL4226	Homo sapiens	Activity	%	81.0
	2417657	CHEMBL954301	Inhibition of human CLK3 at 10 uM	B	O=C1NN(c2ccc(Cl)c(Cl)c2)C(=O)/C1=C/c1ccc(O)c([N+](=O)[O-])c1		CHEMBL511636	=	Activity	%	75.0	CHEMBL4226	Homo sapiens	Activity	%	75.0
	2417658	CHEMBL954301	Inhibition of human CLK3 at 10 uM	B	COc1cc(/C=C2\C(=O)NN(c3ccc(C#N)cc3)C2=O)ccc1O		CHEMBL498718	=	Activity	%	93.0	CHEMBL4226	Homo sapiens	Activity	%	93.0
	2470132	CHEMBL1033252	Inhibition of CLK3 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL4226	Homo sapiens	INH	%	10.0
Not Evaluated	2476760	CHEMBL983558	Binding affinity to human CLK3 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL4226	Homo sapiens	Activity		
Not Evaluated	2478599	CHEMBL983558	Binding affinity to human CLK3 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL4226	Homo sapiens	Activity		
Not Evaluated	2478802	CHEMBL983558	Binding affinity to human CLK3 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL4226	Homo sapiens	Activity		
	2479657	CHEMBL983558	Binding affinity to human CLK3 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Activity	%	13.5	CHEMBL4226	Homo sapiens	Activity	%	13.5
Not Evaluated	2479860	CHEMBL983558	Binding affinity to human CLK3 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167		Activity			CHEMBL4226	Homo sapiens	Activity		
	2480657	CHEMBL983558	Binding affinity to human CLK3 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	2.3	CHEMBL4226	Homo sapiens	Activity	%	2.3
Not Evaluated	2480859	CHEMBL983558	Binding affinity to human CLK3 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL4226	Homo sapiens	Activity		
	2577278	CHEMBL983558	Binding affinity to human CLK3 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901	=	Activity	%	3.6	CHEMBL4226	Homo sapiens	Activity	%	3.6
Not Evaluated	2577481	CHEMBL983558	Binding affinity to human CLK3 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL4226	Homo sapiens	Activity		
Not Evaluated	2593686	CHEMBL983558	Binding affinity to human CLK3 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL4226	Homo sapiens	Activity		
Not Evaluated	2593952	CHEMBL983558	Binding affinity to human CLK3 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL4226	Homo sapiens	Activity		
Not Evaluated	2594155	CHEMBL983558	Binding affinity to human CLK3 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL4226	Homo sapiens	Activity		
Not Evaluated	2594895	CHEMBL983558	Binding affinity to human CLK3 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL4226	Homo sapiens	Activity		
Not Evaluated	2595098	CHEMBL983558	Binding affinity to human CLK3 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL4226	Homo sapiens	Activity		
Not Evaluated	2596295	CHEMBL983558	Binding affinity to human CLK3 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL4226	Homo sapiens	Activity		
Not Evaluated	2596498	CHEMBL983558	Binding affinity to human CLK3 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL4226	Homo sapiens	Activity		
Not Evaluated	2597767	CHEMBL983558	Binding affinity to human CLK3 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL4226	Homo sapiens	Activity		
	2892195	CHEMBL1060240	Binding constant for full-length CLK3	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892196	CHEMBL1060240	Binding constant for full-length CLK3	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892197	CHEMBL1060240	Binding constant for full-length CLK3	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892198	CHEMBL1060240	Binding constant for full-length CLK3	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892199	CHEMBL1060240	Binding constant for full-length CLK3	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892200	CHEMBL1060240	Binding constant for full-length CLK3	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892201	CHEMBL1060240	Binding constant for full-length CLK3	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892202	CHEMBL1060240	Binding constant for full-length CLK3	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892203	CHEMBL1060240	Binding constant for full-length CLK3	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892204	CHEMBL1060240	Binding constant for full-length CLK3	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892205	CHEMBL1060240	Binding constant for full-length CLK3	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892206	CHEMBL1060240	Binding constant for full-length CLK3	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892207	CHEMBL1060240	Binding constant for full-length CLK3	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	5600.0	CHEMBL4226	Homo sapiens	Kd	nM	5600.0
	2892208	CHEMBL1060240	Binding constant for full-length CLK3	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892209	CHEMBL1060240	Binding constant for full-length CLK3	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	1600.0	CHEMBL4226	Homo sapiens	Kd	nM	1600.0
	2892210	CHEMBL1060240	Binding constant for full-length CLK3	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892211	CHEMBL1060240	Binding constant for full-length CLK3	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892212	CHEMBL1060240	Binding constant for full-length CLK3	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892213	CHEMBL1060240	Binding constant for full-length CLK3	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892214	CHEMBL1060240	Binding constant for full-length CLK3	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	310.0	CHEMBL4226	Homo sapiens	Kd	nM	310.0
	2892215	CHEMBL1060240	Binding constant for full-length CLK3	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892216	CHEMBL1060240	Binding constant for full-length CLK3	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892217	CHEMBL1060240	Binding constant for full-length CLK3	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892218	CHEMBL1060240	Binding constant for full-length CLK3	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	2300.0	CHEMBL4226	Homo sapiens	Kd	nM	2300.0
	2892219	CHEMBL1060240	Binding constant for full-length CLK3	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892220	CHEMBL1060240	Binding constant for full-length CLK3	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892221	CHEMBL1060240	Binding constant for full-length CLK3	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892222	CHEMBL1060240	Binding constant for full-length CLK3	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892223	CHEMBL1060240	Binding constant for full-length CLK3	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892224	CHEMBL1060240	Binding constant for full-length CLK3	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892225	CHEMBL1060240	Binding constant for full-length CLK3	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892226	CHEMBL1060240	Binding constant for full-length CLK3	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892227	CHEMBL1060240	Binding constant for full-length CLK3	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	910.0	CHEMBL4226	Homo sapiens	Kd	nM	910.0
	2892228	CHEMBL1060240	Binding constant for full-length CLK3	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892229	CHEMBL1060240	Binding constant for full-length CLK3	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892230	CHEMBL1060240	Binding constant for full-length CLK3	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892231	CHEMBL1060240	Binding constant for full-length CLK3	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2892232	CHEMBL1060240	Binding constant for full-length CLK3	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	2921396	CHEMBL1052896	Inhibition of CLK3 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	94.0	CHEMBL4226	Homo sapiens	Activity	%	94.0
	2938518	CHEMBL1041347	Inhibition of CLK3 at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	9.0	CHEMBL4226	Homo sapiens	INH	%	9.0
	2995385	CHEMBL1039035	Binding affinity to Clk3 assessed as dissociation constant	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Kd	nM	3000.0	CHEMBL4226	Homo sapiens	Kd	nM	3000.0
	2996572	CHEMBL1039035	Binding affinity to Clk3 assessed as dissociation constant	B	c1csc(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)c1		CHEMBL567331	=	Kd	nM	470.0	CHEMBL4226	Homo sapiens	Kd	nM	470.0
	3203243	CHEMBL1103001	Inhibition of CLK3	B	Cn1cc(C2=C(c3cccc(NCC(O)CO)c3)C(=O)NC2=O)c2cc(F)ccc21		CHEMBL1082152	=	Kd	nM	310.0	CHEMBL4226	Homo sapiens	Kd	uM	0.31
	3213911	CHEMBL1114867	Inhibition of CLK3 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	4.0	CHEMBL4226	Homo sapiens	INH	%	4.0
	3224783	CHEMBL1102777	Inhibition of CLK3 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL4226	Homo sapiens	INH	%	50.0
	3225033	CHEMBL1102777	Inhibition of CLK3 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL4226	Homo sapiens	INH	%	50.0
	3331875	CHEMBL1168834	Inhibition of CLK3 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4226	Homo sapiens	INH	%	50.0
	3333290	CHEMBL1168834	Inhibition of CLK3 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4226	Homo sapiens	INH	%	50.0
	3334695	CHEMBL1168834	Inhibition of CLK3 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4226	Homo sapiens	INH	%	50.0
	3336115	CHEMBL1168834	Inhibition of CLK3 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL4226	Homo sapiens	INH	%	50.0
	3337482	CHEMBL1168834	Inhibition of CLK3 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL4226	Homo sapiens	INH	%	50.0
	3337730	CHEMBL1168834	Inhibition of CLK3 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL4226	Homo sapiens	INH	%	50.0
	3339062	CHEMBL1168834	Inhibition of CLK3 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL4226	Homo sapiens	INH	%	50.0
	3340364	CHEMBL1168834	Inhibition of CLK3 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL4226	Homo sapiens	INH	%	50.0
	3340643	CHEMBL1168834	Inhibition of CLK3 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL4226	Homo sapiens	INH	%	50.0
	3342059	CHEMBL1168834	Inhibition of CLK3 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4226	Homo sapiens	INH	%	50.0
	3358507	CHEMBL1174179	Inhibition of CLK3 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	70.0	CHEMBL4226	Homo sapiens	INH	%	70.0
	3358949	CHEMBL1174179	Inhibition of CLK3 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	94.0	CHEMBL4226	Homo sapiens	INH	%	94.0
	3443362	CHEMBL1244395	Inhibition of CLK3 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	9.0	CHEMBL4226	Homo sapiens	INH	%	9.0
	3443579	CHEMBL1244395	Inhibition of CLK3 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	4.0	CHEMBL4226	Homo sapiens	INH	%	4.0
	3444734	CHEMBL1244395	Inhibition of CLK3 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	8.0	CHEMBL4226	Homo sapiens	INH	%	8.0
	3445358	CHEMBL1244395	Inhibition of CLK3 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	5.0	CHEMBL4226	Homo sapiens	INH	%	5.0
	3445575	CHEMBL1244395	Inhibition of CLK3 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	13.0	CHEMBL4226	Homo sapiens	INH	%	13.0
	3448382	CHEMBL1244772	Binding affinity to CLK3	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	3448718	CHEMBL1244772	Binding affinity to CLK3	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	3449608	CHEMBL1244772	Binding affinity to CLK3	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	3449915	CHEMBL1244772	Binding affinity to CLK3	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	3450031	CHEMBL1244772	Binding affinity to CLK3	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	3450309	CHEMBL1244772	Binding affinity to CLK3	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	3450948	CHEMBL1244772	Binding affinity to CLK3	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	uM	10.0
	3463195	CHEMBL1252283	Inhibition of CLK3 at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	92.0	CHEMBL4226	Homo sapiens	INH	%	92.0
	3463414	CHEMBL1252283	Inhibition of CLK3 at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	32.0	CHEMBL4226	Homo sapiens	INH	%	32.0
	3463958	CHEMBL1252283	Inhibition of CLK3 at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	8.0	CHEMBL4226	Homo sapiens	INH	%	8.0
	5120293	CHEMBL1648374	Inhibition of human CLK3 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	96.0	CHEMBL4226	Homo sapiens	INH	%	96.0
	5190279	CHEMBL1663331	Inhibition of human recombinant CLK3 by radiometric assay	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	=	IC50	nM	41.0	CHEMBL4226	Homo sapiens	IC50	nM	41.0
Active	5650478	CHEMBL1738045	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 3 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1coc(CCNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)c1		CHEMBL1357975		Potency_Clk3_uM	uM	2.017	CHEMBL4226	Homo sapiens	Potency_Clk3_uM	uM	2.017
Active	5650479	CHEMBL1738045	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 3 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	CCN(Cc1cccs1)c1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1515144		Potency_Clk3_uM	uM	6.172	CHEMBL4226	Homo sapiens	Potency_Clk3_uM	uM	6.172
inactive	5650480	CHEMBL1738045	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 3 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1nc(N2CCOCC2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1714708		Potency_Clk3_uM	uM	50.0	CHEMBL4226	Homo sapiens	Potency_Clk3_uM	uM	50.0
Active	5650481	CHEMBL1738045	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 3 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1nc(NCC2CCCOC2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1734733		Potency_Clk3_uM	uM	5.461	CHEMBL4226	Homo sapiens	Potency_Clk3_uM	uM	5.461
Active	5650482	CHEMBL1738045	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 3 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	Cc1csc(CN(C)c2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)n1		CHEMBL1704879		Potency_Clk3_uM	uM	3.019	CHEMBL4226	Homo sapiens	Potency_Clk3_uM	uM	3.019
Active	5650483	CHEMBL1738045	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 3 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	CN(Cc1cccs1)c1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1591577		Potency_Clk3_uM	uM	4.949	CHEMBL4226	Homo sapiens	Potency_Clk3_uM	uM	4.949
Active	5650484	CHEMBL1738045	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 3 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1csc(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)n1		CHEMBL1705549		Potency_Clk3_uM	uM	3.527	CHEMBL4226	Homo sapiens	Potency_Clk3_uM	uM	3.527
Active	5650485	CHEMBL1738045	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 3 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	CCN(C)c1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1705397		Potency_Clk3_uM	uM	37.4	CHEMBL4226	Homo sapiens	Potency_Clk3_uM	uM	37.4
Active	5650486	CHEMBL1738045	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 3 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1coc(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)c1		CHEMBL1725513		Potency_Clk3_uM	uM	2.556	CHEMBL4226	Homo sapiens	Potency_Clk3_uM	uM	2.556
Active	5650487	CHEMBL1738045	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 3 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	CN(Cc1nccs1)c1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1396483		Potency_Clk3_uM	uM	4.655	CHEMBL4226	Homo sapiens	Potency_Clk3_uM	uM	4.655
Active	5650488	CHEMBL1738045	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 3 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	Cc1ccsc1CN(C)c1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1318637		Potency_Clk3_uM	uM	15.0	CHEMBL4226	Homo sapiens	Potency_Clk3_uM	uM	15.0
Active	5650489	CHEMBL1738045	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 3 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1nc(NCC2CCCO2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1552755		Potency_Clk3_uM	uM	3.294	CHEMBL4226	Homo sapiens	Potency_Clk3_uM	uM	3.294
Active	5650490	CHEMBL1738045	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 3 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1nc(NCc2ccoc2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL566900		Potency_Clk3_uM	uM	4.65	CHEMBL4226	Homo sapiens	Potency_Clk3_uM	uM	4.65
Active	5665570	CHEMBL1738045	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 3 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1nc(NC[C@@H]2CCCO2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1726934		Potency_Clk3_uM	uM	7.714	CHEMBL4226	Homo sapiens	Potency_Clk3_uM	uM	7.714
Active	5665571	CHEMBL1738045	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 3 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	Cc1occc1CNc1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1476499		Potency_Clk3_uM	uM	6.45	CHEMBL4226	Homo sapiens	Potency_Clk3_uM	uM	6.45
Active	5665572	CHEMBL1738045	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 3 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1nc(NCCc2c[nH]cn2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1515868		Potency_Clk3_uM	uM	12.44	CHEMBL4226	Homo sapiens	Potency_Clk3_uM	uM	12.44
Active	5665573	CHEMBL1738045	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 3 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	CC(Nc1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12)c1ccco1		CHEMBL1569869		Potency_Clk3_uM	uM	15.0	CHEMBL4226	Homo sapiens	Potency_Clk3_uM	uM	15.0
Active	5665574	CHEMBL1738045	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 3 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1nc(NCCc2c[nH]cn2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1515868		Potency_Clk3_uM	uM	12.44	CHEMBL4226	Homo sapiens	Potency_Clk3_uM	uM	12.44
Active	5665575	CHEMBL1738045	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 3 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	Fc1c(-c2ccc3ncnc(NCc4cccs4)c3c2)ccc2c1OCO2		CHEMBL1555138		Potency_Clk3_uM	uM	9.33	CHEMBL4226	Homo sapiens	Potency_Clk3_uM	uM	9.33
Active	5665576	CHEMBL1738045	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 3 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	Cc1ccsc1CNc1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1396654		Potency_Clk3_uM	uM	6.555	CHEMBL4226	Homo sapiens	Potency_Clk3_uM	uM	6.555
Active	5665577	CHEMBL1738045	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 3 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1nc(NCC2CC2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1700905		Potency_Clk3_uM	uM	3.132	CHEMBL4226	Homo sapiens	Potency_Clk3_uM	uM	3.132
Active	5665578	CHEMBL1738045	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 3 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1nc(NCC2CCCCC2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1730209		Potency_Clk3_uM	uM	5.304	CHEMBL4226	Homo sapiens	Potency_Clk3_uM	uM	5.304
Active	5665579	CHEMBL1738045	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 3 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1csc(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)c1		CHEMBL567331		Potency_Clk3_uM	uM	4.385	CHEMBL4226	Homo sapiens	Potency_Clk3_uM	uM	4.385
Active	5665580	CHEMBL1738045	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 3 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	NCCNc1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1519866		Potency_Clk3_uM	uM	15.0	CHEMBL4226	Homo sapiens	Potency_Clk3_uM	uM	15.0
Active	5665581	CHEMBL1738045	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 3 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1c[nH]c(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)n1		CHEMBL1407164		Potency_Clk3_uM	uM	15.0	CHEMBL4226	Homo sapiens	Potency_Clk3_uM	uM	15.0
Active	5665582	CHEMBL1738045	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 3 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1nc(NCC2CCCCO2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1712751		Potency_Clk3_uM	uM	6.566	CHEMBL4226	Homo sapiens	Potency_Clk3_uM	uM	6.566
	6176687	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	c1nc(NCC2CCCC2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1354134	=	IC50	nM	1320.0	CHEMBL4226	Homo sapiens	IC50	nM	1320.0
	6176701	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	Cc1nc(CN(C)c2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)cs1		CHEMBL1474834	=	IC50	nM	1924.0	CHEMBL4226	Homo sapiens	IC50	nM	1924.0
	6176702	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	c1coc(CCNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)c1		CHEMBL1357975	=	IC50	nM	2017.0	CHEMBL4226	Homo sapiens	IC50	nM	2017.0
	6176707	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	c1coc(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)c1		CHEMBL1725513	=	IC50	nM	2556.0	CHEMBL4226	Homo sapiens	IC50	nM	2556.0
	6176709	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	Cc1csc(CN(C)c2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)n1		CHEMBL1704879	=	IC50	nM	3019.0	CHEMBL4226	Homo sapiens	IC50	nM	3019.0
	6176712	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	c1nc(NCC2CCCO2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1552755	=	IC50	nM	3294.0	CHEMBL4226	Homo sapiens	IC50	nM	3294.0
	6176715	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	c1csc(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)n1		CHEMBL1705549	=	IC50	nM	3527.0	CHEMBL4226	Homo sapiens	IC50	nM	3527.0
	6176718	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	c1nc(NCC2CCOC2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1436585	=	IC50	nM	3642.0	CHEMBL4226	Homo sapiens	IC50	nM	3642.0
	6176725	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	c1nc(NCc2ccoc2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL566900	=	IC50	nM	4650.0	CHEMBL4226	Homo sapiens	IC50	nM	4650.0
	6176726	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	CN(Cc1nccs1)c1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1396483	=	IC50	nM	4655.0	CHEMBL4226	Homo sapiens	IC50	nM	4655.0
	6176729	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	CN(Cc1cccs1)c1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1591577	=	IC50	nM	4949.0	CHEMBL4226	Homo sapiens	IC50	nM	4949.0
	6176730	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	c1nc(NCC2CCCOC2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1734733	=	IC50	nM	5461.0	CHEMBL4226	Homo sapiens	IC50	nM	5461.0
	6176733	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	CCN(Cc1cccs1)c1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1515144	=	IC50	nM	6172.0	CHEMBL4226	Homo sapiens	IC50	nM	6172.0
	6176735	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	Cc1occc1CNc1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1476499	=	IC50	nM	6450.0	CHEMBL4226	Homo sapiens	IC50	nM	6450.0
	6176736	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	Cc1ccsc1CNc1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1396654	=	IC50	nM	6555.0	CHEMBL4226	Homo sapiens	IC50	nM	6555.0
	6176737	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	c1csc(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)c1		CHEMBL567331	=	IC50	nM	6936.0	CHEMBL4226	Homo sapiens	IC50	nM	6936.0
	6176738	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	Cc1nc(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)cs1		CHEMBL1435542	=	IC50	nM	7448.0	CHEMBL4226	Homo sapiens	IC50	nM	7448.0
	6176744	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	CN(Cc1ccco1)c1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1374544	=	IC50	nM	8744.0	CHEMBL4226	Homo sapiens	IC50	nM	8744.0
	6176761	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	Cc1ccc(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)s1		CHEMBL1599314	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	nM	10000.0
	6176763	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	Cc1ccsc1CN(C)c1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1318637	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	nM	10000.0
	6176764	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	Cc1ccc(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)o1		CHEMBL1473127	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	nM	10000.0
	6176765	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	c1c[nH]c(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)n1		CHEMBL1407164	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	nM	10000.0
	6176766	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	CN(Cc1ncc[nH]1)c1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1397614	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	nM	10000.0
	6176767	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	c1nc(NCCc2c[nH]cn2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1515868	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	nM	10000.0
	6176768	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	Cc1nnc(CN(C)c2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)o1		CHEMBL1437638	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	nM	10000.0
	6176769	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	Cc1ccsc1CN(C)c1ncnc2ccc(-c3ccoc3)cc12		CHEMBL1612677	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	nM	10000.0
	6176770	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	Cc1ccsc1CN(C)c1ncnc2ccc(-c3ccc(CO)o3)cc12		CHEMBL1476609	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	nM	10000.0
	6176771	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	CCOC(=O)c1ccc(-c2ccc3ncnc(NCc4cccs4)c3c2)o1		CHEMBL1535925	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	nM	10000.0
	6176772	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	CCNCc1ccc(-c2ccc3ncnc(NCC(C)(C)C)c3c2)o1		CHEMBL1770624	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	nM	10000.0
	6176774	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	Cc1ccc(CNc2ncnc3ccc(-c4ccc(CO)o4)cc23)o1		CHEMBL1604618	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	nM	10000.0
	6176775	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	CCOC(=O)c1ccc(-c2ccc3ncnc(NCc4ccc(C)o4)c3c2)o1		CHEMBL1329627	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	nM	10000.0
	6176777	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	Cc1ccc(CNc2ncnc3ccc(-c4ccc(C(=O)O)o4)cc23)o1		CHEMBL1724489	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	nM	10000.0
	6183806	CHEMBL1772036	Inhibition of Clk3 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	CC(C)(C)CNc1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1551169	=	IC50	nM	435.0	CHEMBL4226	Homo sapiens	IC50	nM	435.0
Active	6268873	CHEMBL1805392	Inhibition of CLK3-mediated SRp55 protein phosphorylation in TNFalpha-stimulated human HMEC1 cells after 1 hr by Western blot analysis	B	O=C1NC(Nc2ccccc2)=N/C1=C\c1ccc2c(c1)OCO2		CHEMBL1802358		Inhibition	%		CHEMBL4226	Homo sapiens	INH		
Active	6268877	CHEMBL1805396	Inhibition of CLK3-mediated SRp75 protein phosphorylation in TNFalpha-stimulated human HMEC1 cells after 1 hr by Western blot analysis	B	O=C1NC(Nc2ccccc2)=N/C1=C\c1ccc2c(c1)OCO2		CHEMBL1802358		Inhibition	%		CHEMBL4226	Homo sapiens	INH		
	6339937	CHEMBL1826620	Activity of CLK3 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	77.0	CHEMBL4226	Homo sapiens	Activity	%	77.0
	7567329	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7567788	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7568285	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7568717	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7569302	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7569762	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7569792	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7570255	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	3600.0	CHEMBL4226	Homo sapiens	Kd	nM	3600.0
	7570682	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7571278	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	630.0	CHEMBL4226	Homo sapiens	Kd	nM	630.0
	7571769	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7572232	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Kd	nM	5900.0	CHEMBL4226	Homo sapiens	Kd	nM	5900.0
	7572648	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	210.0	CHEMBL4226	Homo sapiens	Kd	nM	210.0
	7573274	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7573750	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7574219	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	3600.0	CHEMBL4226	Homo sapiens	Kd	nM	3600.0
	7574627	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	Kd	nM	7100.0	CHEMBL4226	Homo sapiens	Kd	nM	7100.0
	7574795	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7575256	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7575727	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7576192	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7576600	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7576769	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7577228	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7577706	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	6200.0	CHEMBL4226	Homo sapiens	Kd	nM	6200.0
	7578176	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7578581	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7578777	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	160.0	CHEMBL4226	Homo sapiens	Kd	nM	160.0
	7579151	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7579601	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	1600.0	CHEMBL4226	Homo sapiens	Kd	nM	1600.0
	7580075	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7581135	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7581520	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7581965	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7582436	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7582458	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7582858	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7583481	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7583878	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7584323	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7584814	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	1900.0	CHEMBL4226	Homo sapiens	Kd	nM	1900.0
	7585218	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7585811	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7586219	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7586694	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7587148	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	=	Kd	nM	13.0	CHEMBL4226	Homo sapiens	Kd	nM	13.0
	7587772	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7588202	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7588673	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7589124	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7589719	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7590186	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7590660	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	6600.0	CHEMBL4226	Homo sapiens	Kd	nM	6600.0
	7591111	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7591268	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7591690	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7592162	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7592635	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	2300.0	CHEMBL4226	Homo sapiens	Kd	nM	2300.0
	7593088	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	300.0	CHEMBL4226	Homo sapiens	Kd	nM	300.0
	7593235	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	5500.0	CHEMBL4226	Homo sapiens	Kd	nM	5500.0
	7593670	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7594142	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7594615	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7595067	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7595203	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	=	Kd	nM	370.0	CHEMBL4226	Homo sapiens	Kd	nM	370.0
	7595647	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7596121	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7596592	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7597175	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7597628	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7598101	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL4226	Homo sapiens	Kd	nM	10000.0
	7598571	CHEMBL1908628	Binding constant for CLK3 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	910.0	CHEMBL4226	Homo sapiens	Kd	nM	910.0
	8046124	CHEMBL1958833	Inhibition of CLK3 at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	=	Inhibition	%	89.0	CHEMBL4226	Homo sapiens	INH	%	89.0
	8061298	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	0.63	CHEMBL4226	Homo sapiens	Inhibition	%	0.63
	8061475	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	9.8	CHEMBL4226	Homo sapiens	Inhibition	%	9.8
	8061806	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	0.59	CHEMBL4226	Homo sapiens	Inhibition	%	0.59
	8061997	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	0.62	CHEMBL4226	Homo sapiens	Inhibition	%	0.62
	8062337	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.0	CHEMBL4226	Homo sapiens	Inhibition	%	1.0
	8062499	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	3.67	CHEMBL4226	Homo sapiens	Inhibition	%	3.67
	8062723	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	0.91	CHEMBL4226	Homo sapiens	Inhibition	%	0.91
	8062821	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.52	CHEMBL4226	Homo sapiens	Inhibition	%	0.52
	8063177	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	3.14	CHEMBL4226	Homo sapiens	Inhibition	%	3.14
	8063344	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.77	CHEMBL4226	Homo sapiens	Inhibition	%	1.77
	8063568	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	0.49	CHEMBL4226	Homo sapiens	Inhibition	%	0.49
	8063676	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	-1.49	CHEMBL4226	Homo sapiens	Inhibition	%	-1.49
	8063858	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	-1.26	CHEMBL4226	Homo sapiens	Inhibition	%	-1.26
	8064082	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	0.73	CHEMBL4226	Homo sapiens	Inhibition	%	0.73
	8064197	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	7.43	CHEMBL4226	Homo sapiens	Inhibition	%	7.43
	8064407	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-0.16	CHEMBL4226	Homo sapiens	Inhibition	%	-0.16
	8064631	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.69	CHEMBL4226	Homo sapiens	Inhibition	%	0.69
	8064769	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	2.0	CHEMBL4226	Homo sapiens	Inhibition	%	2.0
	8065159	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.83	CHEMBL4226	Homo sapiens	Inhibition	%	0.83
	8065275	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.76	CHEMBL4226	Homo sapiens	Inhibition	%	1.76
	8065674	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	0.79	CHEMBL4226	Homo sapiens	Inhibition	%	0.79
	8065789	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	0.38	CHEMBL4226	Homo sapiens	Inhibition	%	0.38
	8066013	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	0.75	CHEMBL4226	Homo sapiens	Inhibition	%	0.75
	8066223	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-0.31	CHEMBL4226	Homo sapiens	Inhibition	%	-0.31
	8066359	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	5.65	CHEMBL4226	Homo sapiens	Inhibition	%	5.65
	8066749	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	2.15	CHEMBL4226	Homo sapiens	Inhibition	%	2.15
	8066873	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.73	CHEMBL4226	Homo sapiens	Inhibition	%	1.73
	8067097	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.74	CHEMBL4226	Homo sapiens	Inhibition	%	1.74
	8067272	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.87	CHEMBL4226	Homo sapiens	Inhibition	%	0.87
	8067617	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.63	CHEMBL4226	Homo sapiens	Inhibition	%	0.63
	8067827	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.23	CHEMBL4226	Homo sapiens	Inhibition	%	2.23
	8067962	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	36.45	CHEMBL4226	Homo sapiens	Inhibition	%	36.45
	8068186	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	77.27	CHEMBL4226	Homo sapiens	Inhibition	%	77.27
	8068350	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.7	CHEMBL4226	Homo sapiens	Inhibition	%	1.7
	8068699	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.44	CHEMBL4226	Homo sapiens	Inhibition	%	0.44
	8068873	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.84	CHEMBL4226	Homo sapiens	Inhibition	%	0.84
	8069222	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.88	CHEMBL4226	Homo sapiens	Inhibition	%	0.88
	8069517	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	8.39	CHEMBL4226	Homo sapiens	Inhibition	%	8.39
	8069678	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.97	CHEMBL4226	Homo sapiens	Inhibition	%	1.97
	8070028	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.61	CHEMBL4226	Homo sapiens	Inhibition	%	0.61
	8070200	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.91	CHEMBL4226	Homo sapiens	Inhibition	%	0.91
	8070424	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.67	CHEMBL4226	Homo sapiens	Inhibition	%	0.67
	8070549	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.15	CHEMBL4226	Homo sapiens	Inhibition	%	0.15
	8070847	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	42.45	CHEMBL4226	Homo sapiens	Inhibition	%	42.45
	8071004	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	0.9	CHEMBL4226	Homo sapiens	Inhibition	%	0.9
	8071228	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	0.83	CHEMBL4226	Homo sapiens	Inhibition	%	0.83
	8071354	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.37	CHEMBL4226	Homo sapiens	Inhibition	%	0.37
	8071751	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	0.97	CHEMBL4226	Homo sapiens	Inhibition	%	0.97
	8071876	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.76	CHEMBL4226	Homo sapiens	Inhibition	%	0.76
	8072100	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.06	CHEMBL4226	Homo sapiens	Inhibition	%	0.06
	8072190	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.93	CHEMBL4226	Homo sapiens	Inhibition	%	-0.93
	8072571	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.37	CHEMBL4226	Homo sapiens	Inhibition	%	1.37
	8072696	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-3.14	CHEMBL4226	Homo sapiens	Inhibition	%	-3.14
	8072920	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.46	CHEMBL4226	Homo sapiens	Inhibition	%	0.46
	8073087	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.72	CHEMBL4226	Homo sapiens	Inhibition	%	2.72
	8073436	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.05	CHEMBL4226	Homo sapiens	Inhibition	%	0.05
	8073555	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-1.33	CHEMBL4226	Homo sapiens	Inhibition	%	-1.33
	8073788	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.16	CHEMBL4226	Homo sapiens	Inhibition	%	0.16
	8074012	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-1.6	CHEMBL4226	Homo sapiens	Inhibition	%	-1.6
	8074164	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	2.0	CHEMBL4226	Homo sapiens	Inhibition	%	2.0
	8074518	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.45	CHEMBL4226	Homo sapiens	Inhibition	%	0.45
	8074675	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.44	CHEMBL4226	Homo sapiens	Inhibition	%	1.44
	8075026	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-0.15	CHEMBL4226	Homo sapiens	Inhibition	%	-0.15
	8075137	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-0.91	CHEMBL4226	Homo sapiens	Inhibition	%	-0.91
	8075361	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-1.43	CHEMBL4226	Homo sapiens	Inhibition	%	-1.43
	8075598	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.53	CHEMBL4226	Homo sapiens	Inhibition	%	0.53
	8075739	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.12	CHEMBL4226	Homo sapiens	Inhibition	%	1.12
	8076105	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.05	CHEMBL4226	Homo sapiens	Inhibition	%	-0.05
	8076253	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.79	CHEMBL4226	Homo sapiens	Inhibition	%	1.79
	8076477	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	0.57	CHEMBL4226	Homo sapiens	Inhibition	%	0.57
	8076611	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	1.89	CHEMBL4226	Homo sapiens	Inhibition	%	1.89
	8076937	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.51	CHEMBL4226	Homo sapiens	Inhibition	%	0.51
	8077184	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-1.43	CHEMBL4226	Homo sapiens	Inhibition	%	-1.43
	8077312	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.4	CHEMBL4226	Homo sapiens	Inhibition	%	2.4
	8077536	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	0.91	CHEMBL4226	Homo sapiens	Inhibition	%	0.91
	8077687	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.85	CHEMBL4226	Homo sapiens	Inhibition	%	0.85
	8078054	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	3.27	CHEMBL4226	Homo sapiens	Inhibition	%	3.27
	8078193	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-0.37	CHEMBL4226	Homo sapiens	Inhibition	%	-0.37
	8078519	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.6	CHEMBL4226	Homo sapiens	Inhibition	%	-0.6
	8078769	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	1.71	CHEMBL4226	Homo sapiens	Inhibition	%	1.71
	8079109	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.62	CHEMBL4226	Homo sapiens	Inhibition	%	1.62
	8079267	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.13	CHEMBL4226	Homo sapiens	Inhibition	%	0.13
	8079633	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.9	CHEMBL4226	Homo sapiens	Inhibition	%	0.9
	8079772	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	2.65	CHEMBL4226	Homo sapiens	Inhibition	%	2.65
	8079996	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	3.2	CHEMBL4226	Homo sapiens	Inhibition	%	3.2
	8080101	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.22	CHEMBL4226	Homo sapiens	Inhibition	%	0.22
	8080353	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-0.32	CHEMBL4226	Homo sapiens	Inhibition	%	-0.32
	8080692	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.35	CHEMBL4226	Homo sapiens	Inhibition	%	0.35
	8080856	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	1.12	CHEMBL4226	Homo sapiens	Inhibition	%	1.12
	8081080	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.13	CHEMBL4226	Homo sapiens	Inhibition	%	-0.13
	8081215	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	11.18	CHEMBL4226	Homo sapiens	Inhibition	%	11.18
	8081583	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	21.98	CHEMBL4226	Homo sapiens	Inhibition	%	21.98
	8081686	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	-0.5	CHEMBL4226	Homo sapiens	Inhibition	%	-0.5
	8081910	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	5.01	CHEMBL4226	Homo sapiens	Inhibition	%	5.01
	8081938	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	11.37	CHEMBL4226	Homo sapiens	Inhibition	%	11.37
	8082162	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-0.8	CHEMBL4226	Homo sapiens	Inhibition	%	-0.8
	8082275	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.64	CHEMBL4226	Homo sapiens	Inhibition	%	1.64
	8082672	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.14	CHEMBL4226	Homo sapiens	Inhibition	%	1.14
	8082795	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.37	CHEMBL4226	Homo sapiens	Inhibition	%	1.37
	8083175	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	1.77	CHEMBL4226	Homo sapiens	Inhibition	%	1.77
	8083498	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-0.87	CHEMBL4226	Homo sapiens	Inhibition	%	-0.87
	8083752	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	2.98	CHEMBL4226	Homo sapiens	Inhibition	%	2.98
	8083862	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	0.99	CHEMBL4226	Homo sapiens	Inhibition	%	0.99
	8084086	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.25	CHEMBL4226	Homo sapiens	Inhibition	%	1.25
	8084271	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	2.36	CHEMBL4226	Homo sapiens	Inhibition	%	2.36
	8084389	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.28	CHEMBL4226	Homo sapiens	Inhibition	%	1.28
	8084613	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.92	CHEMBL4226	Homo sapiens	Inhibition	%	0.92
	8084774	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	8.02	CHEMBL4226	Homo sapiens	Inhibition	%	8.02
	8085096	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.41	CHEMBL4226	Homo sapiens	Inhibition	%	0.41
	8085352	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	0.25	CHEMBL4226	Homo sapiens	Inhibition	%	0.25
	8085684	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	0.75	CHEMBL4226	Homo sapiens	Inhibition	%	0.75
	8085873	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	14.99	CHEMBL4226	Homo sapiens	Inhibition	%	14.99
	8086212	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	1.41	CHEMBL4226	Homo sapiens	Inhibition	%	1.41
	8086374	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	-1.53	CHEMBL4226	Homo sapiens	Inhibition	%	-1.53
	8086697	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-0.93	CHEMBL4226	Homo sapiens	Inhibition	%	-0.93
	8086908	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	-3.56	CHEMBL4226	Homo sapiens	Inhibition	%	-3.56
	8087290	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.16	CHEMBL4226	Homo sapiens	Inhibition	%	0.16
	8087628	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	1.23	CHEMBL4226	Homo sapiens	Inhibition	%	1.23
	8087766	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	0.78	CHEMBL4226	Homo sapiens	Inhibition	%	0.78
	8088132	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	1.12	CHEMBL4226	Homo sapiens	Inhibition	%	1.12
	8088280	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.2	CHEMBL4226	Homo sapiens	Inhibition	%	0.2
	8088632	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	0.71	CHEMBL4226	Homo sapiens	Inhibition	%	0.71
	8088949	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.22	CHEMBL4226	Homo sapiens	Inhibition	%	2.22
	8089077	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.11	CHEMBL4226	Homo sapiens	Inhibition	%	0.11
	8089301	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	1.7	CHEMBL4226	Homo sapiens	Inhibition	%	1.7
	8089449	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	-6.71	CHEMBL4226	Homo sapiens	Inhibition	%	-6.71
	8089793	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.66	CHEMBL4226	Homo sapiens	Inhibition	%	0.66
	8089973	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.23	CHEMBL4226	Homo sapiens	Inhibition	%	0.23
	8090138	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	0.88	CHEMBL4226	Homo sapiens	Inhibition	%	0.88
	8090362	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.39	CHEMBL4226	Homo sapiens	Inhibition	%	1.39
	8090529	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	0.04	CHEMBL4226	Homo sapiens	Inhibition	%	0.04
	8090892	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	0.59	CHEMBL4226	Homo sapiens	Inhibition	%	0.59
	8091097	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	0.41	CHEMBL4226	Homo sapiens	Inhibition	%	0.41
	8091234	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	-3.4	CHEMBL4226	Homo sapiens	Inhibition	%	-3.4
	8091458	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	-0.17	CHEMBL4226	Homo sapiens	Inhibition	%	-0.17
	8091613	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	-0.21	CHEMBL4226	Homo sapiens	Inhibition	%	-0.21
	8091953	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	0.51	CHEMBL4226	Homo sapiens	Inhibition	%	0.51
	8092090	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-3.78	CHEMBL4226	Homo sapiens	Inhibition	%	-3.78
	8092314	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-4.71	CHEMBL4226	Homo sapiens	Inhibition	%	-4.71
	8092465	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	2.21	CHEMBL4226	Homo sapiens	Inhibition	%	2.21
	8092613	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-0.57	CHEMBL4226	Homo sapiens	Inhibition	%	-0.57
	8092837	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.66	CHEMBL4226	Homo sapiens	Inhibition	%	0.66
	8092966	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	2.08	CHEMBL4226	Homo sapiens	Inhibition	%	2.08
	8093278	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.35	CHEMBL4226	Homo sapiens	Inhibition	%	0.35
	8093642	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-0.31	CHEMBL4226	Homo sapiens	Inhibition	%	-0.31
	8093781	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	1.83	CHEMBL4226	Homo sapiens	Inhibition	%	1.83
	8094125	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	8.78	CHEMBL4226	Homo sapiens	Inhibition	%	8.78
	8094305	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.27	CHEMBL4226	Homo sapiens	Inhibition	%	0.27
	8094704	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	1.64	CHEMBL4226	Homo sapiens	Inhibition	%	1.64
	8094860	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	1.74	CHEMBL4226	Homo sapiens	Inhibition	%	1.74
	8095224	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	1.99	CHEMBL4226	Homo sapiens	Inhibition	%	1.99
	8095427	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	0.48	CHEMBL4226	Homo sapiens	Inhibition	%	0.48
	8095792	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	6.97	CHEMBL4226	Homo sapiens	Inhibition	%	6.97
	8095940	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	1.15	CHEMBL4226	Homo sapiens	Inhibition	%	1.15
	8096281	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	0.94	CHEMBL4226	Homo sapiens	Inhibition	%	0.94
	8096644	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.43	CHEMBL4226	Homo sapiens	Inhibition	%	0.43
	8096800	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	0.02	CHEMBL4226	Homo sapiens	Inhibition	%	0.02
	8097171	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-0.15	CHEMBL4226	Homo sapiens	Inhibition	%	-0.15
	8097478	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.7	CHEMBL4226	Homo sapiens	Inhibition	%	0.7
	8097852	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	0.8	CHEMBL4226	Homo sapiens	Inhibition	%	0.8
	8097985	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-3.22	CHEMBL4226	Homo sapiens	Inhibition	%	-3.22
	8098209	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.74	CHEMBL4226	Homo sapiens	Inhibition	%	0.74
	8098329	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.79	CHEMBL4226	Homo sapiens	Inhibition	%	-0.79
	8098509	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.08	CHEMBL4226	Homo sapiens	Inhibition	%	0.08
	8098733	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-0.79	CHEMBL4226	Homo sapiens	Inhibition	%	-0.79
	8098918	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	13.24	CHEMBL4226	Homo sapiens	Inhibition	%	13.24
	8099062	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	-0.2	CHEMBL4226	Homo sapiens	Inhibition	%	-0.2
	8099286	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	0.66	CHEMBL4226	Homo sapiens	Inhibition	%	0.66
	8099428	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	0.94	CHEMBL4226	Homo sapiens	Inhibition	%	0.94
	8099622	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-0.22	CHEMBL4226	Homo sapiens	Inhibition	%	-0.22
	8099846	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-0.84	CHEMBL4226	Homo sapiens	Inhibition	%	-0.84
	8099993	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	1.22	CHEMBL4226	Homo sapiens	Inhibition	%	1.22
	8100139	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	0.4	CHEMBL4226	Homo sapiens	Inhibition	%	0.4
	8100363	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-3.12	CHEMBL4226	Homo sapiens	Inhibition	%	-3.12
	8100479	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	1.46	CHEMBL4226	Homo sapiens	Inhibition	%	1.46
	8100843	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-0.64	CHEMBL4226	Homo sapiens	Inhibition	%	-0.64
	8101003	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.01	CHEMBL4226	Homo sapiens	Inhibition	%	2.01
	8101227	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	0.61	CHEMBL4226	Homo sapiens	Inhibition	%	0.61
	8101369	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	0.69	CHEMBL4226	Homo sapiens	Inhibition	%	0.69
	8101554	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-2.29	CHEMBL4226	Homo sapiens	Inhibition	%	-2.29
	8101778	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-2.47	CHEMBL4226	Homo sapiens	Inhibition	%	-2.47
	8101807	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	2.11	CHEMBL4226	Homo sapiens	Inhibition	%	2.11
	8102031	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	14.01	CHEMBL4226	Homo sapiens	Inhibition	%	14.01
	8102186	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	0.15	CHEMBL4226	Homo sapiens	Inhibition	%	0.15
	8102541	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	0.64	CHEMBL4226	Homo sapiens	Inhibition	%	0.64
	8102661	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.91	CHEMBL4226	Homo sapiens	Inhibition	%	-0.91
	8103063	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-0.29	CHEMBL4226	Homo sapiens	Inhibition	%	-0.29
	8103259	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	1.29	CHEMBL4226	Homo sapiens	Inhibition	%	1.29
	8103621	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	-0.43	CHEMBL4226	Homo sapiens	Inhibition	%	-0.43
	8103771	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.08	CHEMBL4226	Homo sapiens	Inhibition	%	1.08
	8104180	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.01	CHEMBL4226	Homo sapiens	Inhibition	%	0.01
	8104328	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	1.46	CHEMBL4226	Homo sapiens	Inhibition	%	1.46
	8104698	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	1.68	CHEMBL4226	Homo sapiens	Inhibition	%	1.68
	8104812	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	0.28	CHEMBL4226	Homo sapiens	Inhibition	%	0.28
	8105036	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	-0.16	CHEMBL4226	Homo sapiens	Inhibition	%	-0.16
	8105176	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.68	CHEMBL4226	Homo sapiens	Inhibition	%	0.68
	8105566	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-2.76	CHEMBL4226	Homo sapiens	Inhibition	%	-2.76
	8105704	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	0.88	CHEMBL4226	Homo sapiens	Inhibition	%	0.88
	8105984	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	-0.12	CHEMBL4226	Homo sapiens	Inhibition	%	-0.12
	8106373	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-2.82	CHEMBL4226	Homo sapiens	Inhibition	%	-2.82
	8106529	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	8.54	CHEMBL4226	Homo sapiens	Inhibition	%	8.54
	8106882	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	8.6	CHEMBL4226	Homo sapiens	Inhibition	%	8.6
	8107003	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.94	CHEMBL4226	Homo sapiens	Inhibition	%	-0.94
	8107227	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-1.48	CHEMBL4226	Homo sapiens	Inhibition	%	-1.48
	8107399	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	-0.27	CHEMBL4226	Homo sapiens	Inhibition	%	-0.27
	8107600	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	0.92	CHEMBL4226	Homo sapiens	Inhibition	%	0.92
	8107959	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	2.19	CHEMBL4226	Homo sapiens	Inhibition	%	2.19
	8108117	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	0.24	CHEMBL4226	Homo sapiens	Inhibition	%	0.24
	8108341	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	-0.08	CHEMBL4226	Homo sapiens	Inhibition	%	-0.08
	8108516	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-1.09	CHEMBL4226	Homo sapiens	Inhibition	%	-1.09
	8108663	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	1.64	CHEMBL4226	Homo sapiens	Inhibition	%	1.64
	8108887	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	2.9	CHEMBL4226	Homo sapiens	Inhibition	%	2.9
	8109029	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.11	CHEMBL4226	Homo sapiens	Inhibition	%	0.11
	8109367	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	1.88	CHEMBL4226	Homo sapiens	Inhibition	%	1.88
	8109497	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.05	CHEMBL4226	Homo sapiens	Inhibition	%	0.05
	8109721	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.18	CHEMBL4226	Homo sapiens	Inhibition	%	0.18
	8109892	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-2.38	CHEMBL4226	Homo sapiens	Inhibition	%	-2.38
	8110024	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	0.59	CHEMBL4226	Homo sapiens	Inhibition	%	0.59
	8110248	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	1.09	CHEMBL4226	Homo sapiens	Inhibition	%	1.09
	8110303	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	0.73	CHEMBL4226	Homo sapiens	Inhibition	%	0.73
	8110527	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	0.94	CHEMBL4226	Homo sapiens	Inhibition	%	0.94
	8110693	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-2.17	CHEMBL4226	Homo sapiens	Inhibition	%	-2.17
	8110851	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-0.24	CHEMBL4226	Homo sapiens	Inhibition	%	-0.24
	8111075	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-1.34	CHEMBL4226	Homo sapiens	Inhibition	%	-1.34
	8111198	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.3	CHEMBL4226	Homo sapiens	Inhibition	%	0.3
	8111549	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.26	CHEMBL4226	Homo sapiens	Inhibition	%	0.26
	8111715	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	-0.53	CHEMBL4226	Homo sapiens	Inhibition	%	-0.53
	8111920	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	1.1	CHEMBL4226	Homo sapiens	Inhibition	%	1.1
	8112144	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	0.79	CHEMBL4226	Homo sapiens	Inhibition	%	0.79
	8112281	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-1.02	CHEMBL4226	Homo sapiens	Inhibition	%	-1.02
	8112673	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	1.16	CHEMBL4226	Homo sapiens	Inhibition	%	1.16
	8112845	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.17	CHEMBL4226	Homo sapiens	Inhibition	%	-0.17
	8113221	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	-0.84	CHEMBL4226	Homo sapiens	Inhibition	%	-0.84
	8113357	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.14	CHEMBL4226	Homo sapiens	Inhibition	%	0.14
	8113705	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	0.94	CHEMBL4226	Homo sapiens	Inhibition	%	0.94
	8114045	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.49	CHEMBL4226	Homo sapiens	Inhibition	%	0.49
	8114221	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	1.09	CHEMBL4226	Homo sapiens	Inhibition	%	1.09
	8114577	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	0.59	CHEMBL4226	Homo sapiens	Inhibition	%	0.59
	8114853	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.19	CHEMBL4226	Homo sapiens	Inhibition	%	1.19
	8115019	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	-0.08	CHEMBL4226	Homo sapiens	Inhibition	%	-0.08
	8115408	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.78	CHEMBL4226	Homo sapiens	Inhibition	%	-0.78
	8115528	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.82	CHEMBL4226	Homo sapiens	Inhibition	%	0.82
	8115885	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-0.53	CHEMBL4226	Homo sapiens	Inhibition	%	-0.53
	8116044	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-0.48	CHEMBL4226	Homo sapiens	Inhibition	%	-0.48
	8116268	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	9.15	CHEMBL4226	Homo sapiens	Inhibition	%	9.15
	8116471	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	0.62	CHEMBL4226	Homo sapiens	Inhibition	%	0.62
	8116605	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-2.35	CHEMBL4226	Homo sapiens	Inhibition	%	-2.35
	8116829	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.29	CHEMBL4226	Homo sapiens	Inhibition	%	-0.29
	8117001	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	0.34	CHEMBL4226	Homo sapiens	Inhibition	%	0.34
	8117172	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.94	CHEMBL4226	Homo sapiens	Inhibition	%	-0.94
	8117554	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	0.43	CHEMBL4226	Homo sapiens	Inhibition	%	0.43
	8117684	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.36	CHEMBL4226	Homo sapiens	Inhibition	%	0.36
	8117908	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-0.47	CHEMBL4226	Homo sapiens	Inhibition	%	-0.47
	8118046	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-3.62	CHEMBL4226	Homo sapiens	Inhibition	%	-3.62
	8118386	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	0.71	CHEMBL4226	Homo sapiens	Inhibition	%	0.71
	8118558	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	1.18	CHEMBL4226	Homo sapiens	Inhibition	%	1.18
	8118918	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	0.86	CHEMBL4226	Homo sapiens	Inhibition	%	0.86
	8119189	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.76	CHEMBL4226	Homo sapiens	Inhibition	%	1.76
	8119348	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	2.26	CHEMBL4226	Homo sapiens	Inhibition	%	2.26
	8119572	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O	Outside typical range	CHEMBL1789961	=	Inhibition	%	-13.42	CHEMBL4226	Homo sapiens	Inhibition	%	-13.42
	8119739	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.85	CHEMBL4226	Homo sapiens	Inhibition	%	-0.85
	8119858	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	-0.05	CHEMBL4226	Homo sapiens	Inhibition	%	-0.05
	8120082	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	0.43	CHEMBL4226	Homo sapiens	Inhibition	%	0.43
	8120221	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.41	CHEMBL4226	Homo sapiens	Inhibition	%	1.41
	8120605	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.96	CHEMBL4226	Homo sapiens	Inhibition	%	-0.96
	8120806	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	0.2	CHEMBL4226	Homo sapiens	Inhibition	%	0.2
	8121158	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.08	CHEMBL4226	Homo sapiens	Inhibition	%	-0.08
	8121330	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	0.27	CHEMBL4226	Homo sapiens	Inhibition	%	0.27
	8121497	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.97	CHEMBL4226	Homo sapiens	Inhibition	%	0.97
	8121721	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	1.36	CHEMBL4226	Homo sapiens	Inhibition	%	1.36
	8121884	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	0.83	CHEMBL4226	Homo sapiens	Inhibition	%	0.83
	8122229	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	0.74	CHEMBL4226	Homo sapiens	Inhibition	%	0.74
	8122367	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-3.79	CHEMBL4226	Homo sapiens	Inhibition	%	-3.79
	8122711	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	0.31	CHEMBL4226	Homo sapiens	Inhibition	%	0.31
	8122878	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	1.25	CHEMBL4226	Homo sapiens	Inhibition	%	1.25
	8123102	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	2.22	CHEMBL4226	Homo sapiens	Inhibition	%	2.22
	8123244	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	-2.62	CHEMBL4226	Homo sapiens	Inhibition	%	-2.62
	8123522	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	13.17	CHEMBL4226	Homo sapiens	Inhibition	%	13.17
	8123896	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	9.46	CHEMBL4226	Homo sapiens	Inhibition	%	9.46
	8124063	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-3.93	CHEMBL4226	Homo sapiens	Inhibition	%	-3.93
	8124406	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	23.22	CHEMBL4226	Homo sapiens	Inhibition	%	23.22
	8124545	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.07	CHEMBL4226	Homo sapiens	Inhibition	%	0.07
	8124769	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	-0.26	CHEMBL4226	Homo sapiens	Inhibition	%	-0.26
	8124934	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.49	CHEMBL4226	Homo sapiens	Inhibition	%	-0.49
	8125135	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	0.96	CHEMBL4226	Homo sapiens	Inhibition	%	0.96
	8125489	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.24	CHEMBL4226	Homo sapiens	Inhibition	%	0.24
	8125657	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	0.23	CHEMBL4226	Homo sapiens	Inhibition	%	0.23
	8126045	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	1.25	CHEMBL4226	Homo sapiens	Inhibition	%	1.25
	8126209	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	0.92	CHEMBL4226	Homo sapiens	Inhibition	%	0.92
	8126548	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	0.21	CHEMBL4226	Homo sapiens	Inhibition	%	0.21
	8126684	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	1.81	CHEMBL4226	Homo sapiens	Inhibition	%	1.81
	8126908	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	9.47	CHEMBL4226	Homo sapiens	Inhibition	%	9.47
	8127030	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	0.9	CHEMBL4226	Homo sapiens	Inhibition	%	0.9
	8127421	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	2.49	CHEMBL4226	Homo sapiens	Inhibition	%	2.49
	8127563	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	-2.17	CHEMBL4226	Homo sapiens	Inhibition	%	-2.17
	8127851	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.71	CHEMBL4226	Homo sapiens	Inhibition	%	0.71
	8128227	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	-0.01	CHEMBL4226	Homo sapiens	Inhibition	%	-0.01
	8128394	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-2.92	CHEMBL4226	Homo sapiens	Inhibition	%	-2.92
	8128737	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	65.34	CHEMBL4226	Homo sapiens	Inhibition	%	65.34
	8129098	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.15	CHEMBL4226	Homo sapiens	Inhibition	%	2.15
	8129269	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.3	CHEMBL4226	Homo sapiens	Inhibition	%	-0.3
	8129458	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	0.51	CHEMBL4226	Homo sapiens	Inhibition	%	0.51
	8129682	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	0.18	CHEMBL4226	Homo sapiens	Inhibition	%	0.18
	8129821	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	1.3	CHEMBL4226	Homo sapiens	Inhibition	%	1.3
	8129982	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	0.47	CHEMBL4226	Homo sapiens	Inhibition	%	0.47
	8130206	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.91	CHEMBL4226	Homo sapiens	Inhibition	%	2.91
	8130378	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.77	CHEMBL4226	Homo sapiens	Inhibition	%	0.77
	8130538	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	-2.57	CHEMBL4226	Homo sapiens	Inhibition	%	-2.57
	8130762	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	5.2	CHEMBL4226	Homo sapiens	Inhibition	%	5.2
	8130878	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	0.25	CHEMBL4226	Homo sapiens	Inhibition	%	0.25
	8131241	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	1.16	CHEMBL4226	Homo sapiens	Inhibition	%	1.16
	8131361	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	1.21	CHEMBL4226	Homo sapiens	Inhibition	%	1.21
	8131585	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-3.02	CHEMBL4226	Homo sapiens	Inhibition	%	-3.02
	8131752	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	12.08	CHEMBL4226	Homo sapiens	Inhibition	%	12.08
	8131893	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	1.01	CHEMBL4226	Homo sapiens	Inhibition	%	1.01
	8132117	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12	Outside typical range	CHEMBL273564	=	Inhibition	%	-31.39	CHEMBL4226	Homo sapiens	Inhibition	%	-31.39
	8132179	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	2.37	CHEMBL4226	Homo sapiens	Inhibition	%	2.37
	8132403	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-5.35	CHEMBL4226	Homo sapiens	Inhibition	%	-5.35
	8132550	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.59	CHEMBL4226	Homo sapiens	Inhibition	%	1.59
	8132718	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-0.85	CHEMBL4226	Homo sapiens	Inhibition	%	-0.85
	8132942	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.64	CHEMBL4226	Homo sapiens	Inhibition	%	0.64
	8133063	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.27	CHEMBL4226	Homo sapiens	Inhibition	%	1.27
	8133425	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	-0.51	CHEMBL4226	Homo sapiens	Inhibition	%	-0.51
	8133597	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	1.91	CHEMBL4226	Homo sapiens	Inhibition	%	1.91
	8134001	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	-0.46	CHEMBL4226	Homo sapiens	Inhibition	%	-0.46
	8134149	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.59	CHEMBL4226	Homo sapiens	Inhibition	%	0.59
	8134533	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.53	CHEMBL4226	Homo sapiens	Inhibition	%	0.53
	8134717	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	0.94	CHEMBL4226	Homo sapiens	Inhibition	%	0.94
	8135101	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	0.5	CHEMBL4226	Homo sapiens	Inhibition	%	0.5
	8135216	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	0.22	CHEMBL4226	Homo sapiens	Inhibition	%	0.22
	8135440	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	0.57	CHEMBL4226	Homo sapiens	Inhibition	%	0.57
	8135581	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	1.09	CHEMBL4226	Homo sapiens	Inhibition	%	1.09
	8135926	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-2.72	CHEMBL4226	Homo sapiens	Inhibition	%	-2.72
	8136094	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	0.55	CHEMBL4226	Homo sapiens	Inhibition	%	0.55
	8136462	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	0.88	CHEMBL4226	Homo sapiens	Inhibition	%	0.88
	8136752	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-1.03	CHEMBL4226	Homo sapiens	Inhibition	%	-1.03
	8136887	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	0.34	CHEMBL4226	Homo sapiens	Inhibition	%	0.34
	8137274	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	0.61	CHEMBL4226	Homo sapiens	Inhibition	%	0.61
	8137394	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	6.69	CHEMBL4226	Homo sapiens	Inhibition	%	6.69
	8137618	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-2.0	CHEMBL4226	Homo sapiens	Inhibition	%	-2.0
	8137766	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.16	CHEMBL4226	Homo sapiens	Inhibition	%	2.16
	8137932	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.38	CHEMBL4226	Homo sapiens	Inhibition	%	-0.38
	8138156	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.09	CHEMBL4226	Homo sapiens	Inhibition	%	-0.09
	8138335	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.04	CHEMBL4226	Homo sapiens	Inhibition	%	0.04
	8138483	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	11.42	CHEMBL4226	Homo sapiens	Inhibition	%	11.42
	8138707	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-0.64	CHEMBL4226	Homo sapiens	Inhibition	%	-0.64
	8138865	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.49	CHEMBL4226	Homo sapiens	Inhibition	%	0.49
	8139050	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	1.06	CHEMBL4226	Homo sapiens	Inhibition	%	1.06
	8139274	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	-0.91	CHEMBL4226	Homo sapiens	Inhibition	%	-0.91
	8139433	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	0.95	CHEMBL4226	Homo sapiens	Inhibition	%	0.95
	8139771	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	0.19	CHEMBL4226	Homo sapiens	Inhibition	%	0.19
	8139912	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	1.18	CHEMBL4226	Homo sapiens	Inhibition	%	1.18
	8140259	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	0.91	CHEMBL4226	Homo sapiens	Inhibition	%	0.91
	8140418	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.67	CHEMBL4226	Homo sapiens	Inhibition	%	1.67
	8140642	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	0.69	CHEMBL4226	Homo sapiens	Inhibition	%	0.69
	8140785	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	-2.27	CHEMBL4226	Homo sapiens	Inhibition	%	-2.27
	8141087	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.14	CHEMBL4226	Homo sapiens	Inhibition	%	0.14
	8141217	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	2.49	CHEMBL4226	Homo sapiens	Inhibition	%	2.49
	8141441	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.26	CHEMBL4226	Homo sapiens	Inhibition	%	0.26
	8141601	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	9.87	CHEMBL4226	Homo sapiens	Inhibition	%	9.87
	8141944	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-2.04	CHEMBL4226	Homo sapiens	Inhibition	%	-2.04
	8142105	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-0.22	CHEMBL4226	Homo sapiens	Inhibition	%	-0.22
	8142497	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-0.19	CHEMBL4226	Homo sapiens	Inhibition	%	-0.19
	8142673	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	-1.22	CHEMBL4226	Homo sapiens	Inhibition	%	-1.22
	8143046	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	0.67	CHEMBL4226	Homo sapiens	Inhibition	%	0.67
	8143201	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.75	CHEMBL4226	Homo sapiens	Inhibition	%	0.75
	8143612	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	-0.23	CHEMBL4226	Homo sapiens	Inhibition	%	-0.23
	8143771	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	0.65	CHEMBL4226	Homo sapiens	Inhibition	%	0.65
	8144109	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-3.26	CHEMBL4226	Homo sapiens	Inhibition	%	-3.26
	8144248	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	1.25	CHEMBL4226	Homo sapiens	Inhibition	%	1.25
	8144472	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	-0.41	CHEMBL4226	Homo sapiens	Inhibition	%	-0.41
	8144602	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	2.43	CHEMBL4226	Homo sapiens	Inhibition	%	2.43
	8144979	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.45	CHEMBL4226	Homo sapiens	Inhibition	%	1.45
	8145116	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	0.95	CHEMBL4226	Homo sapiens	Inhibition	%	0.95
	8145429	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	2.24	CHEMBL4226	Homo sapiens	Inhibition	%	2.24
	8145777	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.48	CHEMBL4226	Homo sapiens	Inhibition	%	0.48
	8145938	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	-0.2	CHEMBL4226	Homo sapiens	Inhibition	%	-0.2
	8146282	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.48	CHEMBL4226	Homo sapiens	Inhibition	%	0.48
	8146442	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-0.46	CHEMBL4226	Homo sapiens	Inhibition	%	-0.46
	8146666	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	1.22	CHEMBL4226	Homo sapiens	Inhibition	%	1.22
	8146833	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	3.73	CHEMBL4226	Homo sapiens	Inhibition	%	3.73
	8147002	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	0.88	CHEMBL4226	Homo sapiens	Inhibition	%	0.88
	8147368	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.66	CHEMBL4226	Homo sapiens	Inhibition	%	1.66
	8147521	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.7	CHEMBL4226	Homo sapiens	Inhibition	%	0.7
	8147745	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	-0.4	CHEMBL4226	Homo sapiens	Inhibition	%	-0.4
	8147932	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	0.44	CHEMBL4226	Homo sapiens	Inhibition	%	0.44
	8148090	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	2.3	CHEMBL4226	Homo sapiens	Inhibition	%	2.3
	8148314	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	-0.17	CHEMBL4226	Homo sapiens	Inhibition	%	-0.17
	8148428	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-3.65	CHEMBL4226	Homo sapiens	Inhibition	%	-3.65
	8148791	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	-0.16	CHEMBL4226	Homo sapiens	Inhibition	%	-0.16
	8148929	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	2.43	CHEMBL4226	Homo sapiens	Inhibition	%	2.43
	8149153	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	1.67	CHEMBL4226	Homo sapiens	Inhibition	%	1.67
	8149312	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-3.63	CHEMBL4226	Homo sapiens	Inhibition	%	-3.63
	8149446	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	-0.68	CHEMBL4226	Homo sapiens	Inhibition	%	-0.68
	8149670	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	-2.71	CHEMBL4226	Homo sapiens	Inhibition	%	-2.71
	8149768	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	0.33	CHEMBL4226	Homo sapiens	Inhibition	%	0.33
	8150117	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-3.23	CHEMBL4226	Homo sapiens	Inhibition	%	-3.23
	8150277	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	1.23	CHEMBL4226	Homo sapiens	Inhibition	%	1.23
	8150501	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-0.87	CHEMBL4226	Homo sapiens	Inhibition	%	-0.87
	8150621	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	2.87	CHEMBL4226	Homo sapiens	Inhibition	%	2.87
	8151010	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	2.92	CHEMBL4226	Homo sapiens	Inhibition	%	2.92
	8151173	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-0.51	CHEMBL4226	Homo sapiens	Inhibition	%	-0.51
	8151350	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	4.52	CHEMBL4226	Homo sapiens	Inhibition	%	4.52
	8151574	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	0.31	CHEMBL4226	Homo sapiens	Inhibition	%	0.31
	8151712	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	6.92	CHEMBL4226	Homo sapiens	Inhibition	%	6.92
	8152090	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	0.95	CHEMBL4226	Homo sapiens	Inhibition	%	0.95
	8152278	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	7.3	CHEMBL4226	Homo sapiens	Inhibition	%	7.3
	8152660	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	1.62	CHEMBL4226	Homo sapiens	Inhibition	%	1.62
	8152774	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	1.1	CHEMBL4226	Homo sapiens	Inhibition	%	1.1
	8152998	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	2.41	CHEMBL4226	Homo sapiens	Inhibition	%	2.41
	8153137	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-0.14	CHEMBL4226	Homo sapiens	Inhibition	%	-0.14
	8153498	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	2.42	CHEMBL4226	Homo sapiens	Inhibition	%	2.42
	8153655	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-4.13	CHEMBL4226	Homo sapiens	Inhibition	%	-4.13
	8154012	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	9.74	CHEMBL4226	Homo sapiens	Inhibition	%	9.74
	8154109	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	1.86	CHEMBL4226	Homo sapiens	Inhibition	%	1.86
	8154333	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	1.2	CHEMBL4226	Homo sapiens	Inhibition	%	1.2
	8154459	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-2.83	CHEMBL4226	Homo sapiens	Inhibition	%	-2.83
	8154842	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-0.52	CHEMBL4226	Homo sapiens	Inhibition	%	-0.52
	8154962	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-0.8	CHEMBL4226	Homo sapiens	Inhibition	%	-0.8
	8155186	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	2.41	CHEMBL4226	Homo sapiens	Inhibition	%	2.41
	8155362	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.16	CHEMBL4226	Homo sapiens	Inhibition	%	-0.16
	8155523	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	0.04	CHEMBL4226	Homo sapiens	Inhibition	%	0.04
	8155925	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	0.97	CHEMBL4226	Homo sapiens	Inhibition	%	0.97
	8156063	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	0.68	CHEMBL4226	Homo sapiens	Inhibition	%	0.68
	8156287	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	6.13	CHEMBL4226	Homo sapiens	Inhibition	%	6.13
	8156499	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.11	CHEMBL4226	Homo sapiens	Inhibition	%	2.11
	8156649	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	5.96	CHEMBL4226	Homo sapiens	Inhibition	%	5.96
	8157016	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	6.65	CHEMBL4226	Homo sapiens	Inhibition	%	6.65
	8157136	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	2.28	CHEMBL4226	Homo sapiens	Inhibition	%	2.28
	8157360	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	14.12	CHEMBL4226	Homo sapiens	Inhibition	%	14.12
	8157501	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	1.23	CHEMBL4226	Homo sapiens	Inhibition	%	1.23
	8157855	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	2.3	CHEMBL4226	Homo sapiens	Inhibition	%	2.3
	8158016	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-0.53	CHEMBL4226	Homo sapiens	Inhibition	%	-0.53
	8158266	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	2.06	CHEMBL4226	Homo sapiens	Inhibition	%	2.06
	8158490	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	1.31	CHEMBL4226	Homo sapiens	Inhibition	%	1.31
	8158648	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	-1.68	CHEMBL4226	Homo sapiens	Inhibition	%	-1.68
	8158817	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	0.11	CHEMBL4226	Homo sapiens	Inhibition	%	0.11
	8159041	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	1.26	CHEMBL4226	Homo sapiens	Inhibition	%	1.26
	8159176	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	2.68	CHEMBL4226	Homo sapiens	Inhibition	%	2.68
	8159520	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-2.3	CHEMBL4226	Homo sapiens	Inhibition	%	-2.3
	8159651	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	2.62	CHEMBL4226	Homo sapiens	Inhibition	%	2.62
	8159875	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	4.01	CHEMBL4226	Homo sapiens	Inhibition	%	4.01
	8160016	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.02	CHEMBL4226	Homo sapiens	Inhibition	%	1.02
	8160153	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	4.98	CHEMBL4226	Homo sapiens	Inhibition	%	4.98
	8160377	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	7.77	CHEMBL4226	Homo sapiens	Inhibition	%	7.77
	8160527	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	1.02	CHEMBL4226	Homo sapiens	Inhibition	%	1.02
	8160821	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	7.45	CHEMBL4226	Homo sapiens	Inhibition	%	7.45
	8160971	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	0.77	CHEMBL4226	Homo sapiens	Inhibition	%	0.77
	8161195	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	1.43	CHEMBL4226	Homo sapiens	Inhibition	%	1.43
	8161338	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	12.58	CHEMBL4226	Homo sapiens	Inhibition	%	12.58
	8161687	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.2	CHEMBL4226	Homo sapiens	Inhibition	%	2.2
	8161825	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	2.91	CHEMBL4226	Homo sapiens	Inhibition	%	2.91
	8162049	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	1.43	CHEMBL4226	Homo sapiens	Inhibition	%	1.43
	8162179	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	8.2	CHEMBL4226	Homo sapiens	Inhibition	%	8.2
	8162339	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-3.87	CHEMBL4226	Homo sapiens	Inhibition	%	-3.87
	8162563	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-3.62	CHEMBL4226	Homo sapiens	Inhibition	%	-3.62
	8162816	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	1.82	CHEMBL4226	Homo sapiens	Inhibition	%	1.82
	8162964	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	3.57	CHEMBL4226	Homo sapiens	Inhibition	%	3.57
	8163357	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	0.63	CHEMBL4226	Homo sapiens	Inhibition	%	0.63
	8163491	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	2.04	CHEMBL4226	Homo sapiens	Inhibition	%	2.04
	8163838	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-1.56	CHEMBL4226	Homo sapiens	Inhibition	%	-1.56
	8164196	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	22.31	CHEMBL4226	Homo sapiens	Inhibition	%	22.31
	8164336	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.82	CHEMBL4226	Homo sapiens	Inhibition	%	0.82
	8164715	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	56.66	CHEMBL4226	Homo sapiens	Inhibition	%	56.66
	8164859	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	3.28	CHEMBL4226	Homo sapiens	Inhibition	%	3.28
	8165153	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	1.98	CHEMBL4226	Homo sapiens	Inhibition	%	1.98
	8165518	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.59	CHEMBL4226	Homo sapiens	Inhibition	%	3.59
	8165661	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	51.98	CHEMBL4226	Homo sapiens	Inhibition	%	51.98
	8166011	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	21.84	CHEMBL4226	Homo sapiens	Inhibition	%	21.84
	8166373	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	2.68	CHEMBL4226	Homo sapiens	Inhibition	%	2.68
	8166503	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	1.66	CHEMBL4226	Homo sapiens	Inhibition	%	1.66
	8166828	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	6.44	CHEMBL4226	Homo sapiens	Inhibition	%	6.44
	8167140	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	0.57	CHEMBL4226	Homo sapiens	Inhibition	%	0.57
	8167281	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	17.29	CHEMBL4226	Homo sapiens	Inhibition	%	17.29
	8167505	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	2.0	CHEMBL4226	Homo sapiens	Inhibition	%	2.0
	8167669	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.09	CHEMBL4226	Homo sapiens	Inhibition	%	1.09
	8167802	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	2.12	CHEMBL4226	Homo sapiens	Inhibition	%	2.12
	8168026	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	1.23	CHEMBL4226	Homo sapiens	Inhibition	%	1.23
	8168150	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.34	CHEMBL4226	Homo sapiens	Inhibition	%	3.34
	8168515	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	0.97	CHEMBL4226	Homo sapiens	Inhibition	%	0.97
	8168651	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.38	CHEMBL4226	Homo sapiens	Inhibition	%	1.38
	8168875	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	0.83	CHEMBL4226	Homo sapiens	Inhibition	%	0.83
	8169039	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	78.39	CHEMBL4226	Homo sapiens	Inhibition	%	78.39
	8169181	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.51	CHEMBL4226	Homo sapiens	Inhibition	%	1.51
	8169405	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	4.08	CHEMBL4226	Homo sapiens	Inhibition	%	4.08
	8169485	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	4.34	CHEMBL4226	Homo sapiens	Inhibition	%	4.34
	8169843	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	4.11	CHEMBL4226	Homo sapiens	Inhibition	%	4.11
	8169988	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.61	CHEMBL4226	Homo sapiens	Inhibition	%	0.61
	8170212	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.36	CHEMBL4226	Homo sapiens	Inhibition	%	1.36
	8170337	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.44	CHEMBL4226	Homo sapiens	Inhibition	%	1.44
	8170701	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-2.14	CHEMBL4226	Homo sapiens	Inhibition	%	-2.14
	8170836	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	2.52	CHEMBL4226	Homo sapiens	Inhibition	%	2.52
	8171060	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	3.13	CHEMBL4226	Homo sapiens	Inhibition	%	3.13
	8171257	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	0.25	CHEMBL4226	Homo sapiens	Inhibition	%	0.25
	8171474	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	1.22	CHEMBL4226	Homo sapiens	Inhibition	%	1.22
	8171839	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	4.74	CHEMBL4226	Homo sapiens	Inhibition	%	4.74
	8171992	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-2.19	CHEMBL4226	Homo sapiens	Inhibition	%	-2.19
	8172348	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	1.23	CHEMBL4226	Homo sapiens	Inhibition	%	1.23
	8172476	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.47	CHEMBL4226	Homo sapiens	Inhibition	%	1.47
	8172700	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	3.95	CHEMBL4226	Homo sapiens	Inhibition	%	3.95
	8172842	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	2.71	CHEMBL4226	Homo sapiens	Inhibition	%	2.71
	8173202	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	1.36	CHEMBL4226	Homo sapiens	Inhibition	%	1.36
	8173367	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	4.27	CHEMBL4226	Homo sapiens	Inhibition	%	4.27
	8173732	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	7.23	CHEMBL4226	Homo sapiens	Inhibition	%	7.23
	8173819	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	4.48	CHEMBL4226	Homo sapiens	Inhibition	%	4.48
	8174043	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	24.17	CHEMBL4226	Homo sapiens	Inhibition	%	24.17
	8174175	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.11	CHEMBL4226	Homo sapiens	Inhibition	%	2.11
	8174547	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	0.44	CHEMBL4226	Homo sapiens	Inhibition	%	0.44
	8174669	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.84	CHEMBL4226	Homo sapiens	Inhibition	%	3.84
	8174893	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	0.76	CHEMBL4226	Homo sapiens	Inhibition	%	0.76
	8175036	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-1.7	CHEMBL4226	Homo sapiens	Inhibition	%	-1.7
	8175396	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	13.96	CHEMBL4226	Homo sapiens	Inhibition	%	13.96
	8175652	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	1.52	CHEMBL4226	Homo sapiens	Inhibition	%	1.52
	8175815	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	1.2	CHEMBL4226	Homo sapiens	Inhibition	%	1.2
	8176192	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	2.13	CHEMBL4226	Homo sapiens	Inhibition	%	2.13
	8176341	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-0.14	CHEMBL4226	Homo sapiens	Inhibition	%	-0.14
	8176697	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	4.44	CHEMBL4226	Homo sapiens	Inhibition	%	4.44
	8177051	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.82	CHEMBL4226	Homo sapiens	Inhibition	%	0.82
	8177193	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl	Outside typical range	CHEMBL1909352	=	Inhibition	%	-11.28	CHEMBL4226	Homo sapiens	Inhibition	%	-11.28
	8177555	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	2.17	CHEMBL4226	Homo sapiens	Inhibition	%	2.17
	8177719	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	19.29	CHEMBL4226	Homo sapiens	Inhibition	%	19.29
	8178083	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	38.62	CHEMBL4226	Homo sapiens	Inhibition	%	38.62
	8178395	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.51	CHEMBL4226	Homo sapiens	Inhibition	%	1.51
	8178522	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	3.16	CHEMBL4226	Homo sapiens	Inhibition	%	3.16
	8178746	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	3.03	CHEMBL4226	Homo sapiens	Inhibition	%	3.03
	8178895	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.44	CHEMBL4226	Homo sapiens	Inhibition	%	2.44
	8179242	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.52	CHEMBL4226	Homo sapiens	Inhibition	%	2.52
	8179386	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	1.92	CHEMBL4226	Homo sapiens	Inhibition	%	1.92
	8179747	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.51	CHEMBL4226	Homo sapiens	Inhibition	%	1.51
	8180004	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	1.91	CHEMBL4226	Homo sapiens	Inhibition	%	1.91
	8180158	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	3.34	CHEMBL4226	Homo sapiens	Inhibition	%	3.34
	8180382	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-2.46	CHEMBL4226	Homo sapiens	Inhibition	%	-2.46
	8180538	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	3.13	CHEMBL4226	Homo sapiens	Inhibition	%	3.13
	8180686	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	0.66	CHEMBL4226	Homo sapiens	Inhibition	%	0.66
	8180910	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	3.39	CHEMBL4226	Homo sapiens	Inhibition	%	3.39
	8181043	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	1.75	CHEMBL4226	Homo sapiens	Inhibition	%	1.75
	8181398	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-0.03	CHEMBL4226	Homo sapiens	Inhibition	%	-0.03
	8181538	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	-1.62	CHEMBL4226	Homo sapiens	Inhibition	%	-1.62
	8181762	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	0.78	CHEMBL4226	Homo sapiens	Inhibition	%	0.78
	8181901	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	4.44	CHEMBL4226	Homo sapiens	Inhibition	%	4.44
	8182064	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	3.31	CHEMBL4226	Homo sapiens	Inhibition	%	3.31
	8182288	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	6.28	CHEMBL4226	Homo sapiens	Inhibition	%	6.28
	8182428	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	2.2	CHEMBL4226	Homo sapiens	Inhibition	%	2.2
	8182744	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.86	CHEMBL4226	Homo sapiens	Inhibition	%	1.86
	8183090	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	6.29	CHEMBL4226	Homo sapiens	Inhibition	%	6.29
	8183239	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	2.36	CHEMBL4226	Homo sapiens	Inhibition	%	2.36
	8183592	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	5.98	CHEMBL4226	Homo sapiens	Inhibition	%	5.98
	8183734	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	3.91	CHEMBL4226	Homo sapiens	Inhibition	%	3.91
	8183958	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	1.72	CHEMBL4226	Homo sapiens	Inhibition	%	1.72
	8184094	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	3.58	CHEMBL4226	Homo sapiens	Inhibition	%	3.58
	8184360	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	2.52	CHEMBL4226	Homo sapiens	Inhibition	%	2.52
	8184731	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-1.03	CHEMBL4226	Homo sapiens	Inhibition	%	-1.03
	8184888	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	1.15	CHEMBL4226	Homo sapiens	Inhibition	%	1.15
	8185261	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.32	CHEMBL4226	Homo sapiens	Inhibition	%	0.32
	8185392	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	3.42	CHEMBL4226	Homo sapiens	Inhibition	%	3.42
	8185616	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	-1.3	CHEMBL4226	Homo sapiens	Inhibition	%	-1.3
	8185747	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	1.28	CHEMBL4226	Homo sapiens	Inhibition	%	1.28
	8186110	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	2.33	CHEMBL4226	Homo sapiens	Inhibition	%	2.33
	8186251	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	2.08	CHEMBL4226	Homo sapiens	Inhibition	%	2.08
	8186639	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	2.88	CHEMBL4226	Homo sapiens	Inhibition	%	2.88
	8186778	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	4.71	CHEMBL4226	Homo sapiens	Inhibition	%	4.71
	8187002	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.16	CHEMBL4226	Homo sapiens	Inhibition	%	2.16
	8187100	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.21	CHEMBL4226	Homo sapiens	Inhibition	%	1.21
	8187448	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	13.25	CHEMBL4226	Homo sapiens	Inhibition	%	13.25
	8187596	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	13.23	CHEMBL4226	Homo sapiens	Inhibition	%	13.23
	8187820	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.35	CHEMBL4226	Homo sapiens	Inhibition	%	1.35
	8187949	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	5.27	CHEMBL4226	Homo sapiens	Inhibition	%	5.27
	8188316	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	1.92	CHEMBL4226	Homo sapiens	Inhibition	%	1.92
	8188451	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-0.53	CHEMBL4226	Homo sapiens	Inhibition	%	-0.53
	8188725	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.15	CHEMBL4226	Homo sapiens	Inhibition	%	1.15
	8189097	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	5.21	CHEMBL4226	Homo sapiens	Inhibition	%	5.21
	8189253	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	0.91	CHEMBL4226	Homo sapiens	Inhibition	%	0.91
	8189477	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	1.92	CHEMBL4226	Homo sapiens	Inhibition	%	1.92
	8189626	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.27	CHEMBL4226	Homo sapiens	Inhibition	%	0.27
	8189982	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	-1.87	CHEMBL4226	Homo sapiens	Inhibition	%	-1.87
	8190114	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	2.35	CHEMBL4226	Homo sapiens	Inhibition	%	2.35
	8190478	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	1.22	CHEMBL4226	Homo sapiens	Inhibition	%	1.22
	8190615	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	3.23	CHEMBL4226	Homo sapiens	Inhibition	%	3.23
	8190839	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	3.29	CHEMBL4226	Homo sapiens	Inhibition	%	3.29
	8191003	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	4.16	CHEMBL4226	Homo sapiens	Inhibition	%	4.16
	8191365	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.89	CHEMBL4226	Homo sapiens	Inhibition	%	2.89
	8191461	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	3.45	CHEMBL4226	Homo sapiens	Inhibition	%	3.45
	8191685	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.34	CHEMBL4226	Homo sapiens	Inhibition	%	1.34
	8191807	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	52.78	CHEMBL4226	Homo sapiens	Inhibition	%	52.78
	8192180	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.66	CHEMBL4226	Homo sapiens	Inhibition	%	1.66
	8192309	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	2.46	CHEMBL4226	Homo sapiens	Inhibition	%	2.46
	8192677	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	1.79	CHEMBL4226	Homo sapiens	Inhibition	%	1.79
	8192813	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	13.51	CHEMBL4226	Homo sapiens	Inhibition	%	13.51
	8193037	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	3.69	CHEMBL4226	Homo sapiens	Inhibition	%	3.69
	8193085	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.08	CHEMBL4226	Homo sapiens	Inhibition	%	2.08
	8193309	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.01	CHEMBL4226	Homo sapiens	Inhibition	%	1.01
	8193454	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	31.56	CHEMBL4226	Homo sapiens	Inhibition	%	31.56
	8193835	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	3.43	CHEMBL4226	Homo sapiens	Inhibition	%	3.43
	8193984	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	1.0	CHEMBL4226	Homo sapiens	Inhibition	%	1.0
	8194339	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	1.39	CHEMBL4226	Homo sapiens	Inhibition	%	1.39
	8194470	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	9.88	CHEMBL4226	Homo sapiens	Inhibition	%	9.88
	8194694	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	2.68	CHEMBL4226	Homo sapiens	Inhibition	%	2.68
	8194837	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	2.34	CHEMBL4226	Homo sapiens	Inhibition	%	2.34
	8195194	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	3.15	CHEMBL4226	Homo sapiens	Inhibition	%	3.15
	8195358	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	22.32	CHEMBL4226	Homo sapiens	Inhibition	%	22.32
	8195721	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	1.94	CHEMBL4226	Homo sapiens	Inhibition	%	1.94
	8196043	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.08	CHEMBL4226	Homo sapiens	Inhibition	%	2.08
	8196160	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.76	CHEMBL4226	Homo sapiens	Inhibition	%	2.76
	8196384	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	5.49	CHEMBL4226	Homo sapiens	Inhibition	%	5.49
	8196534	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	1.04	CHEMBL4226	Homo sapiens	Inhibition	%	1.04
	8196662	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	2.16	CHEMBL4226	Homo sapiens	Inhibition	%	2.16
	8196886	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-1.61	CHEMBL4226	Homo sapiens	Inhibition	%	-1.61
	8197027	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	2.09	CHEMBL4226	Homo sapiens	Inhibition	%	2.09
	8197388	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	21.75	CHEMBL4226	Homo sapiens	Inhibition	%	21.75
	8197663	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	0.95	CHEMBL4226	Homo sapiens	Inhibition	%	0.95
	8197803	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	1.33	CHEMBL4226	Homo sapiens	Inhibition	%	1.33
	8198027	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	4.39	CHEMBL4226	Homo sapiens	Inhibition	%	4.39
	8198184	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-1.51	CHEMBL4226	Homo sapiens	Inhibition	%	-1.51
	8198322	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	1.31	CHEMBL4226	Homo sapiens	Inhibition	%	1.31
	8198546	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	1.32	CHEMBL4226	Homo sapiens	Inhibition	%	1.32
	8198676	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	2.38	CHEMBL4226	Homo sapiens	Inhibition	%	2.38
	8199031	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	2.44	CHEMBL4226	Homo sapiens	Inhibition	%	2.44
	8199179	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	2.14	CHEMBL4226	Homo sapiens	Inhibition	%	2.14
	8199403	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	3.0	CHEMBL4226	Homo sapiens	Inhibition	%	3.0
	8199537	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.41	CHEMBL4226	Homo sapiens	Inhibition	%	2.41
	8199700	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	63.81	CHEMBL4226	Homo sapiens	Inhibition	%	63.81
	8199924	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	3.45	CHEMBL4226	Homo sapiens	Inhibition	%	3.45
	8200062	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	2.95	CHEMBL4226	Homo sapiens	Inhibition	%	2.95
	8200390	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.63	CHEMBL4226	Homo sapiens	Inhibition	%	1.63
	8200729	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	2.85	CHEMBL4226	Homo sapiens	Inhibition	%	2.85
	8200879	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	1.61	CHEMBL4226	Homo sapiens	Inhibition	%	1.61
	8201233	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	0.59	CHEMBL4226	Homo sapiens	Inhibition	%	0.59
	8201368	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	1.44	CHEMBL4226	Homo sapiens	Inhibition	%	1.44
	8201592	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	3.69	CHEMBL4226	Homo sapiens	Inhibition	%	3.69
	8201725	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.64	CHEMBL4226	Homo sapiens	Inhibition	%	0.64
	8202004	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	1.49	CHEMBL4226	Homo sapiens	Inhibition	%	1.49
	8202368	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.15	CHEMBL4226	Homo sapiens	Inhibition	%	0.15
	8202535	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-2.32	CHEMBL4226	Homo sapiens	Inhibition	%	-2.32
	8202884	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	0.54	CHEMBL4226	Homo sapiens	Inhibition	%	0.54
	8203014	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	1.85	CHEMBL4226	Homo sapiens	Inhibition	%	1.85
	8203238	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	4.88	CHEMBL4226	Homo sapiens	Inhibition	%	4.88
	8203369	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	-1.14	CHEMBL4226	Homo sapiens	Inhibition	%	-1.14
	8203739	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	0.39	CHEMBL4226	Homo sapiens	Inhibition	%	0.39
	8203873	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.05	CHEMBL4226	Homo sapiens	Inhibition	%	2.05
	8204263	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	6.2	CHEMBL4226	Homo sapiens	Inhibition	%	6.2
	8204400	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	2.09	CHEMBL4226	Homo sapiens	Inhibition	%	2.09
	8204729	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	2.2	CHEMBL4226	Homo sapiens	Inhibition	%	2.2
	8205068	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	13.17	CHEMBL4226	Homo sapiens	Inhibition	%	13.17
	8205217	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	1.88	CHEMBL4226	Homo sapiens	Inhibition	%	1.88
	8205441	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	8.62	CHEMBL4226	Homo sapiens	Inhibition	%	8.62
	8205577	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	1.37	CHEMBL4226	Homo sapiens	Inhibition	%	1.37
	8205940	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	1.44	CHEMBL4226	Homo sapiens	Inhibition	%	1.44
	8206072	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	2.67	CHEMBL4226	Homo sapiens	Inhibition	%	2.67
	8206348	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	0.98	CHEMBL4226	Homo sapiens	Inhibition	%	0.98
	8206715	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	2.88	CHEMBL4226	Homo sapiens	Inhibition	%	2.88
	8206895	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	1.05	CHEMBL4226	Homo sapiens	Inhibition	%	1.05
	8207245	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	2.15	CHEMBL4226	Homo sapiens	Inhibition	%	2.15
	8207599	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	2.91	CHEMBL4226	Homo sapiens	Inhibition	%	2.91
	8207731	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	1.11	CHEMBL4226	Homo sapiens	Inhibition	%	1.11
	8208100	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	0.72	CHEMBL4226	Homo sapiens	Inhibition	%	0.72
	8208232	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	3.07	CHEMBL4226	Homo sapiens	Inhibition	%	3.07
	8208456	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	1.7	CHEMBL4226	Homo sapiens	Inhibition	%	1.7
	8208622	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	2.41	CHEMBL4226	Homo sapiens	Inhibition	%	2.41
	8208755	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	2.88	CHEMBL4226	Homo sapiens	Inhibition	%	2.88
	8208979	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.8	CHEMBL4226	Homo sapiens	Inhibition	%	1.8
	8209084	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	2.7	CHEMBL4226	Homo sapiens	Inhibition	%	2.7
	8209424	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.95	CHEMBL4226	Homo sapiens	Inhibition	%	2.95
	8209798	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	0.84	CHEMBL4226	Homo sapiens	Inhibition	%	0.84
	8209934	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.9	CHEMBL4226	Homo sapiens	Inhibition	%	2.9
	8210299	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	1.83	CHEMBL4226	Homo sapiens	Inhibition	%	1.83
	8210435	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	0.48	CHEMBL4226	Homo sapiens	Inhibition	%	0.48
	8210659	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	4.44	CHEMBL4226	Homo sapiens	Inhibition	%	4.44
	8210694	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-1.37	CHEMBL4226	Homo sapiens	Inhibition	%	-1.37
	8210918	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-1.79	CHEMBL4226	Homo sapiens	Inhibition	%	-1.79
	8211062	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	0.11	CHEMBL4226	Homo sapiens	Inhibition	%	0.11
	8211232	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	1.96	CHEMBL4226	Homo sapiens	Inhibition	%	1.96
	8211456	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.27	CHEMBL4226	Homo sapiens	Inhibition	%	1.27
	8211579	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	3.8	CHEMBL4226	Homo sapiens	Inhibition	%	3.8
	8211932	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	8.39	CHEMBL4226	Homo sapiens	Inhibition	%	8.39
	8212064	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	1.46	CHEMBL4226	Homo sapiens	Inhibition	%	1.46
	8212288	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	3.46	CHEMBL4226	Homo sapiens	Inhibition	%	3.46
	8212429	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	1.11	CHEMBL4226	Homo sapiens	Inhibition	%	1.11
	8212786	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	2.84	CHEMBL4226	Homo sapiens	Inhibition	%	2.84
	8212956	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	4.72	CHEMBL4226	Homo sapiens	Inhibition	%	4.72
	8213309	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.54	CHEMBL4226	Homo sapiens	Inhibition	%	2.54
	8213413	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	13.86	CHEMBL4226	Homo sapiens	Inhibition	%	13.86
	8213637	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	1.39	CHEMBL4226	Homo sapiens	Inhibition	%	1.39
	8213750	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	4.76	CHEMBL4226	Homo sapiens	Inhibition	%	4.76
	8214121	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.75	CHEMBL4226	Homo sapiens	Inhibition	%	2.75
	8214258	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	2.12	CHEMBL4226	Homo sapiens	Inhibition	%	2.12
	8214482	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	7.93	CHEMBL4226	Homo sapiens	Inhibition	%	7.93
	8214616	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	-0.76	CHEMBL4226	Homo sapiens	Inhibition	%	-0.76
	8214992	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	0.66	CHEMBL4226	Homo sapiens	Inhibition	%	0.66
	8215243	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	1.31	CHEMBL4226	Homo sapiens	Inhibition	%	1.31
	8215396	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	0.53	CHEMBL4226	Homo sapiens	Inhibition	%	0.53
	8215784	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.89	CHEMBL4226	Homo sapiens	Inhibition	%	1.89
	8215903	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-0.73	CHEMBL4226	Homo sapiens	Inhibition	%	-0.73
	8216127	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	4.1	CHEMBL4226	Homo sapiens	Inhibition	%	4.1
	8216246	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.31	CHEMBL4226	Homo sapiens	Inhibition	%	2.31
	8216606	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	1.61	CHEMBL4226	Homo sapiens	Inhibition	%	1.61
	8216744	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	1.03	CHEMBL4226	Homo sapiens	Inhibition	%	1.03
	8217102	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	2.8	CHEMBL4226	Homo sapiens	Inhibition	%	2.8
	8217276	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.6	CHEMBL4226	Homo sapiens	Inhibition	%	0.6
	8217500	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.59	CHEMBL4226	Homo sapiens	Inhibition	%	1.59
	8217631	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	2.39	CHEMBL4226	Homo sapiens	Inhibition	%	2.39
	8217956	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	4.58	CHEMBL4226	Homo sapiens	Inhibition	%	4.58
	8218071	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	1.97	CHEMBL4226	Homo sapiens	Inhibition	%	1.97
	8218295	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	3.66	CHEMBL4226	Homo sapiens	Inhibition	%	3.66
	8218422	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	5.88	CHEMBL4226	Homo sapiens	Inhibition	%	5.88
	8218789	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	1.97	CHEMBL4226	Homo sapiens	Inhibition	%	1.97
	8218920	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	3.09	CHEMBL4226	Homo sapiens	Inhibition	%	3.09
	8219304	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	0.55	CHEMBL4226	Homo sapiens	Inhibition	%	0.55
	8219554	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	1.24	CHEMBL4226	Homo sapiens	Inhibition	%	1.24
	8219715	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	1.07	CHEMBL4226	Homo sapiens	Inhibition	%	1.07
	8219939	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	1.54	CHEMBL4226	Homo sapiens	Inhibition	%	1.54
	8220108	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	2.02	CHEMBL4226	Homo sapiens	Inhibition	%	2.02
	8220461	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	2.99	CHEMBL4226	Homo sapiens	Inhibition	%	2.99
	8220575	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	4.85	CHEMBL4226	Homo sapiens	Inhibition	%	4.85
	8220937	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	3.11	CHEMBL4226	Homo sapiens	Inhibition	%	3.11
	8221073	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-2.05	CHEMBL4226	Homo sapiens	Inhibition	%	-2.05
	8221297	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-2.2	CHEMBL4226	Homo sapiens	Inhibition	%	-2.2
	8221430	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	3.73	CHEMBL4226	Homo sapiens	Inhibition	%	3.73
	8221819	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.41	CHEMBL4226	Homo sapiens	Inhibition	%	1.41
	8221950	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	3.74	CHEMBL4226	Homo sapiens	Inhibition	%	3.74
	8222272	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	1.61	CHEMBL4226	Homo sapiens	Inhibition	%	1.61
	8222630	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	2.28	CHEMBL4226	Homo sapiens	Inhibition	%	2.28
	8222748	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	31.71	CHEMBL4226	Homo sapiens	Inhibition	%	31.71
	8223116	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	4.8	CHEMBL4226	Homo sapiens	Inhibition	%	4.8
	8223245	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	1.59	CHEMBL4226	Homo sapiens	Inhibition	%	1.59
	8223469	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	3.71	CHEMBL4226	Homo sapiens	Inhibition	%	3.71
	8223630	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-0.25	CHEMBL4226	Homo sapiens	Inhibition	%	-0.25
	8223880	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	1.66	CHEMBL4226	Homo sapiens	Inhibition	%	1.66
	8224266	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	-1.85	CHEMBL4226	Homo sapiens	Inhibition	%	-1.85
	8224436	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	2.74	CHEMBL4226	Homo sapiens	Inhibition	%	2.74
	8224795	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	2.19	CHEMBL4226	Homo sapiens	Inhibition	%	2.19
	8224909	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	1.15	CHEMBL4226	Homo sapiens	Inhibition	%	1.15
	8225133	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	1.64	CHEMBL4226	Homo sapiens	Inhibition	%	1.64
	8225267	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	1.95	CHEMBL4226	Homo sapiens	Inhibition	%	1.95
	8225629	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	3.62	CHEMBL4226	Homo sapiens	Inhibition	%	3.62
	8225764	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	7.82	CHEMBL4226	Homo sapiens	Inhibition	%	7.82
	8226146	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.38	CHEMBL4226	Homo sapiens	Inhibition	%	2.38
	8226271	CHEMBL1962034	GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	1.85	CHEMBL4226	Homo sapiens	Inhibition	%	1.85
	8226495	CHEMBL1962035	GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	3.1	CHEMBL4226	Homo sapiens	Inhibition	%	3.1
	10838686	CHEMBL2014912	Inhibition of CLK3 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	37.0	CHEMBL4226	Homo sapiens	INH	%	37.0
	12046275	CHEMBL2156512	Inhibition of CLK3 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	8.7	CHEMBL4226	Homo sapiens	INH	%	8.7
Active	12140052	CHEMBL2186706	Binding affinity to CLK3	B	CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1N		CHEMBL485053		Activity			CHEMBL4226	Homo sapiens	Activity		
Active	12140053	CHEMBL2186706	Binding affinity to CLK3	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538		Activity			CHEMBL4226	Homo sapiens	Activity		
	12141731	CHEMBL2186706	Binding affinity to CLK3	B	O=C1NC(Nc2ccccc2)=N/C1=C\c1ccc2c(c1)OCO2		CHEMBL1802358	=	Kd	nM	1100.0	CHEMBL4226	Homo sapiens	Kd	nM	1100.0
	12173684	CHEMBL2209320	Inhibition of CLK3 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	58.0	CHEMBL4226	Homo sapiens	Activity	%	58.0
	12222516	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	100.0	CHEMBL4226	Homo sapiens	Residual Activity	%	100.0
	12222517	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	60.0	CHEMBL4226	Homo sapiens	Residual Activity	%	60.0
	12222518	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	89.0	CHEMBL4226	Homo sapiens	Residual Activity	%	89.0
	12222519	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	90.0	CHEMBL4226	Homo sapiens	Residual Activity	%	90.0
	12222520	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	95.0	CHEMBL4226	Homo sapiens	Residual Activity	%	95.0
	12222521	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	87.0	CHEMBL4226	Homo sapiens	Residual Activity	%	87.0
	12222522	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	45.0	CHEMBL4226	Homo sapiens	Residual Activity	%	45.0
	12222523	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	94.0	CHEMBL4226	Homo sapiens	Residual Activity	%	94.0
	12222524	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	99.0	CHEMBL4226	Homo sapiens	Residual Activity	%	99.0
	12222525	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	91.0	CHEMBL4226	Homo sapiens	Residual Activity	%	91.0
	12222526	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	83.0	CHEMBL4226	Homo sapiens	Residual Activity	%	83.0
	12222527	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	55.0	CHEMBL4226	Homo sapiens	Residual Activity	%	55.0
	12222528	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	76.0	CHEMBL4226	Homo sapiens	Residual Activity	%	76.0
	12222529	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	95.0	CHEMBL4226	Homo sapiens	Residual Activity	%	95.0
	12222530	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	82.0	CHEMBL4226	Homo sapiens	Residual Activity	%	82.0
	12222531	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	82.0	CHEMBL4226	Homo sapiens	Residual Activity	%	82.0
	12222532	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	91.0	CHEMBL4226	Homo sapiens	Residual Activity	%	91.0
	12222533	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	74.0	CHEMBL4226	Homo sapiens	Residual Activity	%	74.0
	12222534	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	50.0	CHEMBL4226	Homo sapiens	Residual Activity	%	50.0
	12222535	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	68.0	CHEMBL4226	Homo sapiens	Residual Activity	%	68.0
	12222536	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	81.0	CHEMBL4226	Homo sapiens	Residual Activity	%	81.0
	12222537	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	79.0	CHEMBL4226	Homo sapiens	Residual Activity	%	79.0
	12222538	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	91.0	CHEMBL4226	Homo sapiens	Residual Activity	%	91.0
	12222539	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	83.0	CHEMBL4226	Homo sapiens	Residual Activity	%	83.0
	12222540	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	98.0	CHEMBL4226	Homo sapiens	Residual Activity	%	98.0
	12222541	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	92.0	CHEMBL4226	Homo sapiens	Residual Activity	%	92.0
	12222542	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	69.0	CHEMBL4226	Homo sapiens	Residual Activity	%	69.0
	12222543	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	82.0	CHEMBL4226	Homo sapiens	Residual Activity	%	82.0
	12222544	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	64.0	CHEMBL4226	Homo sapiens	Residual Activity	%	64.0
	12222545	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	55.0	CHEMBL4226	Homo sapiens	Residual Activity	%	55.0
	12222546	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	86.0	CHEMBL4226	Homo sapiens	Residual Activity	%	86.0
	12222547	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	80.0	CHEMBL4226	Homo sapiens	Residual Activity	%	80.0
	12222548	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	105.0	CHEMBL4226	Homo sapiens	Residual Activity	%	105.0
	12222549	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	91.0	CHEMBL4226	Homo sapiens	Residual Activity	%	91.0
	12222550	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	86.0	CHEMBL4226	Homo sapiens	Residual Activity	%	86.0
	12222551	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	74.0	CHEMBL4226	Homo sapiens	Residual Activity	%	74.0
	12222552	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	59.0	CHEMBL4226	Homo sapiens	Residual Activity	%	59.0
	12222553	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	80.0	CHEMBL4226	Homo sapiens	Residual Activity	%	80.0
	12222554	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	90.0	CHEMBL4226	Homo sapiens	Residual Activity	%	90.0
	12222555	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	91.0	CHEMBL4226	Homo sapiens	Residual Activity	%	91.0
	12222556	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	89.0	CHEMBL4226	Homo sapiens	Residual Activity	%	89.0
	12222557	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	85.0	CHEMBL4226	Homo sapiens	Residual Activity	%	85.0
	12222558	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	80.0	CHEMBL4226	Homo sapiens	Residual Activity	%	80.0
	12222559	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	7.0	CHEMBL4226	Homo sapiens	Residual Activity	%	7.0
	12222560	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	66.0	CHEMBL4226	Homo sapiens	Residual Activity	%	66.0
	12224922	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	87.0	CHEMBL4226	Homo sapiens	Residual Activity	%	87.0
	12224923	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	89.0	CHEMBL4226	Homo sapiens	Residual Activity	%	89.0
	12224924	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	80.0	CHEMBL4226	Homo sapiens	Residual Activity	%	80.0
	12224925	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	83.0	CHEMBL4226	Homo sapiens	Residual Activity	%	83.0
	12224926	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	79.0	CHEMBL4226	Homo sapiens	Residual Activity	%	79.0
	12224927	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	59.0	CHEMBL4226	Homo sapiens	Residual Activity	%	59.0
	12224928	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	82.0	CHEMBL4226	Homo sapiens	Residual Activity	%	82.0
	12224929	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	38.0	CHEMBL4226	Homo sapiens	Residual Activity	%	38.0
	12224930	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	76.0	CHEMBL4226	Homo sapiens	Residual Activity	%	76.0
	12224931	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	82.0	CHEMBL4226	Homo sapiens	Residual Activity	%	82.0
	12224932	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	80.0	CHEMBL4226	Homo sapiens	Residual Activity	%	80.0
	12224933	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	83.0	CHEMBL4226	Homo sapiens	Residual Activity	%	83.0
	12224934	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	90.0	CHEMBL4226	Homo sapiens	Residual Activity	%	90.0
	12224935	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	86.0	CHEMBL4226	Homo sapiens	Residual Activity	%	86.0
	12224936	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	80.0	CHEMBL4226	Homo sapiens	Residual Activity	%	80.0
	12224937	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	70.0	CHEMBL4226	Homo sapiens	Residual Activity	%	70.0
	12224938	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	51.0	CHEMBL4226	Homo sapiens	Residual Activity	%	51.0
	12224939	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	87.0	CHEMBL4226	Homo sapiens	Residual Activity	%	87.0
	12224940	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	89.0	CHEMBL4226	Homo sapiens	Residual Activity	%	89.0
	12224941	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	97.0	CHEMBL4226	Homo sapiens	Residual Activity	%	97.0
	12224942	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	77.0	CHEMBL4226	Homo sapiens	Residual Activity	%	77.0
	12224943	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	88.0	CHEMBL4226	Homo sapiens	Residual Activity	%	88.0
	12224944	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	81.0	CHEMBL4226	Homo sapiens	Residual Activity	%	81.0
	12224945	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	19.0	CHEMBL4226	Homo sapiens	Residual Activity	%	19.0
	12224946	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	82.0	CHEMBL4226	Homo sapiens	Residual Activity	%	82.0
	12224947	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	98.0	CHEMBL4226	Homo sapiens	Residual Activity	%	98.0
	12224948	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	76.0	CHEMBL4226	Homo sapiens	Residual Activity	%	76.0
	12224949	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	66.0	CHEMBL4226	Homo sapiens	Residual Activity	%	66.0
	12224950	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	82.0	CHEMBL4226	Homo sapiens	Residual Activity	%	82.0
	12224951	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	86.0	CHEMBL4226	Homo sapiens	Residual Activity	%	86.0
	12224952	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	51.0	CHEMBL4226	Homo sapiens	Residual Activity	%	51.0
	12224953	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	91.0	CHEMBL4226	Homo sapiens	Residual Activity	%	91.0
	12224954	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	77.0	CHEMBL4226	Homo sapiens	Residual Activity	%	77.0
	12224955	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	92.0	CHEMBL4226	Homo sapiens	Residual Activity	%	92.0
	12224956	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	56.0	CHEMBL4226	Homo sapiens	Residual Activity	%	56.0
	12224957	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	94.0	CHEMBL4226	Homo sapiens	Residual Activity	%	94.0
	12224958	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	20.0	CHEMBL4226	Homo sapiens	Residual Activity	%	20.0
	12224959	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	82.0	CHEMBL4226	Homo sapiens	Residual Activity	%	82.0
	12224960	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	99.0	CHEMBL4226	Homo sapiens	Residual Activity	%	99.0
	12224961	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	39.0	CHEMBL4226	Homo sapiens	Residual Activity	%	39.0
	12224962	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	92.0	CHEMBL4226	Homo sapiens	Residual Activity	%	92.0
	12224963	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	84.0	CHEMBL4226	Homo sapiens	Residual Activity	%	84.0
	12224964	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	98.0	CHEMBL4226	Homo sapiens	Residual Activity	%	98.0
	12224965	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	100.0	CHEMBL4226	Homo sapiens	Residual Activity	%	100.0
	12224966	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	79.0	CHEMBL4226	Homo sapiens	Residual Activity	%	79.0
	12224967	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	90.0	CHEMBL4226	Homo sapiens	Residual Activity	%	90.0
	12224968	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	84.0	CHEMBL4226	Homo sapiens	Residual Activity	%	84.0
	12224969	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	53.0	CHEMBL4226	Homo sapiens	Residual Activity	%	53.0
	12224970	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	98.0	CHEMBL4226	Homo sapiens	Residual Activity	%	98.0
	12224971	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	91.0	CHEMBL4226	Homo sapiens	Residual Activity	%	91.0
	12224972	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	94.0	CHEMBL4226	Homo sapiens	Residual Activity	%	94.0
	12224973	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	94.0	CHEMBL4226	Homo sapiens	Residual Activity	%	94.0
	12224974	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	96.0	CHEMBL4226	Homo sapiens	Residual Activity	%	96.0
	12224975	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	95.0	CHEMBL4226	Homo sapiens	Residual Activity	%	95.0
	12224976	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	85.0	CHEMBL4226	Homo sapiens	Residual Activity	%	85.0
	12224977	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	70.0	CHEMBL4226	Homo sapiens	Residual Activity	%	70.0
	12224978	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	72.0	CHEMBL4226	Homo sapiens	Residual Activity	%	72.0
	12224979	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	90.0	CHEMBL4226	Homo sapiens	Residual Activity	%	90.0
	12224980	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	95.0	CHEMBL4226	Homo sapiens	Residual Activity	%	95.0
	12224981	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	99.0	CHEMBL4226	Homo sapiens	Residual Activity	%	99.0
	12224982	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	88.0	CHEMBL4226	Homo sapiens	Residual Activity	%	88.0
	12224983	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	77.0	CHEMBL4226	Homo sapiens	Residual Activity	%	77.0
	12224984	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	79.0	CHEMBL4226	Homo sapiens	Residual Activity	%	79.0
	12224985	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	83.0	CHEMBL4226	Homo sapiens	Residual Activity	%	83.0
	12224986	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	78.0	CHEMBL4226	Homo sapiens	Residual Activity	%	78.0
	12224987	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	89.0	CHEMBL4226	Homo sapiens	Residual Activity	%	89.0
	12224988	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	82.0	CHEMBL4226	Homo sapiens	Residual Activity	%	82.0
	12224989	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	84.0	CHEMBL4226	Homo sapiens	Residual Activity	%	84.0
	12224990	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	94.0	CHEMBL4226	Homo sapiens	Residual Activity	%	94.0
	12224991	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	89.0	CHEMBL4226	Homo sapiens	Residual Activity	%	89.0
	12224992	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	64.0	CHEMBL4226	Homo sapiens	Residual Activity	%	64.0
	12224993	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	71.0	CHEMBL4226	Homo sapiens	Residual Activity	%	71.0
	12224994	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	89.0	CHEMBL4226	Homo sapiens	Residual Activity	%	89.0
	12224995	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	89.0	CHEMBL4226	Homo sapiens	Residual Activity	%	89.0
	12224996	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	97.0	CHEMBL4226	Homo sapiens	Residual Activity	%	97.0
	12224997	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	83.0	CHEMBL4226	Homo sapiens	Residual Activity	%	83.0
	12224998	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	76.0	CHEMBL4226	Homo sapiens	Residual Activity	%	76.0
	12224999	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	55.0	CHEMBL4226	Homo sapiens	Residual Activity	%	55.0
	12225000	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	65.0	CHEMBL4226	Homo sapiens	Residual Activity	%	65.0
	12225001	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	58.0	CHEMBL4226	Homo sapiens	Residual Activity	%	58.0
	12225002	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	86.0	CHEMBL4226	Homo sapiens	Residual Activity	%	86.0
	12225003	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	55.0	CHEMBL4226	Homo sapiens	Residual Activity	%	55.0
	12225004	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	92.0	CHEMBL4226	Homo sapiens	Residual Activity	%	92.0
	12225005	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	85.0	CHEMBL4226	Homo sapiens	Residual Activity	%	85.0
	12225006	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	-4.0	CHEMBL4226	Homo sapiens	Residual Activity	%	-4.0
	12225007	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	87.0	CHEMBL4226	Homo sapiens	Residual Activity	%	87.0
	12225008	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	89.0	CHEMBL4226	Homo sapiens	Residual Activity	%	89.0
	12225009	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	72.0	CHEMBL4226	Homo sapiens	Residual Activity	%	72.0
	12225010	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	89.0	CHEMBL4226	Homo sapiens	Residual Activity	%	89.0
	12225011	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	75.0	CHEMBL4226	Homo sapiens	Residual Activity	%	75.0
	12225012	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	19.0	CHEMBL4226	Homo sapiens	Residual Activity	%	19.0
	12225013	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	88.0	CHEMBL4226	Homo sapiens	Residual Activity	%	88.0
	12225014	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	65.0	CHEMBL4226	Homo sapiens	Residual Activity	%	65.0
	12225015	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	79.0	CHEMBL4226	Homo sapiens	Residual Activity	%	79.0
	12225016	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	76.0	CHEMBL4226	Homo sapiens	Residual Activity	%	76.0
	12225017	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	95.0	CHEMBL4226	Homo sapiens	Residual Activity	%	95.0
	12225018	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	79.0	CHEMBL4226	Homo sapiens	Residual Activity	%	79.0
	12225019	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	77.0	CHEMBL4226	Homo sapiens	Residual Activity	%	77.0
	12225020	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	62.0	CHEMBL4226	Homo sapiens	Residual Activity	%	62.0
	12225021	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	81.0	CHEMBL4226	Homo sapiens	Residual Activity	%	81.0
	12225022	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	77.0	CHEMBL4226	Homo sapiens	Residual Activity	%	77.0
	12225023	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	82.0	CHEMBL4226	Homo sapiens	Residual Activity	%	82.0
	12225024	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	39.0	CHEMBL4226	Homo sapiens	Residual Activity	%	39.0
	12225025	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	87.0	CHEMBL4226	Homo sapiens	Residual Activity	%	87.0
	12225026	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	86.0	CHEMBL4226	Homo sapiens	Residual Activity	%	86.0
	12225027	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	83.0	CHEMBL4226	Homo sapiens	Residual Activity	%	83.0
	12225028	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	79.0	CHEMBL4226	Homo sapiens	Residual Activity	%	79.0
	12225029	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	93.0	CHEMBL4226	Homo sapiens	Residual Activity	%	93.0
	12225030	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	74.0	CHEMBL4226	Homo sapiens	Residual Activity	%	74.0
	12225031	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	77.0	CHEMBL4226	Homo sapiens	Residual Activity	%	77.0
	12225032	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	94.0	CHEMBL4226	Homo sapiens	Residual Activity	%	94.0
	12225033	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	94.0	CHEMBL4226	Homo sapiens	Residual Activity	%	94.0
	12225034	CHEMBL2219004	Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	84.0	CHEMBL4226	Homo sapiens	Residual Activity	%	84.0
	12225035	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	108.0	CHEMBL4226	Homo sapiens	Residual Activity	%	108.0
	12225036	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	29.0	CHEMBL4226	Homo sapiens	Residual Activity	%	29.0
	12225037	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	32.0	CHEMBL4226	Homo sapiens	Residual Activity	%	32.0
	12225038	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	107.0	CHEMBL4226	Homo sapiens	Residual Activity	%	107.0
	12225039	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	33.0	CHEMBL4226	Homo sapiens	Residual Activity	%	33.0
	12225040	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	99.0	CHEMBL4226	Homo sapiens	Residual Activity	%	99.0
	12225041	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	-3.0	CHEMBL4226	Homo sapiens	Residual Activity	%	-3.0
	12225042	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	84.0	CHEMBL4226	Homo sapiens	Residual Activity	%	84.0
	12225043	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	53.0	CHEMBL4226	Homo sapiens	Residual Activity	%	53.0
	12225044	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	112.0	CHEMBL4226	Homo sapiens	Residual Activity	%	112.0
	12225045	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	125.0	CHEMBL4226	Homo sapiens	Residual Activity	%	125.0
	12225046	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	56.0	CHEMBL4226	Homo sapiens	Residual Activity	%	56.0
	12225047	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	142.0	CHEMBL4226	Homo sapiens	Residual Activity	%	142.0
	12225048	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	32.0	CHEMBL4226	Homo sapiens	Residual Activity	%	32.0
	12225049	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	63.0	CHEMBL4226	Homo sapiens	Residual Activity	%	63.0
	12225050	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	73.0	CHEMBL4226	Homo sapiens	Residual Activity	%	73.0
	12225051	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	58.0	CHEMBL4226	Homo sapiens	Residual Activity	%	58.0
	12225052	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	80.0	CHEMBL4226	Homo sapiens	Residual Activity	%	80.0
	12225053	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	52.0	CHEMBL4226	Homo sapiens	Residual Activity	%	52.0
	12225054	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	13.0	CHEMBL4226	Homo sapiens	Residual Activity	%	13.0
	12225055	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	111.0	CHEMBL4226	Homo sapiens	Residual Activity	%	111.0
	12225056	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	129.0	CHEMBL4226	Homo sapiens	Residual Activity	%	129.0
	12225057	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	132.0	CHEMBL4226	Homo sapiens	Residual Activity	%	132.0
	12225058	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	119.0	CHEMBL4226	Homo sapiens	Residual Activity	%	119.0
	12225059	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	116.0	CHEMBL4226	Homo sapiens	Residual Activity	%	116.0
	12225060	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	59.0	CHEMBL4226	Homo sapiens	Residual Activity	%	59.0
	12225061	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	4.0	CHEMBL4226	Homo sapiens	Residual Activity	%	4.0
	12225062	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	118.0	CHEMBL4226	Homo sapiens	Residual Activity	%	118.0
	12225063	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	68.0	CHEMBL4226	Homo sapiens	Residual Activity	%	68.0
	12225064	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	36.0	CHEMBL4226	Homo sapiens	Residual Activity	%	36.0
	12225065	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	132.0	CHEMBL4226	Homo sapiens	Residual Activity	%	132.0
	12225066	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	4.0	CHEMBL4226	Homo sapiens	Residual Activity	%	4.0
	12225067	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	76.0	CHEMBL4226	Homo sapiens	Residual Activity	%	76.0
	12225068	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	112.0	CHEMBL4226	Homo sapiens	Residual Activity	%	112.0
	12225069	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	3.0	CHEMBL4226	Homo sapiens	Residual Activity	%	3.0
	12225070	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	104.0	CHEMBL4226	Homo sapiens	Residual Activity	%	104.0
	12225071	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	48.0	CHEMBL4226	Homo sapiens	Residual Activity	%	48.0
	12225072	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	95.0	CHEMBL4226	Homo sapiens	Residual Activity	%	95.0
	12225073	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	145.0	CHEMBL4226	Homo sapiens	Residual Activity	%	145.0
	12225074	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	53.0	CHEMBL4226	Homo sapiens	Residual Activity	%	53.0
	12225075	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	92.0	CHEMBL4226	Homo sapiens	Residual Activity	%	92.0
	12225076	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	91.0	CHEMBL4226	Homo sapiens	Residual Activity	%	91.0
	12225077	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	1.0	CHEMBL4226	Homo sapiens	Residual Activity	%	1.0
	12225078	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	1.0	CHEMBL4226	Homo sapiens	Residual Activity	%	1.0
	12225079	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	46.0	CHEMBL4226	Homo sapiens	Residual Activity	%	46.0
	12225080	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	108.0	CHEMBL4226	Homo sapiens	Residual Activity	%	108.0
	12225081	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	126.0	CHEMBL4226	Homo sapiens	Residual Activity	%	126.0
	12225082	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	11.0	CHEMBL4226	Homo sapiens	Residual Activity	%	11.0
	12225083	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	119.0	CHEMBL4226	Homo sapiens	Residual Activity	%	119.0
	12225084	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	30.0	CHEMBL4226	Homo sapiens	Residual Activity	%	30.0
	12225085	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	45.0	CHEMBL4226	Homo sapiens	Residual Activity	%	45.0
	12225086	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	6.0	CHEMBL4226	Homo sapiens	Residual Activity	%	6.0
	12225087	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	3.0	CHEMBL4226	Homo sapiens	Residual Activity	%	3.0
	12225088	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	98.0	CHEMBL4226	Homo sapiens	Residual Activity	%	98.0
	12225089	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	116.0	CHEMBL4226	Homo sapiens	Residual Activity	%	116.0
	12225090	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	61.0	CHEMBL4226	Homo sapiens	Residual Activity	%	61.0
	12225091	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	39.0	CHEMBL4226	Homo sapiens	Residual Activity	%	39.0
	12225092	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	64.0	CHEMBL4226	Homo sapiens	Residual Activity	%	64.0
	12225093	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	14.0	CHEMBL4226	Homo sapiens	Residual Activity	%	14.0
	12225094	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	89.0	CHEMBL4226	Homo sapiens	Residual Activity	%	89.0
	12225095	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	29.0	CHEMBL4226	Homo sapiens	Residual Activity	%	29.0
	12225096	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	4.0	CHEMBL4226	Homo sapiens	Residual Activity	%	4.0
	12225097	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	126.0	CHEMBL4226	Homo sapiens	Residual Activity	%	126.0
	12225098	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	103.0	CHEMBL4226	Homo sapiens	Residual Activity	%	103.0
	12225099	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	132.0	CHEMBL4226	Homo sapiens	Residual Activity	%	132.0
	12225100	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	13.0	CHEMBL4226	Homo sapiens	Residual Activity	%	13.0
	12225101	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	89.0	CHEMBL4226	Homo sapiens	Residual Activity	%	89.0
	12225102	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	100.0	CHEMBL4226	Homo sapiens	Residual Activity	%	100.0
	12225103	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	-1.0	CHEMBL4226	Homo sapiens	Residual Activity	%	-1.0
	12225104	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	99.0	CHEMBL4226	Homo sapiens	Residual Activity	%	99.0
	12225105	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	96.0	CHEMBL4226	Homo sapiens	Residual Activity	%	96.0
	12225106	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	9.0	CHEMBL4226	Homo sapiens	Residual Activity	%	9.0
	12225107	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	21.0	CHEMBL4226	Homo sapiens	Residual Activity	%	21.0
	12225108	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	87.0	CHEMBL4226	Homo sapiens	Residual Activity	%	87.0
	12225109	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	27.0	CHEMBL4226	Homo sapiens	Residual Activity	%	27.0
	12225110	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	10.0	CHEMBL4226	Homo sapiens	Residual Activity	%	10.0
	12225111	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	94.0	CHEMBL4226	Homo sapiens	Residual Activity	%	94.0
	12225112	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	4.0	CHEMBL4226	Homo sapiens	Residual Activity	%	4.0
	12225113	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	81.0	CHEMBL4226	Homo sapiens	Residual Activity	%	81.0
	12225114	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	1.0	CHEMBL4226	Homo sapiens	Residual Activity	%	1.0
	12225115	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	89.0	CHEMBL4226	Homo sapiens	Residual Activity	%	89.0
	12225116	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	0.0	CHEMBL4226	Homo sapiens	Residual Activity	%	0.0
	12225117	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	81.0	CHEMBL4226	Homo sapiens	Residual Activity	%	81.0
	12225118	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	90.0	CHEMBL4226	Homo sapiens	Residual Activity	%	90.0
	12225119	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	28.0	CHEMBL4226	Homo sapiens	Residual Activity	%	28.0
	12225120	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	89.0	CHEMBL4226	Homo sapiens	Residual Activity	%	89.0
	12225121	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	86.0	CHEMBL4226	Homo sapiens	Residual Activity	%	86.0
	12225122	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	98.0	CHEMBL4226	Homo sapiens	Residual Activity	%	98.0
	12225123	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	87.0	CHEMBL4226	Homo sapiens	Residual Activity	%	87.0
	12225124	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	54.0	CHEMBL4226	Homo sapiens	Residual Activity	%	54.0
	12225125	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	81.0	CHEMBL4226	Homo sapiens	Residual Activity	%	81.0
	12225126	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	90.0	CHEMBL4226	Homo sapiens	Residual Activity	%	90.0
	12225127	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	15.0	CHEMBL4226	Homo sapiens	Residual Activity	%	15.0
	12225128	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	92.0	CHEMBL4226	Homo sapiens	Residual Activity	%	92.0
	12225129	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	81.0	CHEMBL4226	Homo sapiens	Residual Activity	%	81.0
	12225130	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	81.0	CHEMBL4226	Homo sapiens	Residual Activity	%	81.0
	12225131	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	84.0	CHEMBL4226	Homo sapiens	Residual Activity	%	84.0
	12225132	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	96.0	CHEMBL4226	Homo sapiens	Residual Activity	%	96.0
	12225133	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	88.0	CHEMBL4226	Homo sapiens	Residual Activity	%	88.0
	12225134	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	96.0	CHEMBL4226	Homo sapiens	Residual Activity	%	96.0
	12225135	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	53.0	CHEMBL4226	Homo sapiens	Residual Activity	%	53.0
	12225136	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	33.0	CHEMBL4226	Homo sapiens	Residual Activity	%	33.0
	12225137	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	71.0	CHEMBL4226	Homo sapiens	Residual Activity	%	71.0
	12225138	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	85.0	CHEMBL4226	Homo sapiens	Residual Activity	%	85.0
	12225139	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	82.0	CHEMBL4226	Homo sapiens	Residual Activity	%	82.0
	12225140	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	67.0	CHEMBL4226	Homo sapiens	Residual Activity	%	67.0
	12225141	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	40.0	CHEMBL4226	Homo sapiens	Residual Activity	%	40.0
	12225142	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	72.0	CHEMBL4226	Homo sapiens	Residual Activity	%	72.0
	12225143	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	81.0	CHEMBL4226	Homo sapiens	Residual Activity	%	81.0
	12225144	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	67.0	CHEMBL4226	Homo sapiens	Residual Activity	%	67.0
	12225145	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	87.0	CHEMBL4226	Homo sapiens	Residual Activity	%	87.0
	12225146	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	84.0	CHEMBL4226	Homo sapiens	Residual Activity	%	84.0
	12225147	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	60.0	CHEMBL4226	Homo sapiens	Residual Activity	%	60.0
	12225148	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	76.0	CHEMBL4226	Homo sapiens	Residual Activity	%	76.0
	12225149	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	82.0	CHEMBL4226	Homo sapiens	Residual Activity	%	82.0
	12225150	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	74.0	CHEMBL4226	Homo sapiens	Residual Activity	%	74.0
	12225151	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	45.0	CHEMBL4226	Homo sapiens	Residual Activity	%	45.0
	12225152	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	86.0	CHEMBL4226	Homo sapiens	Residual Activity	%	86.0
	12225153	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	68.0	CHEMBL4226	Homo sapiens	Residual Activity	%	68.0
	12225154	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	86.0	CHEMBL4226	Homo sapiens	Residual Activity	%	86.0
	12225155	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	52.0	CHEMBL4226	Homo sapiens	Residual Activity	%	52.0
	12225156	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	30.0	CHEMBL4226	Homo sapiens	Residual Activity	%	30.0
	12225157	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	12.0	CHEMBL4226	Homo sapiens	Residual Activity	%	12.0
	12225158	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	45.0	CHEMBL4226	Homo sapiens	Residual Activity	%	45.0
	12225159	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	25.0	CHEMBL4226	Homo sapiens	Residual Activity	%	25.0
	12225160	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	88.0	CHEMBL4226	Homo sapiens	Residual Activity	%	88.0
	12225161	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	11.0	CHEMBL4226	Homo sapiens	Residual Activity	%	11.0
	12227529	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	75.0	CHEMBL4226	Homo sapiens	Residual Activity	%	75.0
	12227530	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	73.0	CHEMBL4226	Homo sapiens	Residual Activity	%	73.0
	12227531	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	-5.0	CHEMBL4226	Homo sapiens	Residual Activity	%	-5.0
	12227532	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	62.0	CHEMBL4226	Homo sapiens	Residual Activity	%	62.0
	12227533	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	88.0	CHEMBL4226	Homo sapiens	Residual Activity	%	88.0
	12227534	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	34.0	CHEMBL4226	Homo sapiens	Residual Activity	%	34.0
	12227535	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	79.0	CHEMBL4226	Homo sapiens	Residual Activity	%	79.0
	12227536	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	63.0	CHEMBL4226	Homo sapiens	Residual Activity	%	63.0
	12227537	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	-2.0	CHEMBL4226	Homo sapiens	Residual Activity	%	-2.0
	12227538	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	71.0	CHEMBL4226	Homo sapiens	Residual Activity	%	71.0
	12227539	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	20.0	CHEMBL4226	Homo sapiens	Residual Activity	%	20.0
	12227540	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	54.0	CHEMBL4226	Homo sapiens	Residual Activity	%	54.0
	12227541	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	66.0	CHEMBL4226	Homo sapiens	Residual Activity	%	66.0
	12227542	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	92.0	CHEMBL4226	Homo sapiens	Residual Activity	%	92.0
	12227543	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	79.0	CHEMBL4226	Homo sapiens	Residual Activity	%	79.0
	12227544	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	32.0	CHEMBL4226	Homo sapiens	Residual Activity	%	32.0
	12227545	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	23.0	CHEMBL4226	Homo sapiens	Residual Activity	%	23.0
	12227546	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	76.0	CHEMBL4226	Homo sapiens	Residual Activity	%	76.0
	12227547	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	59.0	CHEMBL4226	Homo sapiens	Residual Activity	%	59.0
	12227548	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	76.0	CHEMBL4226	Homo sapiens	Residual Activity	%	76.0
	12227549	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	6.0	CHEMBL4226	Homo sapiens	Residual Activity	%	6.0
	12227550	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	83.0	CHEMBL4226	Homo sapiens	Residual Activity	%	83.0
	12227551	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	84.0	CHEMBL4226	Homo sapiens	Residual Activity	%	84.0
	12227552	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	46.0	CHEMBL4226	Homo sapiens	Residual Activity	%	46.0
	12227553	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	52.0	CHEMBL4226	Homo sapiens	Residual Activity	%	52.0
	12227554	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	86.0	CHEMBL4226	Homo sapiens	Residual Activity	%	86.0
	12227555	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	78.0	CHEMBL4226	Homo sapiens	Residual Activity	%	78.0
	12227556	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	87.0	CHEMBL4226	Homo sapiens	Residual Activity	%	87.0
	12227557	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	92.0	CHEMBL4226	Homo sapiens	Residual Activity	%	92.0
	12227558	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	90.0	CHEMBL4226	Homo sapiens	Residual Activity	%	90.0
	12227559	CHEMBL2219005	Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	51.0	CHEMBL4226	Homo sapiens	Residual Activity	%	51.0
	12728867	CHEMBL2349951	Inhibition of CLK3 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	91.0	CHEMBL4226	Homo sapiens	Activity	%	91.0
	12730009	CHEMBL2353653	Inhibition of CLK3 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	101.0	CHEMBL4226	Homo sapiens	Activity	%	101.0
	12730257	CHEMBL2349951	Inhibition of CLK3 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	95.0	CHEMBL4226	Homo sapiens	Activity	%	95.0
	12730888	CHEMBL2349816	Inhibition of CLK3 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	95.0	CHEMBL4226	Homo sapiens	Activity	%	95.0
	13341502	CHEMBL2394342	Inhibition of CLK3 (unknown origin)	B	Clc1cc(Cl)cc(CNc2ncncc2-c2ccc3c(c2)OCO3)c1		CHEMBL1885748	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	nM	10000.0
	13341503	CHEMBL2394342	Inhibition of CLK3 (unknown origin)	B	FC(F)(F)c1cccc(Nc2nccc(-c3ccc4c(c3)OCO4)n2)c1		CHEMBL1868723	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	nM	10000.0
	13341505	CHEMBL2394342	Inhibition of CLK3 (unknown origin)	B	Clc1ccc(CNc2nccc(-c3ccc4c(c3)OCCO4)n2)cc1Cl		CHEMBL1904905	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	nM	10000.0
	13341506	CHEMBL2394342	Inhibition of CLK3 (unknown origin)	B	Clc1cc(Cl)cc(CNc2nccc(-c3ccc4c(c3)OCO4)n2)c1		CHEMBL2392364	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	nM	10000.0
	13341548	CHEMBL2394342	Inhibition of CLK3 (unknown origin)	B	Clc1ccc(CNc2nccc(-c3ccc4c(c3)OCO4)n2)cc1Cl		CHEMBL1898197	=	IC50	nM	3634.0	CHEMBL4226	Homo sapiens	IC50	nM	3634.0
	13341551	CHEMBL2394342	Inhibition of CLK3 (unknown origin)	B	Brc1ccc(CNc2nccc(-c3ccc4c(c3)OCO4)n2)cc1Br		CHEMBL1899256	=	IC50	nM	3232.0	CHEMBL4226	Homo sapiens	IC50	nM	3232.0
	13341552	CHEMBL2394342	Inhibition of CLK3 (unknown origin)	B	Clc1ccc(CNc2nccc(-c3ccc4[nH]ncc4c3)n2)cc1Cl		CHEMBL1892019	=	IC50	nM	2934.0	CHEMBL4226	Homo sapiens	IC50	nM	2934.0
	13341553	CHEMBL2394342	Inhibition of CLK3 (unknown origin)	B	c1cncc(CNc2nccc(-c3ccc4[nH]ncc4c3)n2)c1		CHEMBL1902528	=	IC50	nM	2663.0	CHEMBL4226	Homo sapiens	IC50	nM	2663.0
	13341567	CHEMBL2394342	Inhibition of CLK3 (unknown origin)	B	c1cncc(CNc2nccc(-c3ccc4c(c3)OCO4)n2)c1		CHEMBL1877990	=	IC50	nM	1473.0	CHEMBL4226	Homo sapiens	IC50	nM	1473.0
	13341588	CHEMBL2394350	Inhibition of human recombinant CLK3 (275 to 632 amino acids) expressed in Escherichia coli BL21(DE3) preincubated for 10 mins prior to substrate addition by LDH assay	B	CCOC(=O)c1c(/C(C#N)=C\N)c2ccc(Cl)c(Cl)c2n1C		CHEMBL1236620	=	IC50	nM	530.0	CHEMBL4226	Homo sapiens	IC50	nM	530.0
	13342325	CHEMBL2394157	Competitive binding affinity to CLK3 (unknown origin) assessed as enzyme remaining bound to anchored active-site ligand at 10 uM relative to control	B	Clc1ccc(CNc2nccc(-c3ccc4[nH]ncc4c3)n2)cc1Cl		CHEMBL1892019	<	Activity	%	30.0	CHEMBL4226	Homo sapiens	Activity	%	30.0
	13375910	CHEMBL2405319	Inhibition of CLK3 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	2.0	CHEMBL4226	Homo sapiens	INH	%	2.0
	13442384	CHEMBL2428006	Competitive binding affinity to CLK3 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL4226	Homo sapiens	INH	%	50.0
	13445519	CHEMBL2428006	Competitive binding affinity to CLK3 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	94.0	CHEMBL4226	Homo sapiens	INH	%	94.0
	13448574	CHEMBL2428006	Competitive binding affinity to CLK3 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL4226	Homo sapiens	INH	%	50.0
	13448710	CHEMBL2428006	Competitive binding affinity to CLK3 (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL4226	Homo sapiens	INH	%	50.0
	13451505	CHEMBL2428006	Competitive binding affinity to CLK3 (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	=	Inhibition	%	94.0	CHEMBL4226	Homo sapiens	INH	%	94.0
	13454690	CHEMBL2428006	Competitive binding affinity to CLK3 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	82.0	CHEMBL4226	Homo sapiens	INH	%	82.0
	13872176	CHEMBL3101928	Inhibition of human CLK3 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	86.0	CHEMBL4226	Homo sapiens	Activity	%	86.0
	14582470	CHEMBL3240430	Inhibition of human CLK3 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	96.0	CHEMBL4226	Homo sapiens	Activity	%	96.0
	14750918	CHEMBL3299310	Inhibition of CLK3 (unknown origin)	B	COc1c(O)ccc2c(=O)c3c(O)cc4c(c3[nH]c12)C=CC(C)(C)O4		CHEMBL3297832	=	IC50	nM	2300.0	CHEMBL4226	Homo sapiens	IC50	uM	2.3
	15258345	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Thermal melting change	degrees C	2.2	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	2.2
	15258405	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Thermal melting change	degrees C	0.9	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.9
	15258465	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Thermal melting change	degrees C	2.5	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	2.5
	15258525	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Thermal melting change	degrees C	3.5	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	3.5
	15258585	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Thermal melting change	degrees C	0.9	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.9
	15258645	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Thermal melting change	degrees C	0.5	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.5
	15258705	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Thermal melting change	degrees C	3.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	3.0
	15258765	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=C(O)Cc1ccc(O)c([N+](=O)[O-])c1		CHEMBL501822	=	Thermal melting change	degrees C	-0.6	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	-0.6
	15258825	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	Thermal melting change	degrees C	1.3	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	1.3
	15258885	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Thermal melting change	degrees C	2.3	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	2.3
	15258945	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1642	=	Thermal melting change	degrees C	0.5	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.5
	15259005	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Thermal melting change	degrees C	4.9	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	4.9
	15259065	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Thermal melting change	degrees C	2.3	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	2.3
	15259125	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL216543	=	Thermal melting change	degrees C	4.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	4.0
	15259185	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Thermal melting change	degrees C	14.7	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	14.7
	15259245	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Cn1cc(/C=C2/C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL3430785	=	Thermal melting change	degrees C	3.2	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	3.2
	15259305	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B			CHEMBL3430786	=	Thermal melting change	degrees C	-0.7	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	-0.7
	15259365	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CCOc1ccc(/C=C2/SC(=O)N(CCN)C2=O)cc1		CHEMBL262615	=	Thermal melting change	degrees C	0.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.1
	15259425	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=c1c(-c2ccc(F)cc2)c(-c2ccncc2)[nH]n1-c1ccc(Cl)cc1		CHEMBL408678	=	Thermal melting change	degrees C	0.3	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.3
	15259485	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Thermal melting change	degrees C	-0.2	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	-0.2
	15259545	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Thermal melting change	degrees C	0.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.1
	15259605	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL97162	=	Thermal melting change	degrees C	0.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.1
	15259665	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Thermal melting change	degrees C	0.3	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.3
	15259725	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Thermal melting change	degrees C	2.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	2.1
	15259785	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl		CHEMBL406381	=	Thermal melting change	degrees C	0.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.1
	15259845	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Thermal melting change	degrees C	0.4	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.4
	15259905	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Thermal melting change	degrees C	0.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.1
	15259965	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Cl.NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL558969	=	Thermal melting change	degrees C	1.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	1.0
	15260025	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641	=	Thermal melting change	degrees C	3.7	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	3.7
	15260085	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Thermal melting change	degrees C	0.3	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.3
	15260145	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Thermal melting change	degrees C	0.4	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.4
	15260205	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B			CHEMBL3430787	=	Thermal melting change	degrees C	6.3	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	6.3
	15260265	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Thermal melting change	degrees C	1.5	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	1.5
	15260325	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CN(c1cccnc1)c1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cn1		CHEMBL261238	=	Thermal melting change	degrees C	1.2	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	1.2
	15260385	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Thermal melting change	degrees C	0.6	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.6
	15260445	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Thermal melting change	degrees C	-0.5	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	-0.5
	15260505	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	=	Thermal melting change	degrees C	4.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	4.0
	15260565	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Thermal melting change	degrees C	0.6	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.6
	15260625	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B			CHEMBL3430788	=	Thermal melting change	degrees C	0.6	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.6
	15260685	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Thermal melting change	degrees C	6.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	6.1
	15260745	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Thermal melting change	degrees C	-0.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	-0.1
	15260805	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CN1CCc2[nH]c(=S)c(C#N)c(-c3cccs3)c2C1		CHEMBL261211	=	Thermal melting change	degrees C	-0.2	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	-0.2
	15260865	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(O)c1c(F)cccc1F		CHEMBL259605	=	Thermal melting change	degrees C	3.4	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	3.4
	15260925	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Thermal melting change	degrees C	4.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	4.1
	15260985	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Thermal melting change	degrees C	1.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	1.1
	15261045	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1		CHEMBL258940	=	Thermal melting change	degrees C	2.7	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	2.7
	15261105	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Thermal melting change	degrees C	0.8	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.8
	15261188	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Thermal melting change	degrees C	0.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.1
	15261248	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Thermal melting change	degrees C	2.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	2.0
	15261308	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Nc1cc2ncnc(Nc3cccc(Br)c3)c2cc1N		CHEMBL328216	=	Thermal melting change	degrees C	1.6	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	1.6
	15261368	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Thermal melting change	degrees C	0.3	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.3
	15261423	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1		CHEMBL255465	=	Thermal melting change	degrees C	4.5	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	4.5
	15261483	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O		CHEMBL435734	=	Thermal melting change	degrees C	0.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.0
	15261543	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=C1C=C2C(=Nc3c2c2c(c4c3=NC3=C4CCC=C3)C=NC=2)CC1		CHEMBL408953	=	Thermal melting change	degrees C	2.3	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	2.3
	15261603	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC.[Cl-]		CHEMBL258893	=	Thermal melting change	degrees C	-1.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	-1.0
	15261676	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL29197	=	Thermal melting change	degrees C	0.2	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.2
	15261736	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	C[S+]([O-])c1ccc(CSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL111456	=	Thermal melting change	degrees C	-0.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	-0.1
	15261796	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Thermal melting change	degrees C	3.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	3.1
	15261856	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44	=	Thermal melting change	degrees C	1.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	1.0
	15261912	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Thermal melting change	degrees C	0.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.1
	15261972	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CC(C)c1cc(/C=C(\C#N)C(=O)NCCCc2ccccc2)cc(C(C)C)c1O		CHEMBL261508	=	Thermal melting change	degrees C	1.2	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	1.2
	15262032	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Thermal melting change	degrees C	0.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.0
	15262092	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B			CHEMBL3430782	=	Thermal melting change	degrees C	1.9	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	1.9
	15262165	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Thermal melting change	degrees C	0.2	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.2
	15262225	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Thermal melting change	degrees C	0.7	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.7
	15262285	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Thermal melting change	degrees C	7.3	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	7.3
	15262345	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=C(O)c1cc(NCc2cc(O)ccc2O)ccc1O		CHEMBL319620	=	Thermal melting change	degrees C	0.2	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.2
	15262405	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	OC[C@H]1O[C@@H](n2cnc3cc(Cl)c(Cl)cc32)[C@H](O)[C@@H]1O		CHEMBL375530	=	Thermal melting change	degrees C	1.4	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	1.4
	15262465	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=C(O)c1cc(N(Cc2ccccc2O)Cc2cc(O)ccc2O)ccc1O		CHEMBL103552	=	Thermal melting change	degrees C	0.3	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.3
	15262525	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C\c1cc(Br)c(O)c(Br)c1		CHEMBL264949	=	Thermal melting change	degrees C	0.5	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.5
	15262585	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Thermal melting change	degrees C	1.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	1.0
	15262645	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CN(C)c1ncnc2nc[nH]c12		CHEMBL407391	=	Thermal melting change	degrees C	0.4	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.4
	15262705	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Cc1ccc2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL405992	=	Thermal melting change	degrees C	0.6	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.6
	15262765	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=c1ccc2ccc(O)c(O)c2o1		CHEMBL244948	=	Thermal melting change	degrees C	0.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.1
	15262825	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	COc1cc(O)c2c(c1)oc(=O)c1c3cc(O)c(O)cc3oc21		CHEMBL97453	=	Thermal melting change	degrees C	2.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	2.1
	15262885	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Thermal melting change	degrees C	1.5	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	1.5
	15262945	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Thermal melting change	degrees C	0.5	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.5
	15263005	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Thermal melting change	degrees C	0.8	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.8
	15263065	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Thermal melting change	degrees C	1.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	1.0
	15263125	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	N#CC(C#N)=Cc1ccc(O)c(O)c1		CHEMBL76904	=	Thermal melting change	degrees C	0.4	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.4
	15263185	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Thermal melting change	degrees C	0.5	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.5
	15263245	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)Nc1ccccc1		CHEMBL56731	=	Thermal melting change	degrees C	0.2	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.2
	15263305	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CCOc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccccc2)c1O		CHEMBL485070	=	Thermal melting change	degrees C	0.3	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.3
	15263365	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br		CHEMBL228043	=	Thermal melting change	degrees C	0.3	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.3
	15263401	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Thermal melting change	degrees C	-0.8	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	-0.8
	15263461	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Thermal melting change	degrees C	1.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	1.0
	15263516	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=C1c2ccccc2-c2n[nH]c3cccc1c23		CHEMBL7064	=	Thermal melting change	degrees C	2.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	2.0
	15263576	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B			CHEMBL3430783	=	Thermal melting change	degrees C	0.9	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.9
	15263636	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccccc2)c2ccc(F)cc2)CC1		CHEMBL259388	=	Thermal melting change	degrees C	3.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	3.0
	15263696	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Cc1c2ccncc2c(C)c2c1[nH]c1ccccc12		CHEMBL123	=	Thermal melting change	degrees C	4.2	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	4.2
	15263770	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Thermal melting change	degrees C	2.6	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	2.6
	15263830	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Thermal melting change	degrees C	-0.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	-0.1
	15263890	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CN(C)c1ccc(CC2C(=O)Nc3ccccc32)cc1		CHEMBL1373282	=	Thermal melting change	degrees C	0.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.1
	15263950	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCC(Br)C2		CHEMBL408565	=	Thermal melting change	degrees C	1.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	1.0
	15264004	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CCOC(=O)c1cnc2oc3ccc(O)cc3c2c1-c1ccccc1		CHEMBL132904	=	Thermal melting change	degrees C	1.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	1.0
	15264064	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-]		CHEMBL258765	=	Thermal melting change	degrees C	-0.9	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	-0.9
	15264124	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O		CHEMBL278315	=	Thermal melting change	degrees C	-0.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	-0.1
	15264184	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Thermal melting change	degrees C	0.7	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.7
	15264257	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cnc[nH]1		CHEMBL261692	=	Thermal melting change	degrees C	1.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	1.0
	15264317	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=S(=O)(c1cccc2c(Cl)cccc12)N1CCCNCC1		CHEMBL429298	=	Thermal melting change	degrees C	-0.2	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	-0.2
	15264377	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O		CHEMBL116438	=	Thermal melting change	degrees C	3.6	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	3.6
	15264437	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	Thermal melting change	degrees C	8.3	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	8.3
	15264493	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Thermal melting change	degrees C	2.7	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	2.7
	15264553	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	COC(=O)[C@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL416056	=	Thermal melting change	degrees C	0.6	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.6
	15264613	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Thermal melting change	degrees C	-0.3	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	-0.3
	15264673	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Cl.NCCNS(=O)(=O)c1cccc2c(Cl)cccc12		CHEMBL1255867	=	Thermal melting change	degrees C	-0.2	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	-0.2
	15264745	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Cc1cc(C=C2C(=O)C=CC2=O)cc(C)c1O		CHEMBL437612	=	Thermal melting change	degrees C	-1.5	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	-1.5
	15264805	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CC(C)(C)c1cc(C=C2C(=O)C=CC2=O)cc(C(C)(C)C)c1O		CHEMBL258726	=	Thermal melting change	degrees C	0.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.1
	15264865	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Thermal melting change	degrees C	2.4	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	2.4
	15264925	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CC(C)N(CCO)c1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL126254	=	Thermal melting change	degrees C	4.2	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	4.2
	15264981	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	N=C(N)NCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL143054	=	Thermal melting change	degrees C	0.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.0
	15265041	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CNC(=O)c1cc(Oc2ccc(Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL3430784	=	Thermal melting change	degrees C	0.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.0
	15265101	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Thermal melting change	degrees C	0.4	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.4
	15265161	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CCn1cnc2c(N)nc(N(c3cccc(Cl)c3)[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL411901	=	Thermal melting change	degrees C	2.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	2.0
	15265234	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Thermal melting change	degrees C	4.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	4.0
	15265294	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL280074	=	Thermal melting change	degrees C	-0.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	-0.1
	15265354	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3O)nc(NCCCO)nc21		CHEMBL419931	=	Thermal melting change	degrees C	0.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.1
	15265414	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Thermal melting change	degrees C	0.6	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.6
	15265470	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Thermal melting change	degrees C	1.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	1.0
	15265530	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Thermal melting change	degrees C	0.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.0
	15265590	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Thermal melting change	degrees C	0.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.0
	15265650	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1		CHEMBL414883	=	Thermal melting change	degrees C	0.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.0
	15265710	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Thermal melting change	degrees C	4.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	4.1
	15265722	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Thermal melting change	degrees C	0.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.1
	15265782	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Thermal melting change	degrees C	0.8	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.8
	15265842	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=C(O)/C=C/c1cc(CO)ccc1CO		CHEMBL407534	=	Thermal melting change	degrees C	0.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.0
	15265902	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Thermal melting change	degrees C	0.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.0
	15266019	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Oc1cc(O)cc(/C=C/c2ccc(O)c(O)c2)c1		CHEMBL69863	=	Thermal melting change	degrees C	0.7	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.7
	15266079	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	N#C/C(=C(/N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL261237	=	Thermal melting change	degrees C	0.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.0
	15266139	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL411645	=	Thermal melting change	degrees C	3.5	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	3.5
	15266199	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=C1Nc2ccc(S(=O)(=O)O)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL440411	=	Thermal melting change	degrees C	3.5	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	3.5
	15266211	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=C1CC(=O)c2[nH]c3c4[nH]c5c(c4c4cn(Br)cc4c3c2C1)CCC=C5		CHEMBL264685	=	Thermal melting change	degrees C	1.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	1.0
	15266271	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Thermal melting change	degrees C	-1.3	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	-1.3
	15266331	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Thermal melting change	degrees C	1.5	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	1.5
	15266391	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=C1Nc2ccccc2/C1=C\c1ccc[nH]1		CHEMBL101797	=	Thermal melting change	degrees C	0.5	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.5
	15266451	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	Thermal melting change	degrees C	5.4	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	5.4
	15266506	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CC(=O)O/N=C1C(=C2/C(=O)Nc3cc(Br)ccc32)/Nc2ccccc2/1		CHEMBL430226	=	Thermal melting change	degrees C	-0.4	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	-0.4
	15266566	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Thermal melting change	degrees C	2.7	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	2.7
	15266626	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CC(=O)O.Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3430781	=	Thermal melting change	degrees C	3.5	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	3.5
	15266686	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Thermal melting change	degrees C	2.5	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	2.5
	15266759	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Thermal melting change	degrees C	0.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.0
	15266819	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Thermal melting change	degrees C	1.3	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	1.3
	15266879	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Thermal melting change	degrees C	0.2	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.2
	15266939	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Thermal melting change	degrees C	0.5	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.5
	15266994	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CS(=O)(=O)O.Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL1591531	=	Thermal melting change	degrees C	4.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	4.1
	15267054	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Cl.Cn1cc(C2=C(c3ccc4cc5n(c4c3)CCC(CN)C5)C(=O)NC2=O)c2ccccc21		CHEMBL541401	=	Thermal melting change	degrees C	0.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.0
	15267114	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CN(C)CC1CCn2c(c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc32)C1		CHEMBL372585	=	Thermal melting change	degrees C	0.3	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.3
	15267174	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	CN[C@@H]1CC2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL162	=	Thermal melting change	degrees C	4.2	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	4.2
	15267247	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Thermal melting change	degrees C	0.0	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.0
	15267307	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	Thermal melting change	degrees C	0.5	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.5
	15267367	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Thermal melting change	degrees C	-0.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	-0.1
	15267427	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Thermal melting change	degrees C	-0.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	-0.1
	15267482	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	O=c1sn(Cc2ccccc2)c(=S)n1Cc1ccccc1		CHEMBL24338	=	Thermal melting change	degrees C	-0.3	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	-0.3
	15267542	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	C=CNC#N		CHEMBL259526	=	Thermal melting change	degrees C	0.2	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.2
	15267602	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(/N)Sc1ccccc1N		CHEMBL100473	=	Thermal melting change	degrees C	0.3	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.3
	15267662	CHEMBL3430804	Delta TM value showing the stabilisation of CLK3 produced by compound binding	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Thermal melting change	degrees C	0.1	CHEMBL4226	Homo sapiens	Thermal melting change	degrees C	0.1
	15756049	CHEMBL3632424	Inhibition of CLK3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	36.74	CHEMBL4226	Homo sapiens	INH	%	36.74
	15757010	CHEMBL3632424	Inhibition of CLK3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	9.12	CHEMBL4226	Homo sapiens	INH	%	9.12
	15758673	CHEMBL3632424	Inhibition of CLK3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	5.68	CHEMBL4226	Homo sapiens	INH	%	5.68
	16425312	CHEMBL3751072	Inhibition of CLK3 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	2.9	CHEMBL4226	Homo sapiens	INH	%	2.9
	16431790	CHEMBL3748994	Inhibition of human CLK3 using MBP as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	uM	10.0
	16450797	CHEMBL3762315	Inhibition of CLK3 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	3.3	CHEMBL4226	Homo sapiens	INH	%	3.3
	16495377	CHEMBL3778357	Inhibition of N-terminal His6-tagged recombinant human CLK3 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	0.0	CHEMBL4226	Homo sapiens	Activity	%	0.0
	16506479	CHEMBL3778445	Inhibition of recombinant human GST-tagged CLK3 expressed in baculovirus expression system at 5 uM by lantha screen kinase binding assay relative to control	B	O=C1NC(=S)S/C1=C\c1ccc2ncsc2c1		CHEMBL3775393	=	Inhibition	%	44.0	CHEMBL4226	Homo sapiens	INH	%	44.0
	16506480	CHEMBL3778446	Inhibition of recombinant human GST-tagged CLK3 expressed in baculovirus expression system at 1 uM by lantha screen kinase binding assay relative to control	B	O=C1NC(=S)S/C1=C\c1ccc2ncccc2c1		CHEMBL3774448	=	Inhibition	%	95.0	CHEMBL4226	Homo sapiens	INH	%	95.0
	16506535	CHEMBL3778447	Inhibition of recombinant human GST-tagged CLK3 expressed in baculovirus expression system by lantha screen kinase binding assay	B	O=C1NC(=S)S/C1=C\c1ccc2ncccc2c1		CHEMBL3774448	=	IC50	nM	86.6	CHEMBL4226	Homo sapiens	IC50	nM	86.6
	16508146	CHEMBL3778357	Inhibition of N-terminal His6-tagged recombinant human CLK3 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-10.0	CHEMBL4226	Homo sapiens	Activity	%	-10.0
	16509123	CHEMBL3778357	Inhibition of N-terminal His6-tagged recombinant human CLK3 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-5.0	CHEMBL4226	Homo sapiens	Activity	%	-5.0
	16614437	CHEMBL3817303	Inhibition of human CLK3 at 1 uM using MBP as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	8.0	CHEMBL4226	Homo sapiens	INH	%	8.0
	16618253	CHEMBL3817071	Inhibition of full length recombinant human GST-tagged CLK3 expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL4226	Homo sapiens	INH	%	50.0
	16836273	CHEMBL3875860	Inhibition of GST-tagged human recombinant CLK3 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	N#C/C(=C\c1cccnc1)c1c[nH]c2ncccc12		CHEMBL3753668	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	uM	10.0
	16836274	CHEMBL3875860	Inhibition of GST-tagged human recombinant CLK3 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1ccc2c(/C(C#N)=C/c3cccnc3)c[nH]c2n1		CHEMBL3884570	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	uM	10.0
	16836275	CHEMBL3875860	Inhibition of GST-tagged human recombinant CLK3 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	N#Cc1cc2ccncc2c2[nH]c3ccccc3c12		CHEMBL3883820	=	IC50	nM	1800.0	CHEMBL4226	Homo sapiens	IC50	uM	1.8
	16836276	CHEMBL3875860	Inhibition of GST-tagged human recombinant CLK3 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1cccc2[nH]c3c4ccncc4cc(C#N)c3c12		CHEMBL3884250	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	uM	10.0
	16836277	CHEMBL3875860	Inhibition of GST-tagged human recombinant CLK3 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1ccc2[nH]c3c4ccncc4cc(C#N)c3c2c1		CHEMBL3883639	=	IC50	nM	710.0	CHEMBL4226	Homo sapiens	IC50	uM	0.71
	16836278	CHEMBL3875860	Inhibition of GST-tagged human recombinant CLK3 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1ccc2c(c1)[nH]c1c3ccncc3cc(C#N)c21		CHEMBL3883660	=	IC50	nM	190.0	CHEMBL4226	Homo sapiens	IC50	uM	0.19
	16836279	CHEMBL3875860	Inhibition of GST-tagged human recombinant CLK3 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1cccc2c1[nH]c1c3ccncc3cc(C#N)c21		CHEMBL3885431	=	IC50	nM	180.0	CHEMBL4226	Homo sapiens	IC50	uM	0.18
	16836280	CHEMBL3875860	Inhibition of GST-tagged human recombinant CLK3 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	N#Cc1cc2cnccc2c2[nH]c3ncccc3c12		CHEMBL3884015	=	IC50	nM	6800.0	CHEMBL4226	Homo sapiens	IC50	uM	6.8
	16836281	CHEMBL3875860	Inhibition of GST-tagged human recombinant CLK3 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	N#Cc1cc2cnccc2c2[nH]c3ccc(F)cc3c12		CHEMBL3883414	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	uM	10.0
Not Determined	16836282	CHEMBL3875860	Inhibition of GST-tagged human recombinant CLK3 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1ccc2[nH]c3c4c(OC)cncc4cc(C#N)c3c2c1		CHEMBL3884932		IC50			CHEMBL4226	Homo sapiens	IC50		
	16836283	CHEMBL3875860	Inhibition of GST-tagged human recombinant CLK3 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1ccc2c(n1)[nH]c1c3ccncc3cc(C#N)c21		CHEMBL3885316	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	uM	10.0
	16836284	CHEMBL3875860	Inhibition of GST-tagged human recombinant CLK3 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1ccc2c(c1)[nH]c1c3c(OC)cncc3cc(C#N)c21		CHEMBL3884821	=	IC50	nM	320.0	CHEMBL4226	Homo sapiens	IC50	uM	0.32
	16836285	CHEMBL3875860	Inhibition of GST-tagged human recombinant CLK3 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1cccc2c1[nH]c1c3ccncc3cc(C(N)=O)c21		CHEMBL3884627	=	IC50	nM	6100.0	CHEMBL4226	Homo sapiens	IC50	uM	6.1
	16836286	CHEMBL3875860	Inhibition of GST-tagged human recombinant CLK3 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1ccc2c(c1)[nH]c1c3ccncc3cc(CN)c21		CHEMBL3885328	=	IC50	nM	7000.0	CHEMBL4226	Homo sapiens	IC50	uM	7.0
	16836287	CHEMBL3875860	Inhibition of GST-tagged human recombinant CLK3 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1ccc2c(c1)[nH]c1c3ccncc3cc(CNC(C)=O)c21		CHEMBL3885360	=	IC50	nM	8000.0	CHEMBL4226	Homo sapiens	IC50	uM	8.0
Not Determined	16836288	CHEMBL3875860	Inhibition of GST-tagged human recombinant CLK3 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1ccc2c(c1)[nH]c1c3ccncc3cc(CN(C)C)c21		CHEMBL3884845		IC50			CHEMBL4226	Homo sapiens	IC50		
	16836289	CHEMBL3875860	Inhibition of GST-tagged human recombinant CLK3 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1ccc2[nH]c3c(=O)[nH]c(-c4cccnc4)c(C#N)c3c2c1		CHEMBL3885036	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	uM	10.0
	16836290	CHEMBL3875860	Inhibition of GST-tagged human recombinant CLK3 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1ccc2[nH]cc(-c3cc4cnccc4cc3NC(C)=O)c2c1		CHEMBL3885335	=	IC50	nM	7000.0	CHEMBL4226	Homo sapiens	IC50	uM	7.0
	16836291	CHEMBL3875860	Inhibition of GST-tagged human recombinant CLK3 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1ccc2c(-c3ccncc3)c[nH]c2n1		CHEMBL3883448	=	IC50	nM	6100.0	CHEMBL4226	Homo sapiens	IC50	uM	6.1
Inactive	17892671	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892672	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892673	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892674	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892675	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892676	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892677	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892678	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892679	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892680	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892681	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892682	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Active	17892683	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	=	Kd	nM	3498.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	3498.0
Inactive	17892684	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892685	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892686	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892687	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892688	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892689	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892690	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892691	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892692	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892693	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892694	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892695	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892696	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892697	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892698	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892699	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892700	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17892701	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	=	Kd	nM	12.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	12.0
Inactive	17892702	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892703	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892704	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892705	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892706	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892707	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892708	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892709	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892710	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892711	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892712	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892713	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892714	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892715	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892716	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892717	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892718	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892719	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892720	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892721	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892722	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892723	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892724	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892725	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892726	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892727	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892728	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892729	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892730	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892731	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892732	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892733	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892734	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892735	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892736	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892737	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892738	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892739	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892740	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892741	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892742	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892743	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892744	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892745	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892746	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892747	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892748	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892749	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892750	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892751	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892752	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17892753	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	=	Kd	nM	40.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	40.0
Inactive	17892754	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892755	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892756	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892757	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892758	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892759	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892760	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892761	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892762	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892763	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892764	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892765	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892766	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892767	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Active	17892768	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	=	Kd	nM	1479.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	1479.0
Inactive	17892769	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Active	17892770	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	=	Kd	nM	10.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	10.0
Inactive	17892771	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892772	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892773	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892774	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892775	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892776	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892777	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892778	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892779	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892780	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892781	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892782	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892783	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892784	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Active	17892785	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	=	Kd	nM	1397.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	1397.0
Inactive	17892786	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892787	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892788	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892789	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892790	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892791	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892792	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892793	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892794	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892795	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892796	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892797	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892798	CHEMBL3991670	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL4226	Homo sapiens	Kd apparent	nM	30000.0
	18006645	CHEMBL4003367	Inhibition of human CLK3 (275 to 632 residues) expressed in Escherichia coli BL21(DE3) preincubated for 10 mins followed by substrate addition by pyruvate kinase and lactate dehydrogenase coupled enzyme assay	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	IC50	nM	29.2	CHEMBL4226	Homo sapiens	IC50	nM	29.2
	18006646	CHEMBL4003367	Inhibition of human CLK3 (275 to 632 residues) expressed in Escherichia coli BL21(DE3) preincubated for 10 mins followed by substrate addition by pyruvate kinase and lactate dehydrogenase coupled enzyme assay	B	CCOC(=O)c1c(/C(C#N)=C/N)c2ccc(Cl)c(Cl)c2n1C		CHEMBL4090007	=	IC50	nM	530.0	CHEMBL4226	Homo sapiens	IC50	nM	530.0
	18006653	CHEMBL4003364	Binding affinity to full length recombinant human CLK3 (M1 to R490 residues) expressed in bacterial expression system by KinomeScan assay	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	300.0	CHEMBL4226	Homo sapiens	Kd	nM	300.0
	18008496	CHEMBL4003770	Inhibition of human CLK3 using ERMRPRKRQGSVRRRV as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cc(N)cc(Cl)c3)nc(N[C@H]3CCNC3)nc21		CHEMBL4102101	>	IC50	nM	1000.0	CHEMBL4226	Homo sapiens	IC50	nM	1000.0
	18008497	CHEMBL4003770	Inhibition of human CLK3 using ERMRPRKRQGSVRRRV as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cc(N)cc(Cl)c3)nc(N[C@@H]3CCNC3)nc21		CHEMBL4084116	>	IC50	nM	1000.0	CHEMBL4226	Homo sapiens	IC50	nM	1000.0
	18008593	CHEMBL4003770	Inhibition of human CLK3 using ERMRPRKRQGSVRRRV as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cc(N)cc(Cl)c3)nc(N[C@@H]3CCCNC3)nc21		CHEMBL4091876	>	IC50	nM	1000.0	CHEMBL4226	Homo sapiens	IC50	nM	1000.0
	18008594	CHEMBL4003770	Inhibition of human CLK3 using ERMRPRKRQGSVRRRV as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cc(N)cc(Cl)c3)nc(N[C@H]3CCCNC3)nc21		CHEMBL4064123	>	IC50	nM	1000.0	CHEMBL4226	Homo sapiens	IC50	nM	1000.0
	18008595	CHEMBL4003770	Inhibition of human CLK3 using ERMRPRKRQGSVRRRV as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cc(N)cc(Cl)c3)nc(N[C@@H]3CCCC[C@H]3N)nc21		CHEMBL4100324	>	IC50	nM	1000.0	CHEMBL4226	Homo sapiens	IC50	nM	1000.0
	18008596	CHEMBL4003770	Inhibition of human CLK3 using ERMRPRKRQGSVRRRV as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cc(N)cc(Cl)c3)nc(N[C@H]3CCCC[C@@H]3N)nc21		CHEMBL4082309	>	IC50	nM	1000.0	CHEMBL4226	Homo sapiens	IC50	nM	1000.0
	18008597	CHEMBL4003770	Inhibition of human CLK3 using ERMRPRKRQGSVRRRV as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(=O)Nc1cc(Cl)cc(Nc2nc(N[C@H]3CCCC[C@H]3N)nc3c2ncn3C(C)C)c1		CHEMBL4067013	>	IC50	nM	1000.0	CHEMBL4226	Homo sapiens	IC50	nM	1000.0
	18008598	CHEMBL4003770	Inhibition of human CLK3 using ERMRPRKRQGSVRRRV as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(=O)Nc1cc(Cl)cc(Nc2nc(N[C@@H]3CCCC[C@@H]3N)nc3c2ncn3C(C)C)c1		CHEMBL4094492	>	IC50	nM	1000.0	CHEMBL4226	Homo sapiens	IC50	nM	1000.0
	18008599	CHEMBL4003770	Inhibition of human CLK3 using ERMRPRKRQGSVRRRV as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cc(N)cc(Cl)c3)nc(N[C@H]3CCCC[C@H]3N)nc21		CHEMBL4104657	>	IC50	nM	1000.0	CHEMBL4226	Homo sapiens	IC50	nM	1000.0
	18008600	CHEMBL4003770	Inhibition of human CLK3 using ERMRPRKRQGSVRRRV as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cc(N)cc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL4078898	>	IC50	nM	1000.0	CHEMBL4226	Homo sapiens	IC50	nM	1000.0
	18008601	CHEMBL4003770	Inhibition of human CLK3 using ERMRPRKRQGSVRRRV as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(=O)Nc1cc(Cl)cc(Nc2nc(N[C@@H]3CCCC[C@@H]3N)nc3c2ncn3C(C)C)c1		CHEMBL4094492	>	IC50	nM	1000.0	CHEMBL4226	Homo sapiens	IC50	nM	1000.0
	18008602	CHEMBL4003770	Inhibition of human CLK3 using ERMRPRKRQGSVRRRV as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cc(N)cc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL4078898	>	IC50	nM	1000.0	CHEMBL4226	Homo sapiens	IC50	nM	1000.0
	18008603	CHEMBL4003770	Inhibition of human CLK3 using ERMRPRKRQGSVRRRV as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CCCC[C@H]3N)nc21		CHEMBL4073318	>	IC50	nM	1000.0	CHEMBL4226	Homo sapiens	IC50	nM	1000.0
	18008604	CHEMBL4003770	Inhibition of human CLK3 using ERMRPRKRQGSVRRRV as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL4066861	>	IC50	nM	1000.0	CHEMBL4226	Homo sapiens	IC50	nM	1000.0
	18008605	CHEMBL4003770	Inhibition of human CLK3 using ERMRPRKRQGSVRRRV as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CCCC[C@@H]3N)nc21		CHEMBL4088144	>	IC50	nM	1000.0	CHEMBL4226	Homo sapiens	IC50	nM	1000.0
	18008606	CHEMBL4003770	Inhibition of human CLK3 using ERMRPRKRQGSVRRRV as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@H]3N)nc21		CHEMBL4104505	>	IC50	nM	1000.0	CHEMBL4226	Homo sapiens	IC50	nM	1000.0
	18008607	CHEMBL4003770	Inhibition of human CLK3 using ERMRPRKRQGSVRRRV as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CCCC[C@@H]3N)nc21		CHEMBL4080283	>	IC50	nM	1000.0	CHEMBL4226	Homo sapiens	IC50	nM	1000.0
	18008608	CHEMBL4003770	Inhibition of human CLK3 using ERMRPRKRQGSVRRRV as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@H]3N)nc21		CHEMBL1532768	>	IC50	nM	1000.0	CHEMBL4226	Homo sapiens	IC50	nM	1000.0
	18008609	CHEMBL4003770	Inhibition of human CLK3 using ERMRPRKRQGSVRRRV as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	>	IC50	nM	1000.0	CHEMBL4226	Homo sapiens	IC50	nM	1000.0
	18064943	CHEMBL4014116	Inhibition of human CLK3	B	C[C@@H](c1ccc(F)cc1)n1nnc2cnc3ccc(-c4ccc5ocnc5c4)cc3c21		CHEMBL4083249	=	IC50	nM	5590.0	CHEMBL4226	Homo sapiens	IC50	nM	5590.0
	18114425	CHEMBL4025069	Inhibition of wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	98.0	CHEMBL4226	Homo sapiens	Activity	%	98.0
	18122283	CHEMBL4027015	Inhibition of recombinant full length N-terminal His6-tagged human CLK3 expressed in baculovirus infected Sf21 cells	B	c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1		CHEMBL4064608	>	IC50	nM	1000.0	CHEMBL4226	Homo sapiens	IC50	uM	1.0
	18153111	CHEMBL4034306	Inhibition of CLK3 ATP loop (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1	Outside typical range	CHEMBL4084955	=	Inhibition	%	-24.0	CHEMBL4226	Homo sapiens	INH	%	-24.0
	18203593	CHEMBL4043880	Inhibition of wild-type human full length CLK3 (M1 to R490 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL4226	Homo sapiens	Activity	%	100.0
	18253773	CHEMBL4055171	Inhibition of wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL4226	Homo sapiens	Activity	%	100.0
	18253774	CHEMBL4055171	Inhibition of wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	96.0	CHEMBL4226	Homo sapiens	Activity	%	96.0
	18265827	CHEMBL4057277	Inhibition of CLK3 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	6.7	CHEMBL4226	Homo sapiens	INH	%	6.7
	18266023	CHEMBL4057473	Inhibition of CLK3 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	0.7	CHEMBL4226	Homo sapiens	INH	%	0.7
	18282015	CHEMBL4119970	Inhibition of full length recombinant GST-tagged human CLK3 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	5.9	CHEMBL4226	Homo sapiens	INH	%	5.9
	18282334	CHEMBL4119970	Inhibition of full length recombinant GST-tagged human CLK3 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	-3.6	CHEMBL4226	Homo sapiens	INH	%	-3.6
	18282867	CHEMBL4120452	Inhibition of CLK3 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	6.7	CHEMBL4226	Homo sapiens	INH	%	6.7
	18283081	CHEMBL4120666	Inhibition of CLK3 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	-1.3	CHEMBL4226	Homo sapiens	INH	%	-1.3
	18283296	CHEMBL4120881	Inhibition of CLK3 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	3.7	CHEMBL4226	Homo sapiens	INH	%	3.7
Active	18410260	CHEMBL4151878	Inhibition of human CLK3 expressed in bacterial expression system at 1 uM	B	O=c1ccc2cnc3ccc(-c4cn[nH]c4)cc3c2n1-c1ccc(F)cc1C(F)(F)F		CHEMBL1765714		Inhibition	%		CHEMBL4226	Homo sapiens	INH		
	18440135	CHEMBL4156959	Binding affinity to wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	83.0	CHEMBL4226	Homo sapiens	Activity	%	83.0
	18484575	CHEMBL4185738	Binding affinity to wild-type human full length CLK3 (M1 to R490 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	91.0	CHEMBL4226	Homo sapiens	Activity	%	91.0
	18485046	CHEMBL4185738	Binding affinity to wild-type human full length CLK3 (M1 to R490 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	89.0	CHEMBL4226	Homo sapiens	Activity	%	89.0
	18507833	CHEMBL4190929	Inhibition of recombinant full-length human CLK3 at 1 uM using ERMRPRKRQGSVRRRV as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-1.0	CHEMBL4226	Homo sapiens	INH	%	-1.0
	18653693	CHEMBL4230057	Inhibition of CLK3 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	-1.0	CHEMBL4226	Homo sapiens	INH	%	-1.0
	18653694	CHEMBL4230057	Inhibition of CLK3 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	6.0	CHEMBL4226	Homo sapiens	INH	%	6.0
	18655597	CHEMBL4230638	Binding affinity to wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	94.0	CHEMBL4226	Homo sapiens	Activity	%	94.0
	18665545	CHEMBL4233307	Inhibition of CLK3 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	1000.0	CHEMBL4226	Homo sapiens	IC50	nM	1000.0
	18674610	CHEMBL4235337	Inhibition of CLK3 (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	2000.0	CHEMBL4226	Homo sapiens	Ki	nM	2000.0
	18674611	CHEMBL4235337	Inhibition of CLK3 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL4226	Homo sapiens	Ki	nM	2000.0
Not Determined	18674612	CHEMBL4235337	Inhibition of CLK3 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525		Ki			CHEMBL4226	Homo sapiens	Ki		
	18751141	CHEMBL4263773	Inhibition of CLK3 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	6.0	CHEMBL4226	Homo sapiens	INH	%	6.0
	18751676	CHEMBL4264227	Binding affinity to wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	92.0	CHEMBL4226	Homo sapiens	Activity	%	92.0
	18761721	CHEMBL4266501	Inhibition of recombinant human full length GST-tagged CLK3 expressed in baculovirus expression system in presence of 150 uM ATP	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	uM	10.0
	18761884	CHEMBL4266501	Inhibition of recombinant human full length GST-tagged CLK3 expressed in baculovirus expression system in presence of 150 uM ATP	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	uM	10.0
	18857896	CHEMBL4307742	Binding affinity to wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	92.0	CHEMBL4226	Homo sapiens	Activity	%	92.0
	18892589	CHEMBL4314764	Inhibition of recombinant full-length human CLK3 assessed as residual activity at 10 uM using ERMRPRKRQGSVRRRV as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	116.0	CHEMBL4226	Homo sapiens	Activity	%	116.0
	18921849	CHEMBL4323542	Inhibition of human recombinant CLK3 expressed in Baculovirus system	B	COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(CC#N)nc34)CC2)CC1		CHEMBL4582624	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	uM	10.0
	18921850	CHEMBL4323542	Inhibition of human recombinant CLK3 expressed in Baculovirus system	B	COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C#N)cc34)CC2)CC1		CHEMBL4455718	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	uM	10.0
	18937841	CHEMBL4327651	Inhibition of human CLK3 assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	92.57	CHEMBL4226	Homo sapiens	Activity	%	92.57
	18937842	CHEMBL4327651	Inhibition of human CLK3 assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	96.19	CHEMBL4226	Homo sapiens	Activity	%	96.19
	18938491	CHEMBL4328011	Inhibition of human CLK3 assessed as residual activity at 100 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL4226	Homo sapiens	Activity	%	65.0
	18938867	CHEMBL4328375	Inhibition of human CLK3 using MBP as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1310.0	CHEMBL4226	Homo sapiens	IC50	10'-6M	1.31
	18958814	CHEMBL4333333	Binding affinity to wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	74.0	CHEMBL4226	Homo sapiens	Activity	%	74.0
	18964197	CHEMBL4335035	Inhibition of recombinant full length human CLK3 assessed as residual activity at 1 uM using ERMRPRKRQGSVR as substrate incubated 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	92.0	CHEMBL4226	Homo sapiens	Activity	%	92.0
	18964198	CHEMBL4335035	Inhibition of recombinant full length human CLK3 assessed as residual activity at 1 uM using ERMRPRKRQGSVR as substrate incubated 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	85.0	CHEMBL4226	Homo sapiens	Activity	%	85.0
	18971853	CHEMBL4336863	Inhibition of recombinant full length human CLK3 assessed as residual activity at 10 uM using ERMRPRKRQGSVRRRV as substrate incubated 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	66.0	CHEMBL4226	Homo sapiens	Activity	%	66.0
Not Active	19039828	CHEMBL4351814	Inhibition of recombinant full-length human CLK3 at 10 uM using ERMRPRKRQGSVRRRV as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4226	Homo sapiens	INH		
Active	19041069	CHEMBL4352330	Inhibition of human CLK3 at 10 uM using MBP as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4226	Homo sapiens	INH		
	19059515	CHEMBL4357816	Binding affinity to wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL4226	Homo sapiens	Activity	%	100.0
	19090086	CHEMBL4365660	Inhibition of wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	57.0	CHEMBL4226	Homo sapiens	Activity	%	57.0
	19091884	CHEMBL4366358	Inhibition of human CLK3 at 100 nM using MBP as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	7.47	CHEMBL4226	Homo sapiens	INH	%	7.47
	19144714	CHEMBL4377730	Inhibition of full length recombinant human CLK3 at 1 uM using ERMRPRKRQGSVRRRV as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	37.0	CHEMBL4226	Homo sapiens	INH	%	37.0
	19147805	CHEMBL4379201	Inhibition of recombinant full length human CLK3 using ERMRPRKRQGSVR as substrate incubated 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	uM	10.0
	19159343	CHEMBL4382447	Binding affinity to wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	23.0	CHEMBL4226	Homo sapiens	Activity	%	23.0
	19181000	CHEMBL4387211	Inhibition of recombinant full length human GST-tagged CLK3 expressed in Baculovirus expression system at 0.1 uM using serine/threonine-18 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	6.5	CHEMBL4226	Homo sapiens	INH	%	6.5
	19181226	CHEMBL4387211	Inhibition of recombinant full length human GST-tagged CLK3 expressed in Baculovirus expression system at 0.1 uM using serine/threonine-18 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	4.0	CHEMBL4226	Homo sapiens	INH	%	4.0
	19191664	CHEMBL4389166	Inhibition of wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	87.0	CHEMBL4226	Homo sapiens	INH	%	87.0
	19191829	CHEMBL4389643	Inhibition of wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	94.0	CHEMBL4226	Homo sapiens	INH	%	94.0
	19199953	CHEMBL4391269	Binding affinity to wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	100.0	CHEMBL4226	Homo sapiens	Activity	%	100.0
	19266380	CHEMBL4405330	Inhibition of wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4226	Homo sapiens	INH	%	50.0
	19303859	CHEMBL4414292	Inhibition of CLK3 (unknown origin) assessed as residual activity at 50 uM relative to control	B	O=C(O)c1ccc(Nc2nc(-c3cccc(Br)c3)cs2)cc1		CHEMBL4458300	=	Activity	%	86.0	CHEMBL4226	Homo sapiens	Activity	%	86.0
	20600491	CHEMBL4603443	Inhibition of recombinant full length human GST-tagged CLK3 expressed in baculovirus expression system using serine/threonine-18 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL4226	Homo sapiens	IC50	uM	100.0
	20680066	CHEMBL4622614	Inhibition of recombinant human full length CLK3 (1 to 490 residues) expressed in bacterial expression system at 1 uM by DiscoverX competition binding assay relative to control	B	Cc1cccc(N(C)c2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL4637319	=	Inhibition	%	6.0	CHEMBL4226	Homo sapiens	INH	%	6.0
	22392027	CHEMBL4667122	Inhibition of recombinant human GST-tagged full length CLK3 expressed in baculovirus expression system using Ser/Thr 18 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	4.5	CHEMBL4226	Homo sapiens	INH	%	4.5
	22423703	CHEMBL4674427	Inhibition of human CLK3 using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	101.96	CHEMBL4226	Homo sapiens	Activity	%	101.96
	22423704	CHEMBL4674427	Inhibition of human CLK3 using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	102.56	CHEMBL4226	Homo sapiens	Activity	%	102.56
	22488125	CHEMBL4689201	Inhibition of recombinant human full length CLK3 using ERMRPRKRQGSVRRRV as substrate incubated for 40 mins in presence of [gamma33P-ATP] by scintillation counting analysis	B	Cc1ccc(-n2cc(COc3cccc4cnc(Nc5cccc(Cl)c5)nc34)nn2)c([N+](=O)[O-])c1		CHEMBL4783398	=	IC50	nM	1280.0	CHEMBL4226	Homo sapiens	IC50	nM	1280.0
	22793207	CHEMBL4710179	Inhibition of recombinant human CLK3 in presence of ATP at Km concentration by radiometric filter-binding assay	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	=	IC50	nM	41.0	CHEMBL4226	Homo sapiens	IC50	nM	41.0
	22840054	CHEMBL4719518	Inhibition of CLK3 (unknown origin)	B	COC(=N)c1nc2ccc3ncnc(Nc4ccc(OC)cc4F)c3c2s1		CHEMBL3894571	=	IC50	nM	1420.0	CHEMBL4226	Homo sapiens	IC50	nM	1420.0
	22840055	CHEMBL4719518	Inhibition of CLK3 (unknown origin)	B	COC(=N)c1nc2ccc3ncnc(Nc4ccc(Cl)cc4Cl)c3c2s1		CHEMBL2386747	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	nM	10000.0
	22843435	CHEMBL4720432	Inhibition of human CLK3 assessed as residual activity using MBP as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	100.67	CHEMBL4226	Homo sapiens	Activity	%	100.67
	22843788	CHEMBL4720774	Inhibition of human CLK3 using MBP as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	530.0	CHEMBL4226	Homo sapiens	IC50	10^-7M	5.3
	22844674	CHEMBL4721349	Inhibition of wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	90.14	CHEMBL4226	Homo sapiens	Activity	%	90.14
	22886579	CHEMBL4728282	Binding affinity to CLK3 (unknown origin)	B	CCN1/C(=C\C(C)=O)Sc2ccc(OC)cc21		CHEMBL1349996	=	Kd	nM	1000.0	CHEMBL4226	Homo sapiens	Kd	uM	1.0
	22886601	CHEMBL4728304	Inhibition of human CLK3 by radiometric assay	B	Cn1cc(-c2ccc3occ(-c4cccc(-c5ccncc5)c4)c3n2)cn1		CHEMBL4754195	>	IC50	nM	3000.0	CHEMBL4226	Homo sapiens	IC50	nM	3000.0
	22886653	CHEMBL4728317	Inhibition of recombinant CLK3 (unknown origin) using Ac-ERMRPRKRQGSVdP(Sox)G-NH2 as substrate after 5 mins by Omnia Kinase Assay	B	CCN1/C(=C\C(C)=O)Sc2ccc(OC)cc21		CHEMBL1349996	=	Ki	nM	5200.0	CHEMBL4226	Homo sapiens	Ki	uM	5.2
	22886654	CHEMBL4728317	Inhibition of recombinant CLK3 (unknown origin) using Ac-ERMRPRKRQGSVdP(Sox)G-NH2 as substrate after 5 mins by Omnia Kinase Assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	=	Ki	nM	26900.0	CHEMBL4226	Homo sapiens	Ki	uM	26.9
	22886660	CHEMBL4728321	Inhibition of CLK3 (R134 to T484 residues) (unknown origin) at 15 uM by isothermal titration calorimetry	B	CCN1/C(=C\C(C)=O)Sc2ccc(OC)cc21		CHEMBL1349996	=	Kd	nM	7780.0	CHEMBL4226	Homo sapiens	Kd	uM	7.78
	22886661	CHEMBL4728322	Binding affinity to CLK3 (R134 to T484 residues) (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	CCN1/C(=C\C(C)=O)Sc2ccc(OC)cc21		CHEMBL1349996	=	Delta Tm	degrees C	3.0	CHEMBL4226	Homo sapiens	deltaTm	degrees C	3.0
	22886662	CHEMBL4728322	Binding affinity to CLK3 (R134 to T484 residues) (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	=	Delta Tm	degrees C	1.4	CHEMBL4226	Homo sapiens	deltaTm	degrees C	1.4
	22886663	CHEMBL4728322	Binding affinity to CLK3 (R134 to T484 residues) (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Delta Tm	degrees C	2.0	CHEMBL4226	Homo sapiens	deltaTm	degrees C	2.0
	22886664	CHEMBL4728322	Binding affinity to CLK3 (R134 to T484 residues) (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	O=C1NCc2ccc3c(-c4cccc(Cl)c4)c[nH]c3c21		CHEMBL4796016	=	Delta Tm	degrees C	2.3	CHEMBL4226	Homo sapiens	deltaTm	degrees C	2.3
	22886665	CHEMBL4728322	Binding affinity to CLK3 (R134 to T484 residues) (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	COC(=N)c1nc2ccc3ncnc(Nc4ccc(OC)cc4F)c3c2s1		CHEMBL3894571	=	Delta Tm	degrees C	3.4	CHEMBL4226	Homo sapiens	deltaTm	degrees C	3.4
	22886666	CHEMBL4728322	Binding affinity to CLK3 (R134 to T484 residues) (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	Cn1cc(-c2ccc3occ(-c4cccc(Oc5ccccc5)c4)c3n2)cn1		CHEMBL4751637	=	Delta Tm	degrees C	4.8	CHEMBL4226	Homo sapiens	deltaTm	degrees C	4.8
	22886667	CHEMBL4728322	Binding affinity to CLK3 (R134 to T484 residues) (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Delta Tm	degrees C	5.8	CHEMBL4226	Homo sapiens	deltaTm	degrees C	5.8
	22932972	CHEMBL4739017	Inhibition of human full length recombinant CLK3 using ERMRPRKRQGSVR substrate by radiometric scintillation assay	B	Cn1cc(-c2ccc3occ(-c4cccc(-c5ccncc5)c4)c3n2)cn1		CHEMBL4754195	>	IC50	nM	3000.0	CHEMBL4226	Homo sapiens	IC50	nM	3000.0
	22932973	CHEMBL4739017	Inhibition of human full length recombinant CLK3 using ERMRPRKRQGSVR substrate by radiometric scintillation assay	B	Cn1cc(-c2ccc3occ(-c4cccc(C5CCNCC5)c4)c3n2)cn1		CHEMBL4791451	>	IC50	nM	3000.0	CHEMBL4226	Homo sapiens	IC50	nM	3000.0
	22932974	CHEMBL4739017	Inhibition of human full length recombinant CLK3 using ERMRPRKRQGSVR substrate by radiometric scintillation assay	B	CN1CCC(c2cccc(-c3coc4ccc(-c5cnn(C)c5)nc34)c2)CC1		CHEMBL4741919	>	IC50	nM	3000.0	CHEMBL4226	Homo sapiens	IC50	nM	3000.0
	22932975	CHEMBL4739017	Inhibition of human full length recombinant CLK3 using ERMRPRKRQGSVR substrate by radiometric scintillation assay	B	Cn1cc(-c2ccc3occ(-c4cccc(-c5cn[nH]c5)c4)c3n2)cn1		CHEMBL4789951	=	IC50	nM	1585.0	CHEMBL4226	Homo sapiens	IC50	nM	1585.0
	22932976	CHEMBL4739017	Inhibition of human full length recombinant CLK3 using ERMRPRKRQGSVR substrate by radiometric scintillation assay	B	Cn1cc(-c2cccc(-c3coc4ccc(-c5cnn(C)c5)nc34)c2)cn1		CHEMBL4797457	>	IC50	nM	3000.0	CHEMBL4226	Homo sapiens	IC50	nM	3000.0
	22932977	CHEMBL4739017	Inhibition of human full length recombinant CLK3 using ERMRPRKRQGSVR substrate by radiometric scintillation assay	B	Cn1cc(-c2ccc3occ(-c4cccc(-c5cc[nH]n5)c4)c3n2)cn1		CHEMBL4762964	=	IC50	nM	1642.0	CHEMBL4226	Homo sapiens	IC50	nM	1642.0
	22932978	CHEMBL4739017	Inhibition of human full length recombinant CLK3 using ERMRPRKRQGSVR substrate by radiometric scintillation assay	B	CC(C)(C)c1ccc(-c2coc3ccc(-c4cn[nH]c4)nc23)cc1		CHEMBL4777288	>	IC50	nM	3000.0	CHEMBL4226	Homo sapiens	IC50	nM	3000.0
	22932979	CHEMBL4739017	Inhibition of human full length recombinant CLK3 using ERMRPRKRQGSVR substrate by radiometric scintillation assay	B	CC1(c2ccc(-c3coc4ccc(-c5cn[nH]c5)nc34)cc2)CC1		CHEMBL4740998	>	IC50	nM	3000.0	CHEMBL4226	Homo sapiens	IC50	nM	3000.0
	22932980	CHEMBL4739017	Inhibition of human full length recombinant CLK3 using ERMRPRKRQGSVR substrate by radiometric scintillation assay	B	C=C(C)c1ccc(-c2coc3ccc(-c4cn[nH]c4)nc23)cc1		CHEMBL4743730	>	IC50	nM	3000.0	CHEMBL4226	Homo sapiens	IC50	nM	3000.0
	22932981	CHEMBL4739017	Inhibition of human full length recombinant CLK3 using ERMRPRKRQGSVR substrate by radiometric scintillation assay	B	c1ccc(Cc2ccc(-c3coc4ccc(-c5cn[nH]c5)nc34)cc2)cc1		CHEMBL4789373	>	IC50	nM	3000.0	CHEMBL4226	Homo sapiens	IC50	nM	3000.0
	22932982	CHEMBL4739017	Inhibition of human full length recombinant CLK3 using ERMRPRKRQGSVR substrate by radiometric scintillation assay	B	CC(C)Cc1ccc(-c2coc3ccc(-c4cn[nH]c4)nc23)cc1		CHEMBL4794825	>	IC50	nM	3000.0	CHEMBL4226	Homo sapiens	IC50	nM	3000.0
	22932983	CHEMBL4739017	Inhibition of human full length recombinant CLK3 using ERMRPRKRQGSVR substrate by radiometric scintillation assay	B	c1ccc(-c2ccc(-c3coc4ccc(-c5cn[nH]c5)nc34)cc2)cc1		CHEMBL4778370	>	IC50	nM	3000.0	CHEMBL4226	Homo sapiens	IC50	nM	3000.0
	22932984	CHEMBL4739017	Inhibition of human full length recombinant CLK3 using ERMRPRKRQGSVR substrate by radiometric scintillation assay	B	c1n[nH]cc1-c1ccc2occ(-c3ccc(C4CCCCC4)cc3)c2n1		CHEMBL4777540	>	IC50	nM	3000.0	CHEMBL4226	Homo sapiens	IC50	nM	3000.0
	22932985	CHEMBL4739017	Inhibition of human full length recombinant CLK3 using ERMRPRKRQGSVR substrate by radiometric scintillation assay	B	c1n[nH]cc1-c1ccc2occ(-c3ccc(C45CC6CC(CC(C6)C4)C5)cc3)c2n1		CHEMBL4758047	>	IC50	nM	3000.0	CHEMBL4226	Homo sapiens	IC50	nM	3000.0
	22932986	CHEMBL4739017	Inhibition of human full length recombinant CLK3 using ERMRPRKRQGSVR substrate by radiometric scintillation assay	B	Cn1cc(-c2ccc3occ(-c4ccc(C(C)(C)C)cc4)c3n2)cn1		CHEMBL4747210	>	IC50	nM	3000.0	CHEMBL4226	Homo sapiens	IC50	nM	3000.0
	22932987	CHEMBL4739017	Inhibition of human full length recombinant CLK3 using ERMRPRKRQGSVR substrate by radiometric scintillation assay	B	Cn1cc(-c2ccc3occ(-c4ccc(C(C)(C)C)cc4)c3n2)nn1		CHEMBL4790254	>	IC50	nM	3000.0	CHEMBL4226	Homo sapiens	IC50	nM	3000.0
	22932988	CHEMBL4739017	Inhibition of human full length recombinant CLK3 using ERMRPRKRQGSVR substrate by radiometric scintillation assay	B	CC(C)(C)c1ccc(-c2coc3ccc(-c4cc[nH]n4)nc23)cc1		CHEMBL4800422	>	IC50	nM	3000.0	CHEMBL4226	Homo sapiens	IC50	nM	3000.0
	22932989	CHEMBL4739017	Inhibition of human full length recombinant CLK3 using ERMRPRKRQGSVR substrate by radiometric scintillation assay	B	Cn1ccc(-c2ccc3occ(-c4ccc(C(C)(C)C)cc4)c3n2)n1		CHEMBL4793177	>	IC50	nM	3000.0	CHEMBL4226	Homo sapiens	IC50	nM	3000.0
	22932990	CHEMBL4739017	Inhibition of human full length recombinant CLK3 using ERMRPRKRQGSVR substrate by radiometric scintillation assay	B	CC(C)(C)c1ccc(-c2coc3ccc(-c4nn[nH]n4)nc23)cc1		CHEMBL4777533	>	IC50	nM	3000.0	CHEMBL4226	Homo sapiens	IC50	nM	3000.0
	22932991	CHEMBL4739017	Inhibition of human full length recombinant CLK3 using ERMRPRKRQGSVR substrate by radiometric scintillation assay	B	CC(C)(C)c1ccc(-c2coc3ccc(-c4cnsc4)nc23)cc1		CHEMBL4747520	>	IC50	nM	3000.0	CHEMBL4226	Homo sapiens	IC50	nM	3000.0
	22932992	CHEMBL4739017	Inhibition of human full length recombinant CLK3 using ERMRPRKRQGSVR substrate by radiometric scintillation assay	B	CC(C)(C)c1ccc(-c2coc3ccc(-c4cnn(CCN5CCOCC5)c4)nc23)cc1		CHEMBL4795812	>	IC50	nM	3000.0	CHEMBL4226	Homo sapiens	IC50	nM	3000.0
	22932993	CHEMBL4739017	Inhibition of human full length recombinant CLK3 using ERMRPRKRQGSVR substrate by radiometric scintillation assay	B	CC(C)(C)c1ccc(-c2coc3ccc(-c4cn[nH]n4)nc23)cc1		CHEMBL4778153	>	IC50	nM	3000.0	CHEMBL4226	Homo sapiens	IC50	nM	3000.0
	22933173	CHEMBL4739027	Inhibition of CLK3 (unknown origin) by NanoBRET cellular target engagement assay	B	CC(C)(C)c1ccc(-c2coc3ccc(-c4cn[nH]c4)nc23)cc1		CHEMBL4777288	=	IC50	nM	43000.0	CHEMBL4226	Homo sapiens	IC50	nM	43000.0
	22933174	CHEMBL4739027	Inhibition of CLK3 (unknown origin) by NanoBRET cellular target engagement assay	B	CC(C)(C)c1ccc(-c2coc3ccc(-c4cn[nH]n4)nc23)cc1		CHEMBL4778153	>	IC50	nM	50000.0	CHEMBL4226	Homo sapiens	IC50	nM	50000.0
	22933175	CHEMBL4739027	Inhibition of CLK3 (unknown origin) by NanoBRET cellular target engagement assay	B	COC(=N)c1nc2ccc3ncnc(Nc4ccc(OC)cc4F)c3c2s1		CHEMBL3894571	>	IC50	nM	3000.0	CHEMBL4226	Homo sapiens	IC50	nM	3000.0
	22939667	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1c[nH]nc1C(=O)Nc1cccnc1)c1cccnc1		CHEMBL4783473	=	EC50	nM	5302.0	CHEMBL4226	Homo sapiens	EC50	uM	5.3020000000000005
	22939668	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1c[nH]nc1C(=O)Nc1cncc(-c2cccc(F)c2)c1)c1cncc(F)c1		CHEMBL4778931	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22939669	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccc(C(=O)Nc2c[nH]nc2C(=O)Nc2ccc(OCCN3CCCC3)nc2)cn1		CHEMBL4743606	=	EC50	nM	3700.0	CHEMBL4226	Homo sapiens	EC50	uM	3.7
	22939670	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(C(=O)Nc2c[nH]nc2C(=O)Nc2ccc(CN(C)C)cc2)c1		CHEMBL4760170	=	EC50	nM	6607.0	CHEMBL4226	Homo sapiens	EC50	uM	6.607
	22939671	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(C(=O)Nc2c[nH]nc2C(=O)Nc2ccc(OCCN3CCCC3)nc2)c1		CHEMBL4747048	=	EC50	nM	4927.0	CHEMBL4226	Homo sapiens	EC50	uM	4.927
	22939672	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(C(=O)Nc2c[nH]nc2C(=O)Nc2ccc(N3CCC(F)(F)C3)nc2)c1		CHEMBL4781361	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22939673	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(C(=O)Nc2c[nH]nc2C(=O)Nc2ccc(N3CCNCC3)nc2)c1		CHEMBL4788757	=	EC50	nM	2355.0	CHEMBL4226	Homo sapiens	EC50	uM	2.355
	22939674	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(C(=O)Nc2c[nH]nc2C(=O)Nc2ccc3c(c2)CCNC3)c1		CHEMBL4749673	=	EC50	nM	6159.0	CHEMBL4226	Homo sapiens	EC50	uM	6.159
	22939675	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(C(=O)Nc2c[nH]nc2C(=O)Nc2ccc3c(c2)CCN(C)C3)c1		CHEMBL4743693	=	EC50	nM	6088.0	CHEMBL4226	Homo sapiens	EC50	uM	6.087999999999999
	22939676	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Oc1cncc(C(=O)Nc2c[nH]nc2C(=O)Nc2ccc(OC3CCN(C)CC3)nc2)c1		CHEMBL4790819	=	EC50	nM	1779.0	CHEMBL4226	Homo sapiens	EC50	uM	1.7790000000000001
	22939677	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1c[nH]nc1C(=O)Nc1ccc(N2CCCC2)nc1)c1cncc(OC2CCNCC2)c1		CHEMBL4762971	=	EC50	nM	5154.0	CHEMBL4226	Homo sapiens	EC50	uM	5.154
	22939678	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1c[nH]nc1C(=O)Nc1ccc(N2CCC(F)(F)C2)nc1)c1cncc(OC2CCNCC2)c1		CHEMBL4785525	=	EC50	nM	6020.0	CHEMBL4226	Homo sapiens	EC50	uM	6.02
	22939679	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1c[nH]nc1C(=O)Nc1ccc(N2CCCCC2)nc1)c1cncc(OC2CCNCC2)c1		CHEMBL4785414	=	EC50	nM	3503.0	CHEMBL4226	Homo sapiens	EC50	uM	3.503
	22939680	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1c[nH]nc1C(=O)Nc1cncc(-c2cccc(F)c2)c1)c1cncc(OC2CCNCC2)c1		CHEMBL4783818	=	EC50	nM	4305.0	CHEMBL4226	Homo sapiens	EC50	uM	4.305
	22939681	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1c[nH]nc1-c1nc2c(-c3cccc(F)c3)cccc2[nH]1)c1cccnc1		CHEMBL4788972	=	EC50	nM	485.0	CHEMBL4226	Homo sapiens	EC50	uM	0.485
	22939682	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cccnc1)Nc1c[nH]nc1C(=O)Nc1ccc(C(F)(F)F)nc1		CHEMBL4745480	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22939683	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(CN2CCCC2)cc1)c1n[nH]cc1/C=C/c1cccnc1		CHEMBL4756587	=	EC50	nM	2671.0	CHEMBL4226	Homo sapiens	EC50	uM	2.6710000000000003
	22939684	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1[nH]nc(C(=O)Nc2ccc(CN3CCCC3)cc2)c1/C=C/c1cccnc1		CHEMBL4798742	=	EC50	nM	3989.0	CHEMBL4226	Homo sapiens	EC50	uM	3.989
	22939685	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(OCCN2CCCC2)cc1)c1n[nH]cc1/C=C/c1cccnc1		CHEMBL4797418	=	EC50	nM	967.0	CHEMBL4226	Homo sapiens	EC50	uM	0.9670000000000001
	22939686	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(N2CCNCC2)nc1)c1n[nH]cc1/C=C/c1cccnc1		CHEMBL4777426	=	EC50	nM	563.0	CHEMBL4226	Homo sapiens	EC50	uM	0.563
	22939687	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(Oc2ccc(NC(=O)c3n[nH]cc3/C=C/c3cccnc3)cn2)CC1		CHEMBL4799387	=	EC50	nM	733.0	CHEMBL4226	Homo sapiens	EC50	uM	0.733
	22939688	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1[nH]nc(C(=O)Nc2ccc(OC3CCN(C)CC3)nc2)c1/C=C/c1cccnc1		CHEMBL4799892	=	EC50	nM	2328.0	CHEMBL4226	Homo sapiens	EC50	uM	2.3280000000000003
	22939689	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1ccc(-c2nnc(-c3n[nH]cc3/C=C/c3cccnc3)o2)cc1		CHEMBL4756490	=	EC50	nM	627.0	CHEMBL4226	Homo sapiens	EC50	uM	0.627
	22939690	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1ccc(NC(=O)c2n[nH]cc2/C=C/c2cncc(CN3CCCCC3)c2)cn1		CHEMBL4785138	=	EC50	nM	1252.0	CHEMBL4226	Homo sapiens	EC50	uM	1.252
	22939691	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]cc4/C=C/c4cncc(F)c4)nc23)CC1		CHEMBL4743901	=	EC50	nM	326.0	CHEMBL4226	Homo sapiens	EC50	uM	0.326
	22939692	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1cccc(-c2cccc3[nH]c(-c4n[nH]cc4/C=C/c4cncc(CN5CCCC5)c4)nc23)c1		CHEMBL4788267	=	EC50	nM	492.0	CHEMBL4226	Homo sapiens	EC50	uM	0.49200000000000005
	22939693	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(N2CCC(F)(F)C2)nc1)c1n[nH]cc1C#Cc1cccnc1		CHEMBL4797665	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22939694	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(OCCN2CCCC2)nc1)c1n[nH]cc1C#Cc1cccnc1		CHEMBL4787812	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22939695	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(C#Cc2c[nH]nc2C(=O)Nc2ccc(N3CCNCC3)nc2)c1		CHEMBL4781302	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22939696	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(C#Cc2c[nH]nc2C(=O)Nc2ccc(OC3CCN(C)CC3)nc2)c1		CHEMBL4747378	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22939697	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(C#Cc2c[nH]nc2C(=O)Nc2ccc(OCCN3CCCC3)nc2)c1		CHEMBL4757799	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22939698	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cccnc1)c1n[nH]cc1C#Cc1cncc(OC2CCNCC2)c1		CHEMBL4756455	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22939699	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1cccc(-c2cncc3[nH]c(-c4n[nH]cc4C#Cc4cncc(OC5CCNCC5)c4)nc23)c1		CHEMBL4763219	=	EC50	nM	148.0	CHEMBL4226	Homo sapiens	EC50	uM	0.14800000000000002
	22939700	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	=	EC50	nM	5248.0	CHEMBL4226	Homo sapiens	EC50	uM	5.247999999999999
	22939701	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	EC50	nM	84.0	CHEMBL4226	Homo sapiens	EC50	uM	0.084
	22939702	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(N4CC(C)(N)C4)n3)cc12		CHEMBL4747452	=	EC50	nM	3400.0	CHEMBL4226	Homo sapiens	EC50	uM	3.4
	22939703	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC1(N)CN(c2cncc(-c3ccc4[nH]nc(C)c4c3)n2)C1		CHEMBL4762186	=	EC50	nM	5500.0	CHEMBL4226	Homo sapiens	EC50	uM	5.5
	22939704	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(N4CCC[C@H](N)C4)n3)cc12		CHEMBL4794291	=	EC50	nM	8008.0	CHEMBL4226	Homo sapiens	EC50	uM	8.008
	22939705	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(N4CCC(O)CC4)n3)cc12		CHEMBL4753492	=	EC50	nM	4261.0	CHEMBL4226	Homo sapiens	EC50	uM	4.261
	22939706	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2cc(F)c(-c3cncc(CN4CCCCC4)n3)cc12		CHEMBL4798330	=	EC50	nM	3380.0	CHEMBL4226	Homo sapiens	EC50	uM	3.38
	22939707	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(NC4CCNCC4)n3)cc12		CHEMBL4755807	=	EC50	nM	1420.0	CHEMBL4226	Homo sapiens	EC50	uM	1.42
	22939708	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(N[C@H]4CCNC[C@@H]4F)n3)cc12		CHEMBL4741792	=	EC50	nM	424.0	CHEMBL4226	Homo sapiens	EC50	uM	0.424
	22939709	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(N[C@H]4CC[C@H](O)CC4)n3)cc12		CHEMBL4791039	=	EC50	nM	309.0	CHEMBL4226	Homo sapiens	EC50	uM	0.309
	22939710	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(O[C@H]4CCNC[C@@H]4F)n3)cc12		CHEMBL4761714	=	EC50	nM	1720.0	CHEMBL4226	Homo sapiens	EC50	uM	1.72
	22939711	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(O[C@H]4CCNC[C@H]4F)n3)cc12		CHEMBL4748817	=	EC50	nM	1760.0	CHEMBL4226	Homo sapiens	EC50	uM	1.76
	22939712	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2cc(F)c(-c3cncc(O[C@H]4CCNC[C@@H]4F)n3)cc12		CHEMBL4785637	=	EC50	nM	1300.0	CHEMBL4226	Homo sapiens	EC50	uM	1.3
	22939713	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(O[C@H]4CCNCC4(F)F)n3)cc12		CHEMBL4764315	=	EC50	nM	313.0	CHEMBL4226	Homo sapiens	EC50	uM	0.313
	22939714	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(NCC4(F)CNC4)n3)cc12		CHEMBL4798950	=	EC50	nM	1100.0	CHEMBL4226	Homo sapiens	EC50	uM	1.1
	22939715	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(OCC4(F)CNC4)n3)cc12		CHEMBL4796297	=	EC50	nM	2204.0	CHEMBL4226	Homo sapiens	EC50	uM	2.204
	22939716	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H]4Cc5ccccc5CN4)n3)cc12		CHEMBL4749143	=	EC50	nM	5731.0	CHEMBL4226	Homo sapiens	EC50	uM	5.731
	22939717	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(N[C@H](CO)Cc4cccc(C(F)(F)F)c4)n3)cc12		CHEMBL4794100	=	EC50	nM	3950.0	CHEMBL4226	Homo sapiens	EC50	uM	3.95
	22939718	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@H](N)Cc4ccccc4)n3)cc12		CHEMBL4780416	=	EC50	nM	361.0	CHEMBL4226	Homo sapiens	EC50	uM	0.361
	22939719	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cc(OC[C@H](N)Cc4ccccc4)cnn3)cc12		CHEMBL4754499	=	EC50	nM	3493.0	CHEMBL4226	Homo sapiens	EC50	uM	3.4930000000000003
	22939720	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(C(=O)Nc4cccnc4)c3c2)c1		CHEMBL4750147	=	EC50	nM	20.0	CHEMBL4226	Homo sapiens	EC50	uM	0.02
	22939721	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2ccc(NC(=O)c3n[nH]c4ccc(-c5cncc(NC(=O)C6CC6)c5)cc34)cn2)CC1		CHEMBL4742870	=	EC50	nM	13.0	CHEMBL4226	Homo sapiens	EC50	uM	0.013000000000000001
	22939722	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cccnc1)c1n[nH]c2ccc(-c3cncc(NC(=O)N4CCOCC4)c3)cc12		CHEMBL4790121	=	EC50	nM	47.0	CHEMBL4226	Homo sapiens	EC50	uM	0.047
	22939723	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2ccc(NC(=O)c3n[nH]c4ccc(-c5cncc(NC(=O)c6c(F)cccc6F)c5)cc34)cn2)CC1		CHEMBL4745311	=	EC50	nM	81.0	CHEMBL4226	Homo sapiens	EC50	uM	0.081
	22939724	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)OCCCNC(=O)c1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL4744152	=	EC50	nM	9838.0	CHEMBL4226	Homo sapiens	EC50	uM	9.838
	22939725	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(N[C@H]1C[C@@H]1c1ccccc1)c1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL4776900	=	EC50	nM	6145.0	CHEMBL4226	Homo sapiens	EC50	uM	6.145
	22939726	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1cc2[nH]nc(C(=O)Nc3ccc(CN4CCCC4)cc3)c2cc1-c1cccnc1		CHEMBL4797560	=	EC50	nM	581.0	CHEMBL4226	Homo sapiens	EC50	uM	0.581
	22939727	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cccnc1)c1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL4753797	=	EC50	nM	916.0	CHEMBL4226	Homo sapiens	EC50	uM	0.9159999999999999
	22939728	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(Cc2ccc(NC(=O)c3n[nH]c4ccc(-c5cccnc5)cc34)cn2)CC1		CHEMBL4760183	=	EC50	nM	34.0	CHEMBL4226	Homo sapiens	EC50	uM	0.034
	22939729	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cnccc1NC(=O)C1CC1)c1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL4778412	=	EC50	nM	343.0	CHEMBL4226	Homo sapiens	EC50	uM	0.34299999999999997
	22939730	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccnnc1)c1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL4746176	=	EC50	nM	21.0	CHEMBL4226	Homo sapiens	EC50	uM	0.021
	22939731	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(CN2CCCC2)cc1)c1n[nH]c2ccc(-c3cccnc3F)cc12		CHEMBL4790477	=	EC50	nM	47.0	CHEMBL4226	Homo sapiens	EC50	uM	0.047
	22939732	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(Oc2ccc(NC(=O)c3n[nH]c4ccc(-c5ccc(N)nc5)cc34)cc2)CC1		CHEMBL4788156	=	EC50	nM	49.0	CHEMBL4226	Homo sapiens	EC50	uM	0.049
	22939733	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CO)c4)cc23)cn1		CHEMBL4797346	=	EC50	nM	41.0	CHEMBL4226	Homo sapiens	EC50	uM	0.040999999999999995
	22939734	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(N2CCCC2)nc1)c1n[nH]c2ccc(-c3cncc(CN4CCC4)c3)cc12		CHEMBL4800437	=	EC50	nM	139.0	CHEMBL4226	Homo sapiens	EC50	uM	0.139
	22939735	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cccnc1)c1n[nH]c2ccc(-c3cncc(CN4CC(CO)(CO)C4)c3)cc12		CHEMBL4780576	=	EC50	nM	62.0	CHEMBL4226	Homo sapiens	EC50	uM	0.062
	22939736	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCC5)c4)cc23)c1		CHEMBL4795039	=	EC50	nM	36.0	CHEMBL4226	Homo sapiens	EC50	uM	0.036000000000000004
	22939737	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCC5)c4)cc23)cn1		CHEMBL4799007	=	EC50	nM	109.0	CHEMBL4226	Homo sapiens	EC50	uM	0.109
	22939738	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCC(F)(F)C5)c4)cc23)cn1		CHEMBL4779515	=	EC50	nM	22.0	CHEMBL4226	Homo sapiens	EC50	uM	0.022000000000000002
	22939739	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2ccc(NC(=O)c3n[nH]c4ccc(-c5cncc(CN6CCC(F)(F)C6)c5)cc34)cn2)CC1		CHEMBL4761354	=	EC50	nM	11.0	CHEMBL4226	Homo sapiens	EC50	uM	0.011000000000000001
	22939740	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	NC(=O)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4792282	=	EC50	nM	498.0	CHEMBL4226	Homo sapiens	EC50	uM	0.498
	22939741	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)NC(=O)c1n[nH]c2ccc(-c3cncc(CN4CCC(F)(F)CC4)c3)cc12		CHEMBL4785348	=	EC50	nM	4024.0	CHEMBL4226	Homo sapiens	EC50	uM	4.024
	22939742	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(N[C@H]1C[C@@H]1c1ccccc1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4755660	=	EC50	nM	717.0	CHEMBL4226	Homo sapiens	EC50	uM	0.7170000000000001
	22939743	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(NCc1cc(F)cc(F)c1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4764842	=	EC50	nM	1674.0	CHEMBL4226	Homo sapiens	EC50	uM	1.6740000000000002
	22939744	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCCC5)c4)cc23)cn1		CHEMBL4754606	=	EC50	nM	44.0	CHEMBL4226	Homo sapiens	EC50	uM	0.044000000000000004
	22939745	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1cncc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCCC5)c4)cc23)c1		CHEMBL4776499	=	EC50	nM	352.0	CHEMBL4226	Homo sapiens	EC50	uM	0.35200000000000004
	22939746	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccnc(C(F)(F)F)c1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4744530	=	EC50	nM	93.0	CHEMBL4226	Homo sapiens	EC50	uM	0.09300000000000001
	22939747	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCCC5)c4)cc23)cn1		CHEMBL4800084	=	EC50	nM	32.0	CHEMBL4226	Homo sapiens	EC50	uM	0.032
	22939748	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Oc1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCCC5)c4)cc23)cn1		CHEMBL4762155	=	EC50	nM	616.0	CHEMBL4226	Homo sapiens	EC50	uM	0.616
	22939749	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(OC(CO)CO)nc1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4752327	=	EC50	nM	73.0	CHEMBL4226	Homo sapiens	EC50	uM	0.073
	22939750	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)CCN(C)c1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCCC5)c4)cc23)cn1		CHEMBL4742725	=	EC50	nM	14.0	CHEMBL4226	Homo sapiens	EC50	uM	0.013999999999999999
	22939751	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1ccncc1NC(=O)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4756198	=	EC50	nM	1805.0	CHEMBL4226	Homo sapiens	EC50	uM	1.805
	22939752	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cnccc1NC(=O)C1CC1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4744426	=	EC50	nM	1273.0	CHEMBL4226	Homo sapiens	EC50	uM	1.273
	22939753	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	NC(=O)c1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCCC5)c4)cc23)cn1		CHEMBL4779592	=	EC50	nM	11.0	CHEMBL4226	Homo sapiens	EC50	uM	0.011000000000000001
	22939754	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(C(=O)N2CCCC2)nc1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4752625	=	EC50	nM	12.0	CHEMBL4226	Homo sapiens	EC50	uM	0.012
	22939755	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CS(=O)(=O)c1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCCC5)c4)cc23)cn1		CHEMBL4788275	=	EC50	nM	14.0	CHEMBL4226	Homo sapiens	EC50	uM	0.013999999999999999
	22939756	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(N2CC(CO)(CO)C2)nc1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4782319	=	EC50	nM	39.0	CHEMBL4226	Homo sapiens	EC50	uM	0.039
	22939757	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(N2CCC(O)CC2)nc1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4756030	=	EC50	nM	22.0	CHEMBL4226	Homo sapiens	EC50	uM	0.022000000000000002
	22939758	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	C[C@H]1CN(c2ccc(NC(=O)c3n[nH]c4ccc(-c5cncc(CN6CCCCC6)c5)cc34)cn2)C[C@@H](C)O1		CHEMBL4794727	=	EC50	nM	89.0	CHEMBL4226	Homo sapiens	EC50	uM	0.08900000000000001
	22939759	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(-c2ccccc2)nc1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4743940	=	EC50	nM	71.0	CHEMBL4226	Homo sapiens	EC50	uM	0.071
	22939760	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccnnc1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4748995	=	EC50	nM	11.0	CHEMBL4226	Homo sapiens	EC50	uM	0.011000000000000001
	22939761	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cnccn1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4743856	=	EC50	nM	46.0	CHEMBL4226	Homo sapiens	EC50	uM	0.046
	22939762	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1ncc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCCC5)c4)cc23)cn1		CHEMBL4786934	=	EC50	nM	17.0	CHEMBL4226	Homo sapiens	EC50	uM	0.017
	22939763	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc2c(c1)OCCO2)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4758259	=	EC50	nM	60.0	CHEMBL4226	Homo sapiens	EC50	uM	0.06
	22939764	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC1CCN(Cc2cncc(-c3ccc4[nH]nc(C(=O)Nc5cccnc5)c4c3)c2)CC1		CHEMBL4785547	=	EC50	nM	86.0	CHEMBL4226	Homo sapiens	EC50	uM	0.086
	22939765	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cnccn1)c1n[nH]c2ccc(-c3cncc(CN4CCCCCC4)c3)cc12		CHEMBL4747741	=	EC50	nM	135.0	CHEMBL4226	Homo sapiens	EC50	uM	0.135
	22939766	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cccnc1)c1n[nH]c2ccc(-c3cncc(CN4CCS(=O)(=O)CC4)c3)cc12		CHEMBL4764569	=	EC50	nM	37.0	CHEMBL4226	Homo sapiens	EC50	uM	0.037000000000000005
	22939767	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cccnc1)c1n[nH]c2ccc(-c3cncc(CN4CC5CC(C4)O5)c3)cc12		CHEMBL4743240	=	EC50	nM	44.0	CHEMBL4226	Homo sapiens	EC50	uM	0.044000000000000004
	22939768	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Oc1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CC6CC(C5)O6)c4)cc23)cn1		CHEMBL4743194	=	EC50	nM	88.0	CHEMBL4226	Homo sapiens	EC50	uM	0.08800000000000001
	22939769	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(CN2CCCC2)cc1)c1n[nH]c2ccc(-c3cncnc3)cc12		CHEMBL4755716	=	EC50	nM	1434.0	CHEMBL4226	Homo sapiens	EC50	uM	1.4340000000000002
	22939770	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(CN2CCCC2)cc1)c1n[nH]c2ccc(-c3cnccn3)cc12		CHEMBL4743500	=	EC50	nM	378.0	CHEMBL4226	Homo sapiens	EC50	uM	0.37799999999999995
	22939771	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)NC(=O)c1n[nH]c2ccc(-c3cncc(NC4CCNCC4)n3)cc12		CHEMBL4762097	=	EC50	nM	2440.0	CHEMBL4226	Homo sapiens	EC50	uM	2.44
	22939772	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(n2cc(NC(=O)c3n[nH]c4ccc(-c5cnn(C)c5)cc34)cn2)CC1		CHEMBL4796085	=	EC50	nM	55.0	CHEMBL4226	Homo sapiens	EC50	uM	0.055
	22939773	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2cc3c(C(=O)Nc4ccc(CN5CCCC5)cc4)n[nH]c3cc2F)cn1		CHEMBL4741843	=	EC50	nM	90.0	CHEMBL4226	Homo sapiens	EC50	uM	0.09
	22939774	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2cc3c(C(=O)Nc4ccc(OCCN5CCCC5)cc4)n[nH]c3cc2F)cn1		CHEMBL4756656	=	EC50	nM	101.0	CHEMBL4226	Homo sapiens	EC50	uM	0.10099999999999999
	22939775	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(Nc2ccc(NC(=O)c3n[nH]c4cc(F)c(-c5cnn(C)c5)cc34)cn2)CC1		CHEMBL4794020	=	EC50	nM	79.0	CHEMBL4226	Homo sapiens	EC50	uM	0.079
	22939776	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(Oc2ccc(NC(=O)c3n[nH]c4cc(F)c(-c5cnn(C)c5)cc34)cn2)CC1		CHEMBL4751049	=	EC50	nM	48.0	CHEMBL4226	Homo sapiens	EC50	uM	0.048
	22939777	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(Oc2ncc(NC(=O)c3n[nH]c4cc(F)c(-c5cnn(C)c5)cc34)cc2F)CC1		CHEMBL4778878	=	EC50	nM	89.0	CHEMBL4226	Homo sapiens	EC50	uM	0.08900000000000001
	22939778	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2cc3c(C(=O)Nc4ccc5c(c4)CNC5)n[nH]c3cc2F)cn1		CHEMBL4744452	=	EC50	nM	116.0	CHEMBL4226	Homo sapiens	EC50	uM	0.11599999999999999
	22939779	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(CN2CCCC2)cc1)c1n[nH]c2ccc(-c3cnn(C4CC4)c3)cc12		CHEMBL4744357	=	EC50	nM	133.0	CHEMBL4226	Homo sapiens	EC50	uM	0.133
	22939780	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ncc(NC(=O)c2n[nH]c3ccc(-c4cnn(C5CCN(C)CC5)c4)cc23)s1		CHEMBL4777667	=	EC50	nM	48.0	CHEMBL4226	Homo sapiens	EC50	uM	0.048
	22939781	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ncc(NC(=O)c2n[nH]c3ccc(-c4cnc(C)n4C)cc23)s1		CHEMBL4756183	=	EC50	nM	99.0	CHEMBL4226	Homo sapiens	EC50	uM	0.099
	22939782	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(OC(F)F)cc1)c1n[nH]c2ccc(-c3cnc4n3CCNC4)cc12		CHEMBL4747908	=	EC50	nM	391.0	CHEMBL4226	Homo sapiens	EC50	uM	0.391
	22939783	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccc(OC5CCN(C)CC5)cc4)c3c2)sn1		CHEMBL4789136	=	EC50	nM	147.0	CHEMBL4226	Homo sapiens	EC50	uM	0.147
	22939784	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cccnc1)c1n[nH]c2cnc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4793803	=	EC50	nM	601.0	CHEMBL4226	Homo sapiens	EC50	uM	0.601
	22939785	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1cccc(-c2cncc3[nH]c(-c4n[nH]c5ncc(-c6cccnc6)cc45)nc23)c1		CHEMBL4778616	=	EC50	nM	48.0	CHEMBL4226	Homo sapiens	EC50	uM	0.048
	22939786	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3c2)c1		CHEMBL4750399	=	EC50	nM	61.0	CHEMBL4226	Homo sapiens	EC50	uM	0.061
	22939787	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)ccnc5[nH]4)c3n2)c1		CHEMBL4758546	=	EC50	nM	30.0	CHEMBL4226	Homo sapiens	EC50	uM	0.03
	22939788	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCC(=O)Nc1cncc(-c2cc3c(-c4nc5c(-c6cccc(F)c6)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4745586	=	EC50	nM	6956.0	CHEMBL4226	Homo sapiens	EC50	uM	6.956
	22939789	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5cncc(-c6cccc(F)c6)c5[nH]4)c3c2)c1		CHEMBL4297639	=	EC50	nM	56.0	CHEMBL4226	Homo sapiens	EC50	uM	0.055999999999999994
	22939790	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)ccnc5[nH]4)c3c2)c1		CHEMBL4788446	=	EC50	nM	218.0	CHEMBL4226	Homo sapiens	EC50	uM	0.218
	22939791	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3c2)c1		CHEMBL4757954	=	EC50	nM	57.0	CHEMBL4226	Homo sapiens	EC50	uM	0.057
	22939792	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3c2)c1)C1CC1		CHEMBL4746269	=	EC50	nM	7330.0	CHEMBL4226	Homo sapiens	EC50	uM	7.33
	22939793	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3c2)c1)N1CCOCC1		CHEMBL4799714	=	EC50	nM	42.0	CHEMBL4226	Homo sapiens	EC50	uM	0.042
	22939794	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(CC1CCNCC1)Nc1cncc(-c2cc3c(-c4nc5c(-c6cccc(F)c6)ccnc5[nH]4)n[nH]c3cn2)c1		CHEMBL4782145	=	EC50	nM	28.0	CHEMBL4226	Homo sapiens	EC50	uM	0.027999999999999997
	22939795	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Cc1ccccc1)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3c2)c1		CHEMBL4763425	=	EC50	nM	164.0	CHEMBL4226	Homo sapiens	EC50	uM	0.16399999999999998
	22939796	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)C(=O)Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3c2)c1		CHEMBL4755351	=	EC50	nM	18.0	CHEMBL4226	Homo sapiens	EC50	uM	0.018000000000000002
	22939797	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3c2)c1		CHEMBL4781555	=	EC50	nM	160.0	CHEMBL4226	Homo sapiens	EC50	uM	0.16
	22939798	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)c1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3n2)c1		CHEMBL4783783	=	EC50	nM	12.0	CHEMBL4226	Homo sapiens	EC50	uM	0.012
	22939799	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)c1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)ccnc5[nH]4)c3n2)c1		CHEMBL4755308	=	EC50	nM	37.0	CHEMBL4226	Homo sapiens	EC50	uM	0.037000000000000005
	22939800	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cccc5[nH]4)c3c2)c1		CHEMBL4743067	=	EC50	nM	76.0	CHEMBL4226	Homo sapiens	EC50	uM	0.076
	22939801	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2cc3c(-c4nc5c(-c6cccc(F)c6)cccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4782720	=	EC50	nM	41.0	CHEMBL4226	Homo sapiens	EC50	uM	0.040999999999999995
	22939802	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cccc5[nH]4)c3n2)c1		CHEMBL4741100	=	EC50	nM	109.0	CHEMBL4226	Homo sapiens	EC50	uM	0.109
	22939803	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3c2)c1		CHEMBL4740064	=	EC50	nM	7.0	CHEMBL4226	Homo sapiens	EC50	uM	0.006999999999999999
	22939804	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)nccc5[nH]4)c3n2)c1		CHEMBL4786124	=	EC50	nM	197.0	CHEMBL4226	Homo sapiens	EC50	uM	0.19699999999999998
	22939805	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3n2)c1		CHEMBL4757172	=	EC50	nM	79.0	CHEMBL4226	Homo sapiens	EC50	uM	0.079
	22939806	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCN(C)Cc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3c2)c1		CHEMBL4765065	=	EC50	nM	22.0	CHEMBL4226	Homo sapiens	EC50	uM	0.022000000000000002
	22939807	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1cccc(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CN7CCC(F)(F)C7)c6)cc45)nc23)c1		CHEMBL4761890	=	EC50	nM	33.0	CHEMBL4226	Homo sapiens	EC50	uM	0.033
	22939808	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1cccc(-c2ccnc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CN7CCC(F)(F)C7)c6)cc45)nc23)c1		CHEMBL4798488	=	EC50	nM	90.0	CHEMBL4226	Homo sapiens	EC50	uM	0.09
	22939809	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Oc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)ccnc5[nH]4)c3c2)c1		CHEMBL4747400	=	EC50	nM	45.0	CHEMBL4226	Homo sapiens	EC50	uM	0.045
	22939810	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Oc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)nccc5[nH]4)c3n2)c1		CHEMBL4743122	=	EC50	nM	93.0	CHEMBL4226	Homo sapiens	EC50	uM	0.09300000000000001
	22939811	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Oc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3n2)c1		CHEMBL4753319	=	EC50	nM	74.0	CHEMBL4226	Homo sapiens	EC50	uM	0.07400000000000001
	22939812	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Oc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)ccnc5[nH]4)c3n2)c1		CHEMBL4777958	=	EC50	nM	113.0	CHEMBL4226	Homo sapiens	EC50	uM	0.113
	22939813	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(-c2cc3c(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)n[nH]c3cn2)c1		CHEMBL4764129	=	EC50	nM	493.0	CHEMBL4226	Homo sapiens	EC50	uM	0.493
	22939814	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)nccc5[nH]4)c3n2)c1		CHEMBL4795264	=	EC50	nM	124.0	CHEMBL4226	Homo sapiens	EC50	uM	0.124
	22939815	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3n2)c1		CHEMBL4788759	=	EC50	nM	65.0	CHEMBL4226	Homo sapiens	EC50	uM	0.065
	22939816	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)ccnc5[nH]4)c3n2)c1		CHEMBL4747036	=	EC50	nM	89.0	CHEMBL4226	Homo sapiens	EC50	uM	0.08900000000000001
	22939817	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)CCOc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccc(F)c6)nccc5[nH]4)c3c2)c1		CHEMBL4755870	=	EC50	nM	55.0	CHEMBL4226	Homo sapiens	EC50	uM	0.055
	22939818	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1cccc(-c2cncc3[nH]c(-c4n[nH]c5cnc(-c6cncc(OC7CCNCC7)c6)cc45)nc23)c1		CHEMBL4762436	=	EC50	nM	33.0	CHEMBL4226	Homo sapiens	EC50	uM	0.033
	22939819	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1cccc(-c2ccnc3[nH]c(-c4n[nH]c5ncc(-c6cn[nH]c6)cc45)nc23)c1		CHEMBL4785555	=	EC50	nM	93.0	CHEMBL4226	Homo sapiens	EC50	uM	0.09300000000000001
	22939820	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1cccc(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cn[nH]c6)nc45)nc23)c1		CHEMBL4764261	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22939821	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2cnc3[nH]nc(-c4nc5c(-c6cccc(F)c6)nccc5[nH]4)c3c2)cn1		CHEMBL4753975	=	EC50	nM	138.0	CHEMBL4226	Homo sapiens	EC50	uM	0.138
	22939822	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2cc3c(-c4nc5c(-c6cccc(F)c6)nccc5[nH]4)n[nH]c3cn2)cn1		CHEMBL4762500	=	EC50	nM	1800.0	CHEMBL4226	Homo sapiens	EC50	uM	1.8
	22939823	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2cc3c(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)n[nH]c3cn2)cn1		CHEMBL4760846	=	EC50	nM	416.0	CHEMBL4226	Homo sapiens	EC50	uM	0.41600000000000004
	22939824	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cccc5[nH]4)c3n2)n1C		CHEMBL4752659	=	EC50	nM	83.0	CHEMBL4226	Homo sapiens	EC50	uM	0.083
	22939825	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccc(F)c6)nccc5[nH]4)c3c2)n1C		CHEMBL4791974	=	EC50	nM	34.0	CHEMBL4226	Homo sapiens	EC50	uM	0.034
	22939826	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6ccc(F)cc6)cncc5[nH]4)c3c2)c1		CHEMBL4783909	=	EC50	nM	37.0	CHEMBL4226	Homo sapiens	EC50	uM	0.037000000000000005
	22939827	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccc(F)cc6)cncc5[nH]4)c3c2)c1		CHEMBL4789284	=	EC50	nM	105.0	CHEMBL4226	Homo sapiens	EC50	uM	0.105
	22939828	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccc(F)cc6)cncc5[nH]4)c3n2)c1		CHEMBL4740862	=	EC50	nM	9838.0	CHEMBL4226	Homo sapiens	EC50	uM	9.838
	22939829	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccc(F)cc6)cncc5[nH]4)c3c2)c1		CHEMBL4789715	=	EC50	nM	75.0	CHEMBL4226	Homo sapiens	EC50	uM	0.075
	22939830	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccc(F)cc6)cncc5[nH]4)c3c2)c1)C1CCC1		CHEMBL4747931	=	EC50	nM	87.0	CHEMBL4226	Homo sapiens	EC50	uM	0.087
	22939831	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccccc6F)nccc5[nH]4)c3c2)c1		CHEMBL4761232	=	EC50	nM	20.0	CHEMBL4226	Homo sapiens	EC50	uM	0.02
	22939832	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccccc6F)cccc5[nH]4)c3n2)c1		CHEMBL4793856	=	EC50	nM	209.0	CHEMBL4226	Homo sapiens	EC50	uM	0.209
	22939833	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccccc6F)ccnc5[nH]4)c3c2)c1		CHEMBL4758175	=	EC50	nM	19.0	CHEMBL4226	Homo sapiens	EC50	uM	0.019
	22939834	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6ccccc6F)ccnc5[nH]4)c3c2)c1		CHEMBL4795951	=	EC50	nM	76.0	CHEMBL4226	Homo sapiens	EC50	uM	0.076
	22939835	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccccc6F)nccc5[nH]4)c3n2)c1		CHEMBL4763852	=	EC50	nM	50.0	CHEMBL4226	Homo sapiens	EC50	uM	0.05
	22939836	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccccc6F)cncc5[nH]4)c3n2)c1		CHEMBL4786746	=	EC50	nM	12.0	CHEMBL4226	Homo sapiens	EC50	uM	0.012
	22939837	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccccc6F)ccnc5[nH]4)c3n2)c1		CHEMBL4755429	=	EC50	nM	34.0	CHEMBL4226	Homo sapiens	EC50	uM	0.034
	22939838	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6ccccc6F)cncc5[nH]4)c3c2)c1		CHEMBL4751675	=	EC50	nM	117.0	CHEMBL4226	Homo sapiens	EC50	uM	0.11699999999999999
	22939839	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccccc6F)cncc5[nH]4)c3c2)c1		CHEMBL4792507	=	EC50	nM	24.0	CHEMBL4226	Homo sapiens	EC50	uM	0.024
	22939840	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccccc6F)cncc5[nH]4)c3n2)c1		CHEMBL4753382	=	EC50	nM	9838.0	CHEMBL4226	Homo sapiens	EC50	uM	9.838
	22939841	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccccc6F)cccc5[nH]4)c3n2)c1)C(F)(F)F		CHEMBL4748619	=	EC50	nM	180.0	CHEMBL4226	Homo sapiens	EC50	uM	0.18
	22939842	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccccc6F)ccnc5[nH]4)c3n2)c1)C(F)(F)F		CHEMBL4776672	=	EC50	nM	149.0	CHEMBL4226	Homo sapiens	EC50	uM	0.149
	22939843	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccccc6F)cncc5[nH]4)c3c2)c1		CHEMBL4790668	=	EC50	nM	209.0	CHEMBL4226	Homo sapiens	EC50	uM	0.209
	22939844	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1		CHEMBL4749962	=	EC50	nM	207.0	CHEMBL4226	Homo sapiens	EC50	uM	0.207
	22939845	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2cc3c(-c4nc5c(-c6cccnc6)cccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4759401	=	EC50	nM	969.0	CHEMBL4226	Homo sapiens	EC50	uM	0.9690000000000001
	22939846	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccnc6)cccc5[nH]4)c3n2)c1		CHEMBL4744838	=	EC50	nM	296.0	CHEMBL4226	Homo sapiens	EC50	uM	0.29600000000000004
	22939847	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1		CHEMBL4745260	=	EC50	nM	17.0	CHEMBL4226	Homo sapiens	EC50	uM	0.017
	22939848	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2cc3c(-c4nc5c(-c6cccnc6)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4747019	=	EC50	nM	9838.0	CHEMBL4226	Homo sapiens	EC50	uM	9.838
	22939849	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccnc6)nccc5[nH]4)c3n2)c1		CHEMBL4793989	=	EC50	nM	105.0	CHEMBL4226	Homo sapiens	EC50	uM	0.105
	22939850	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccnc6)cncc5[nH]4)c3n2)c1		CHEMBL4784533	=	EC50	nM	177.0	CHEMBL4226	Homo sapiens	EC50	uM	0.177
	22939851	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccnc6)ccnc5[nH]4)c3n2)c1		CHEMBL4777787	=	EC50	nM	308.0	CHEMBL4226	Homo sapiens	EC50	uM	0.308
	22939852	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1		CHEMBL4762778	=	EC50	nM	37.0	CHEMBL4226	Homo sapiens	EC50	uM	0.037000000000000005
	22939853	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccnc6)ccnc5[nH]4)c3n2)c1		CHEMBL4786522	=	EC50	nM	132.0	CHEMBL4226	Homo sapiens	EC50	uM	0.132
	22939854	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1		CHEMBL4755029	=	EC50	nM	23.0	CHEMBL4226	Homo sapiens	EC50	uM	0.023
	22939855	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1		CHEMBL4754321	=	EC50	nM	26.0	CHEMBL4226	Homo sapiens	EC50	uM	0.026000000000000002
	22939856	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1)C1CC1		CHEMBL4756460	=	EC50	nM	39.0	CHEMBL4226	Homo sapiens	EC50	uM	0.039
	22939857	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1)C1CCC1		CHEMBL4755315	=	EC50	nM	49.0	CHEMBL4226	Homo sapiens	EC50	uM	0.049
	22939858	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1)c1ccccc1		CHEMBL4786564	=	EC50	nM	17.0	CHEMBL4226	Homo sapiens	EC50	uM	0.017
	22939859	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccnc6)nccc5[nH]4)c3n2)c1		CHEMBL4763435	=	EC50	nM	322.0	CHEMBL4226	Homo sapiens	EC50	uM	0.322
	22939860	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccnc6)cncc5[nH]4)c3n2)c1		CHEMBL4797078	=	EC50	nM	213.0	CHEMBL4226	Homo sapiens	EC50	uM	0.213
	22939861	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccnc6)ccnc5[nH]4)c3n2)c1		CHEMBL4755713	=	EC50	nM	280.0	CHEMBL4226	Homo sapiens	EC50	uM	0.28
	22939862	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccncc6)cncc5[nH]4)c3n2)c1		CHEMBL4760198	=	EC50	nM	995.0	CHEMBL4226	Homo sapiens	EC50	uM	0.995
	22939863	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccncc6)ccnc5[nH]4)c3n2)c1)C1CCCCC1		CHEMBL4793590	=	EC50	nM	984.0	CHEMBL4226	Homo sapiens	EC50	uM	0.9840000000000001
	22939864	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccccn6)nccc5[nH]4)c3c2)c1		CHEMBL4744253	=	EC50	nM	136.0	CHEMBL4226	Homo sapiens	EC50	uM	0.136
	22939865	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2cc3c(-c4nc5ccccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4764391	=	EC50	nM	209.0	CHEMBL4226	Homo sapiens	EC50	uM	0.209
	22939866	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccc3[nH]nc(-c4nc5cnccc5[nH]4)c3n2)c1		CHEMBL4744274	=	EC50	nM	2269.0	CHEMBL4226	Homo sapiens	EC50	uM	2.269
	22939867	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5ccncc5[nH]4)c3c2)c1		CHEMBL4783807	=	EC50	nM	65.0	CHEMBL4226	Homo sapiens	EC50	uM	0.065
	22939868	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5ccncc5[nH]4)c3n2)c1		CHEMBL4748882	=	EC50	nM	558.0	CHEMBL4226	Homo sapiens	EC50	uM	0.5579999999999999
	22939869	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5ccncc5[nH]4)c3c2)c1)C1CC1		CHEMBL4790964	=	EC50	nM	206.0	CHEMBL4226	Homo sapiens	EC50	uM	0.20600000000000002
	22939870	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	NC1CN(c2cncc(-c3ccc4[nH]nc(-c5nc6ccncc6[nH]5)c4c3)n2)C1		CHEMBL4747703	=	EC50	nM	182.0	CHEMBL4226	Homo sapiens	EC50	uM	0.182
	22939871	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCCCC6)cncc5[nH]4)c3n2)c1		CHEMBL4795539	=	EC50	nM	213.0	CHEMBL4226	Homo sapiens	EC50	uM	0.213
	22939872	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCCCC6)ccnc5[nH]4)c3n2)c1		CHEMBL4780323	=	EC50	nM	1292.0	CHEMBL4226	Homo sapiens	EC50	uM	1.2919999999999998
	22939873	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCCCC6)cncc5[nH]4)c3c2)c1		CHEMBL4762565	=	EC50	nM	58.0	CHEMBL4226	Homo sapiens	EC50	uM	0.057999999999999996
	22939874	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCCCC6)cncc5[nH]4)c3c2)c1		CHEMBL4784341	=	EC50	nM	94.0	CHEMBL4226	Homo sapiens	EC50	uM	0.094
	22939875	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCCCC6)cncc5[nH]4)c3c2)c1)C1CCC1		CHEMBL4752631	=	EC50	nM	54.0	CHEMBL4226	Homo sapiens	EC50	uM	0.054000000000000006
	22939876	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3ccc4[nH]nc(-c5nc6c(N7CCCCC7)cncc6[nH]5)c4c3)c2)C1		CHEMBL4793999	=	EC50	nM	107.0	CHEMBL4226	Homo sapiens	EC50	uM	0.107
	22939877	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3cc4c(-c5nc6c(N7CCCCC7)cncc6[nH]5)n[nH]c4cn3)c2)C1		CHEMBL4761624	=	EC50	nM	89.0	CHEMBL4226	Homo sapiens	EC50	uM	0.08900000000000001
	22939878	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cccnc6)cc45)nc23)CC1		CHEMBL4751115	=	EC50	nM	51.0	CHEMBL4226	Homo sapiens	EC50	uM	0.051
	22939879	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(N)c6)nc45)nc23)CC1		CHEMBL4749876	=	EC50	nM	344.0	CHEMBL4226	Homo sapiens	EC50	uM	0.344
	22939880	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(N)c6)nc45)nc23)CC1		CHEMBL4757486	=	EC50	nM	500.0	CHEMBL4226	Homo sapiens	EC50	uM	0.5
	22939881	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2ccnc3[nH]c(-c4n[nH]c5ccc(-c6cncc(N)c6)nc45)nc23)CC1		CHEMBL4763984	=	EC50	nM	843.0	CHEMBL4226	Homo sapiens	EC50	uM	0.843
	22939882	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCN(C)CC6)cccc5[nH]4)c3c2)c1		CHEMBL4780561	=	EC50	nM	40.0	CHEMBL4226	Homo sapiens	EC50	uM	0.04
	22939883	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(N7CCOCC7)c6)cc45)nc23)CC1		CHEMBL4760982	=	EC50	nM	32.0	CHEMBL4226	Homo sapiens	EC50	uM	0.032
	22939884	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]c5cc(F)c(-c6cnn(C)c6)cc45)nc23)CC1		CHEMBL4789036	=	EC50	nM	26.0	CHEMBL4226	Homo sapiens	EC50	uM	0.026000000000000002
	22939885	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCOCC6)cncc5[nH]4)c3c2)c1		CHEMBL4782737	=	EC50	nM	61.0	CHEMBL4226	Homo sapiens	EC50	uM	0.061
	22939886	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1cn(-c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)C(C)(C)C)c6)nc45)nc23)cn1		CHEMBL4779228	=	EC50	nM	188.0	CHEMBL4226	Homo sapiens	EC50	uM	0.188
	22939887	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1cn(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)C(C)(C)C)c6)nc45)nc23)cn1		CHEMBL4757581	=	EC50	nM	263.0	CHEMBL4226	Homo sapiens	EC50	uM	0.263
	22939888	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1cn(-c2ccnc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)C(C)(C)C)c6)nc45)nc23)cn1		CHEMBL4759166	=	EC50	nM	123.0	CHEMBL4226	Homo sapiens	EC50	uM	0.12300000000000001
	22939889	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1cn(-c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)CC(C)C)c6)cc45)nc23)cn1		CHEMBL4740717	=	EC50	nM	56.0	CHEMBL4226	Homo sapiens	EC50	uM	0.055999999999999994
	22939890	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1cn(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)CC(C)C)c6)cc45)nc23)cn1		CHEMBL4747740	=	EC50	nM	16.0	CHEMBL4226	Homo sapiens	EC50	uM	0.016
	22939891	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1cn(-c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)CC(C)C)c6)nc45)nc23)cn1		CHEMBL4777273	=	EC50	nM	116.0	CHEMBL4226	Homo sapiens	EC50	uM	0.11599999999999999
	22939892	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1cn(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)C7CCC7)c6)nc45)nc23)cn1		CHEMBL4754156	=	EC50	nM	1305.0	CHEMBL4226	Homo sapiens	EC50	uM	1.305
	22939893	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1cn(-c2ccnc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)C7CCC7)c6)nc45)nc23)cn1		CHEMBL4795493	=	EC50	nM	106.0	CHEMBL4226	Homo sapiens	EC50	uM	0.106
	22939894	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccoc6)cncc5[nH]4)c3c2)c1		CHEMBL4749618	=	EC50	nM	44.0	CHEMBL4226	Homo sapiens	EC50	uM	0.044000000000000004
	22939895	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6ccoc6)cccc5[nH]4)c3c2)c1		CHEMBL4750787	=	EC50	nM	87.0	CHEMBL4226	Homo sapiens	EC50	uM	0.087
	22939896	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccoc6)cncc5[nH]4)c3n2)c1		CHEMBL4786418	=	EC50	nM	361.0	CHEMBL4226	Homo sapiens	EC50	uM	0.361
	22939897	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)C(=O)Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6ccoc6)cncc5[nH]4)c3c2)c1		CHEMBL4792061	=	EC50	nM	143.0	CHEMBL4226	Homo sapiens	EC50	uM	0.14300000000000002
	22939898	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2cc3c(-c4nc5c(-c6ccoc6)cccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4787474	=	EC50	nM	521.0	CHEMBL4226	Homo sapiens	EC50	uM	0.521
	22939899	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Cc1ccccc1)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccoc6)cncc5[nH]4)c3c2)c1		CHEMBL4761923	=	EC50	nM	120.0	CHEMBL4226	Homo sapiens	EC50	uM	0.12
	22939900	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6ccoc6)cncc5[nH]4)c3c2)c1)c1ccccc1		CHEMBL4790036	=	EC50	nM	2629.0	CHEMBL4226	Homo sapiens	EC50	uM	2.6289999999999996
	22939901	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccoc6)nccc5[nH]4)c3c2)c1		CHEMBL4751276	=	EC50	nM	205.0	CHEMBL4226	Homo sapiens	EC50	uM	0.205
	22939902	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6ccoc6)nccc5[nH]4)c3c2)c1		CHEMBL4776491	=	EC50	nM	134.0	CHEMBL4226	Homo sapiens	EC50	uM	0.134
	22939903	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccoc6)nccc5[nH]4)c3n2)c1		CHEMBL4800320	=	EC50	nM	230.0	CHEMBL4226	Homo sapiens	EC50	uM	0.23
	22939904	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccoc6)cncc5[nH]4)c3n2)c1		CHEMBL4795987	=	EC50	nM	87.0	CHEMBL4226	Homo sapiens	EC50	uM	0.087
	22939905	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccoc6)ccnc5[nH]4)c3n2)c1		CHEMBL4755833	=	EC50	nM	113.0	CHEMBL4226	Homo sapiens	EC50	uM	0.113
	22939906	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3cnc4[nH]nc(-c5nc6c(-c7ccoc7)nccc6[nH]5)c4c3)c2)C1		CHEMBL4742707	=	EC50	nM	34.0	CHEMBL4226	Homo sapiens	EC50	uM	0.034
	22939907	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccncc1-c1ccc2[nH]nc(-c3nc4c(-c5ccsc5)nccc4[nH]3)c2c1		CHEMBL4797672	=	EC50	nM	76.0	CHEMBL4226	Homo sapiens	EC50	uM	0.076
	22939908	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6ccsc6)cccc5[nH]4)c3c2)c1		CHEMBL4779032	=	EC50	nM	62.0	CHEMBL4226	Homo sapiens	EC50	uM	0.062
	22939909	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccsc6)cncc5[nH]4)c3c2)c1		CHEMBL4783817	=	EC50	nM	64.0	CHEMBL4226	Homo sapiens	EC50	uM	0.064
	22939910	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccsc6)ccnc5[nH]4)c3c2)c1		CHEMBL4784131	=	EC50	nM	9838.0	CHEMBL4226	Homo sapiens	EC50	uM	9.838
	22939911	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCC(=O)Nc1cncc(-c2cc3c(-c4nc5c(-c6ccsc6)cncc5[nH]4)n[nH]c3cn2)c1		CHEMBL4786673	=	EC50	nM	21.0	CHEMBL4226	Homo sapiens	EC50	uM	0.021
	22939912	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccsc6)cncc5[nH]4)c3n2)c1		CHEMBL4760441	=	EC50	nM	48.0	CHEMBL4226	Homo sapiens	EC50	uM	0.048
	22939913	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(CC1CCNCC1)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccsc6)nccc5[nH]4)c3n2)c1		CHEMBL4747934	=	EC50	nM	66.0	CHEMBL4226	Homo sapiens	EC50	uM	0.066
	22939914	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2cc3c(-c4nc5c(-c6ccsc6)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4755887	=	EC50	nM	30.0	CHEMBL4226	Homo sapiens	EC50	uM	0.03
	22939915	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cc(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CNCC7CCCC7)c6)cc45)nc23)cs1		CHEMBL4780659	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22939916	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6ccsc6)cccc5[nH]4)c3c2)c1		CHEMBL4764778	=	EC50	nM	67.0	CHEMBL4226	Homo sapiens	EC50	uM	0.067
	22939917	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6ccsc6)cncc5[nH]4)c3c2)c1		CHEMBL4788012	=	EC50	nM	118.0	CHEMBL4226	Homo sapiens	EC50	uM	0.11800000000000001
	22939918	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3ccc4[nH]nc(-c5nc6c(-c7ccsc7)cncc6[nH]5)c4c3)c2)C1		CHEMBL4788582	=	EC50	nM	26.0	CHEMBL4226	Homo sapiens	EC50	uM	0.026000000000000002
	22939919	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccs6)cccc5[nH]4)c3c2)c1		CHEMBL4793606	=	EC50	nM	43.0	CHEMBL4226	Homo sapiens	EC50	uM	0.043
	22939920	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccs6)cncc5[nH]4)c3c2)c1		CHEMBL4744433	=	EC50	nM	62.0	CHEMBL4226	Homo sapiens	EC50	uM	0.062
	22939921	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccs6)cncc5[nH]4)c3c2)c1		CHEMBL4746968	=	EC50	nM	62.0	CHEMBL4226	Homo sapiens	EC50	uM	0.062
	22939922	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cc3c(-c4nc5c(-c6cccs6)nccc5[nH]4)n[nH]c3cn2)c1)C1CC1		CHEMBL4777730	=	EC50	nM	115.0	CHEMBL4226	Homo sapiens	EC50	uM	0.115
	22939923	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)c1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccs6)cncc5[nH]4)c3n2)c1		CHEMBL4742246	=	EC50	nM	83.0	CHEMBL4226	Homo sapiens	EC50	uM	0.083
	22939924	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1csc(-c2cncc3[nH]c(-c4n[nH]c5ncc(-c6cncc(CNCC7CCCC7)c6)cc45)nc23)c1		CHEMBL4749762	=	EC50	nM	167.0	CHEMBL4226	Homo sapiens	EC50	uM	0.16699999999999998
	22939925	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccs6)cncc5[nH]4)c3c2)c1		CHEMBL4760436	=	EC50	nM	128.0	CHEMBL4226	Homo sapiens	EC50	uM	0.128
	22939926	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)CCOc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccs6)cccc5[nH]4)c3n2)c1		CHEMBL4755388	=	EC50	nM	150.0	CHEMBL4226	Homo sapiens	EC50	uM	0.15
	22939927	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccc(F)s6)ccnc5[nH]4)c3c2)c1		CHEMBL4776636	=	EC50	nM	754.0	CHEMBL4226	Homo sapiens	EC50	uM	0.754
	22939928	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)C(=O)Nc1cncc(-c2cc3c(-c4nc5c(-c6ccc(F)s6)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4798005	=	EC50	nM	358.0	CHEMBL4226	Homo sapiens	EC50	uM	0.358
	22939929	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1ccc(-c2cncc3[nH]c(-c4n[nH]c5cnc(-c6cncc(CN7CCCC7)c6)cc45)nc23)s1		CHEMBL4778226	=	EC50	nM	35.0	CHEMBL4226	Homo sapiens	EC50	uM	0.035
	22939930	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccc(Cl)s6)cncc5[nH]4)c3n2)c1		CHEMBL4749262	=	EC50	nM	91.0	CHEMBL4226	Homo sapiens	EC50	uM	0.091
	22939931	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccc(Cl)s6)cncc5[nH]4)c3n2)c1		CHEMBL4748599	=	EC50	nM	67.0	CHEMBL4226	Homo sapiens	EC50	uM	0.067
	22939932	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccc(Cl)s6)nccc5[nH]4)c3n2)c1)C1CCC1		CHEMBL4764830	=	EC50	nM	9838.0	CHEMBL4226	Homo sapiens	EC50	uM	9.838
	22939933	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccc(Cl)s6)cncc5[nH]4)c3n2)c1)C1CCC1		CHEMBL4798360	=	EC50	nM	145.0	CHEMBL4226	Homo sapiens	EC50	uM	0.145
	22939934	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccc(Cl)s6)ccnc5[nH]4)c3n2)c1)C1CCC1		CHEMBL4754669	=	EC50	nM	183.0	CHEMBL4226	Homo sapiens	EC50	uM	0.183
	22939935	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Clc1ccc(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CN7CCCC7)c6)nc45)nc23)s1		CHEMBL4758045	=	EC50	nM	88.0	CHEMBL4226	Homo sapiens	EC50	uM	0.08800000000000001
	22939936	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccc(-c2cccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(N)c6)nc45)nc23)s1		CHEMBL4749604	=	EC50	nM	34.0	CHEMBL4226	Homo sapiens	EC50	uM	0.034
	22939937	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccc(-c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(N)c6)cc45)nc23)s1		CHEMBL4753494	=	EC50	nM	52.0	CHEMBL4226	Homo sapiens	EC50	uM	0.052000000000000005
	22939938	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccc(-c2nccc3[nH]c(-c4n[nH]c5cnc(-c6cncc(N)c6)cc45)nc23)s1		CHEMBL4778624	=	EC50	nM	29.0	CHEMBL4226	Homo sapiens	EC50	uM	0.028999999999999998
	22939939	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccc(-c2cncc3[nH]c(-c4n[nH]c5cnc(-c6cncc(N)c6)cc45)nc23)s1		CHEMBL4756438	=	EC50	nM	203.0	CHEMBL4226	Homo sapiens	EC50	uM	0.203
	22939940	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccc(-c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(N)c6)nc45)nc23)s1		CHEMBL4778742	=	EC50	nM	20.0	CHEMBL4226	Homo sapiens	EC50	uM	0.02
	22939941	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccc(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(N)c6)nc45)nc23)s1		CHEMBL4754110	=	EC50	nM	9.0	CHEMBL4226	Homo sapiens	EC50	uM	0.009000000000000001
	22939942	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccc(-c2cncc3[nH]c(-c4n[nH]c5cnc(-c6cncc(NC(=O)C7CCC7)c6)cc45)nc23)s1		CHEMBL4790414	=	EC50	nM	29.0	CHEMBL4226	Homo sapiens	EC50	uM	0.028999999999999998
	22939943	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)CCNc1cc(F)cc(-c2cncc3[nH]c(-c4n[nH]c5ncc(-c6cccnc6)cc45)nc23)c1		CHEMBL4740704	=	EC50	nM	36.0	CHEMBL4226	Homo sapiens	EC50	uM	0.036000000000000004
	22939944	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cc(F)cc(NCCN(C)C)c6)cncc5[nH]4)c3n2)c1		CHEMBL4759161	=	EC50	nM	93.0	CHEMBL4226	Homo sapiens	EC50	uM	0.09300000000000001
	22939945	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cc(F)cc(NCCN(C)C)c6)ccnc5[nH]4)c3n2)c1		CHEMBL4761965	=	EC50	nM	79.0	CHEMBL4226	Homo sapiens	EC50	uM	0.079
	22939946	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cc(F)cc(NCCN(C)C)c6)cncc5[nH]4)c3c2)c1		CHEMBL4749868	=	EC50	nM	25.0	CHEMBL4226	Homo sapiens	EC50	uM	0.025
	22939947	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cc(F)cc(NCCN(C)C)c6)nccc5[nH]4)c3c2)c1		CHEMBL4760437	=	EC50	nM	50.0	CHEMBL4226	Homo sapiens	EC50	uM	0.05
	22939948	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cc(F)cc(NCCN(C)C)c6)nccc5[nH]4)c3c2)c1		CHEMBL4749014	=	EC50	nM	33.0	CHEMBL4226	Homo sapiens	EC50	uM	0.033
	22939949	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cc(F)cc(NCCN(C)C)c6)cncc5[nH]4)c3n2)c1		CHEMBL4754511	=	EC50	nM	25.0	CHEMBL4226	Homo sapiens	EC50	uM	0.025
	22939950	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cc(F)cc(NCCN(C)C)c6)nccc5[nH]4)c3n2)c1		CHEMBL4750400	=	EC50	nM	90.0	CHEMBL4226	Homo sapiens	EC50	uM	0.09
	22939951	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cc(F)cc(NCCN(C)C)c6)ccnc5[nH]4)c3n2)c1		CHEMBL4798951	=	EC50	nM	82.0	CHEMBL4226	Homo sapiens	EC50	uM	0.08199999999999999
	22939952	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ncc(-c2ccc3[nH]nc(-c4nc5c(-c6cc(F)cc(NCCN(C)C)c6)ccnc5[nH]4)c3n2)n1C		CHEMBL4790085	=	EC50	nM	44.0	CHEMBL4226	Homo sapiens	EC50	uM	0.044000000000000004
	22939953	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccncc1-c1cc2c(-c3nc4c(-c5cc(F)cc(CNS(C)(=O)=O)c5)cccc4[nH]3)n[nH]c2cn1		CHEMBL4790637	=	EC50	nM	37.0	CHEMBL4226	Homo sapiens	EC50	uM	0.037000000000000005
	22939954	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccncc1-c1cnc2[nH]nc(-c3nc4c(-c5cc(F)cc(CNS(C)(=O)=O)c5)nccc4[nH]3)c2c1		CHEMBL4763405	=	EC50	nM	39.0	CHEMBL4226	Homo sapiens	EC50	uM	0.039
	22939955	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccncc1-c1cc2c(-c3nc4c(-c5cc(F)cc(CNS(C)(=O)=O)c5)cncc4[nH]3)n[nH]c2cn1		CHEMBL4791409	=	EC50	nM	17.0	CHEMBL4226	Homo sapiens	EC50	uM	0.017
	22939956	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccncc1-c1cc2c(-c3nc4c(-c5cc(F)cc(CNS(C)(=O)=O)c5)ccnc4[nH]3)n[nH]c2cn1		CHEMBL4797300	=	EC50	nM	54.0	CHEMBL4226	Homo sapiens	EC50	uM	0.054000000000000006
	22939957	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cc(F)cc(CNS(C)(=O)=O)c6)cncc5[nH]4)c3c2)c1		CHEMBL4793420	=	EC50	nM	60.0	CHEMBL4226	Homo sapiens	EC50	uM	0.06
	22939958	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CS(=O)(=O)NCc1cc(F)cc(-c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncnc6)cc45)nc23)c1		CHEMBL4744601	=	EC50	nM	186.0	CHEMBL4226	Homo sapiens	EC50	uM	0.18600000000000003
	22939959	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cc(F)cc(N7CCOCC7)c6)cncc5[nH]4)c3c2)c1		CHEMBL4745861	=	EC50	nM	25.0	CHEMBL4226	Homo sapiens	EC50	uM	0.025
	22939960	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cccc(-c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cccnc6)nc45)nc23)c1		CHEMBL4782795	=	EC50	nM	96.0	CHEMBL4226	Homo sapiens	EC50	uM	0.096
	22939961	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cccc(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cccnc6)nc45)nc23)c1		CHEMBL4783753	=	EC50	nM	55.0	CHEMBL4226	Homo sapiens	EC50	uM	0.055
	22939962	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cccc(-c2ccnc3[nH]c(-c4n[nH]c5ccc(-c6cccnc6)nc45)nc23)c1		CHEMBL4788493	=	EC50	nM	84.0	CHEMBL4226	Homo sapiens	EC50	uM	0.084
	22939963	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2cc3c(-c4nc5c(-c6cc(F)cc(OCCN7CCCC7)c6)cncc5[nH]4)n[nH]c3cn2)c1		CHEMBL4746668	=	EC50	nM	13.0	CHEMBL4226	Homo sapiens	EC50	uM	0.013000000000000001
	22939964	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(Oc2ccc3[nH]c(-c4n[nH]c5ccc(-c6cnn(C)c6)cc45)nc3c2)CC1		CHEMBL4744523	=	EC50	nM	29.0	CHEMBL4226	Homo sapiens	EC50	uM	0.028999999999999998
	22939965	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1cccc(-c2cncc3[nH]c(-c4n[nH]c5ncc(-c6cccnc6)cc45)cc23)c1		CHEMBL4749607	=	EC50	nM	122.0	CHEMBL4226	Homo sapiens	EC50	uM	0.122
	22939966	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1cccc(-c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cccnc6)nc45)cc23)c1		CHEMBL4765221	=	EC50	nM	105.0	CHEMBL4226	Homo sapiens	EC50	uM	0.105
	22939967	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccc(F)c6)nccc5[nH]4)c3c2)c1		CHEMBL4796957	=	EC50	nM	46.0	CHEMBL4226	Homo sapiens	EC50	uM	0.046
	22939968	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccc(F)c6)cncc5[nH]4)c3c2)c1		CHEMBL4796795	=	EC50	nM	85.0	CHEMBL4226	Homo sapiens	EC50	uM	0.085
	22939969	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccc(F)c6)ccnc5[nH]4)c3c2)c1		CHEMBL4788382	=	EC50	nM	21.0	CHEMBL4226	Homo sapiens	EC50	uM	0.021
	22939970	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cccc(F)c6)cncc5[nH]4)c3c2)c1		CHEMBL4779327	=	EC50	nM	33.0	CHEMBL4226	Homo sapiens	EC50	uM	0.033
	22939971	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2cc3c(-c4cc5c(-c6cccc(F)c6)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4780543	=	EC50	nM	138.0	CHEMBL4226	Homo sapiens	EC50	uM	0.138
	22939972	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2cc3c(-c4cc5c(-c6cccc(F)c6)cncc5[nH]4)n[nH]c3cn2)c1		CHEMBL4743234	=	EC50	nM	307.0	CHEMBL4226	Homo sapiens	EC50	uM	0.307
	22939973	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccc(F)c6)nccc5[nH]4)c3c2)c1		CHEMBL4757524	=	EC50	nM	83.0	CHEMBL4226	Homo sapiens	EC50	uM	0.083
	22939974	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccc(F)c6)cncc5[nH]4)c3c2)c1		CHEMBL4799281	=	EC50	nM	37.0	CHEMBL4226	Homo sapiens	EC50	uM	0.037000000000000005
	22939975	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cccc(F)c6)nccc5[nH]4)c3c2)c1		CHEMBL4755078	=	EC50	nM	74.0	CHEMBL4226	Homo sapiens	EC50	uM	0.07400000000000001
	22939976	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2cc3c(-c4cc5c(-c6cccc(F)c6)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4741293	=	EC50	nM	218.0	CHEMBL4226	Homo sapiens	EC50	uM	0.218
	22939977	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1cccc(-c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CN7CCCCC7)c6)nc45)cc23)c1		CHEMBL4797290	=	EC50	nM	252.0	CHEMBL4226	Homo sapiens	EC50	uM	0.252
	22939978	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1cccc(-c2cncc3[nH]c(-c4n[nH]c5ncc(-c6cncc(CN7CCCCC7)c6)cc45)cc23)c1		CHEMBL4790211	=	EC50	nM	295.0	CHEMBL4226	Homo sapiens	EC50	uM	0.295
	22939979	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cc3c(-c4cc5c(-c6ccc(F)cc6)nccc5[nH]4)n[nH]c3cn2)c1)C1CC1		CHEMBL4753208	=	EC50	nM	202.0	CHEMBL4226	Homo sapiens	EC50	uM	0.20199999999999999
	22939980	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1ccc(-c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CN7CCCC7)c6)cc45)cc23)cc1		CHEMBL4779789	=	EC50	nM	139.0	CHEMBL4226	Homo sapiens	EC50	uM	0.139
	22939981	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1ccc(-c2nccc3[nH]c(-c4n[nH]c5cnc(-c6cncc(CN7CCC(F)(F)C7)c6)cc45)cc23)cc1		CHEMBL4788785	=	EC50	nM	417.0	CHEMBL4226	Homo sapiens	EC50	uM	0.41700000000000004
	22939982	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1ccc(-c2cncc3[nH]c(-c4n[nH]c5cnc(-c6cncc(CN7CCC(F)(F)C7)c6)cc45)cc23)cc1		CHEMBL4742109	=	EC50	nM	9838.0	CHEMBL4226	Homo sapiens	EC50	uM	9.838
	22939983	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)CCOc1cncc(-c2cc3c(-c4cc5c(-c6ccc(F)cc6)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4746881	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22939984	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1ccc(-c2cncc3[nH]c(-c4n[nH]c5ncc(-c6cncnc6)cc45)cc23)cc1		CHEMBL4741528	=	EC50	nM	817.0	CHEMBL4226	Homo sapiens	EC50	uM	0.8170000000000001
	22939985	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccccc6F)ccnc5[nH]4)c3c2)c1		CHEMBL4755268	=	EC50	nM	33.0	CHEMBL4226	Homo sapiens	EC50	uM	0.033
	22939986	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccccc6F)nccc5[nH]4)c3c2)c1		CHEMBL4760948	=	EC50	nM	67.0	CHEMBL4226	Homo sapiens	EC50	uM	0.067
	22939987	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccccc6F)ccnc5[nH]4)c3c2)c1		CHEMBL4756589	=	EC50	nM	66.0	CHEMBL4226	Homo sapiens	EC50	uM	0.066
	22939988	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2cc3c(-c4cc5c(-c6ccccc6F)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4780582	=	EC50	nM	59.0	CHEMBL4226	Homo sapiens	EC50	uM	0.059000000000000004
	22939989	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2cc3c(-c4cc5c(-c6ccccc6F)cncc5[nH]4)n[nH]c3cn2)c1		CHEMBL4748029	=	EC50	nM	205.0	CHEMBL4226	Homo sapiens	EC50	uM	0.205
	22939990	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2cc3c(-c4cc5c(-c6ccccc6F)ccnc5[nH]4)n[nH]c3cn2)c1		CHEMBL4763075	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22939991	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccccc6F)nccc5[nH]4)c3n2)c1		CHEMBL4800107	=	EC50	nM	144.0	CHEMBL4226	Homo sapiens	EC50	uM	0.14400000000000002
	22939992	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)CC(=O)Nc1cncc(-c2cc3c(-c4cc5c(-c6ccccc6F)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4788394	=	EC50	nM	414.0	CHEMBL4226	Homo sapiens	EC50	uM	0.414
	22939993	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccccc6F)nccc5[nH]4)c3c2)c1)C1CC1		CHEMBL4745228	=	EC50	nM	47.0	CHEMBL4226	Homo sapiens	EC50	uM	0.047
	22939994	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccccc6F)cncc5[nH]4)c3c2)c1)C1CC1		CHEMBL4753703	=	EC50	nM	42.0	CHEMBL4226	Homo sapiens	EC50	uM	0.042
	22939995	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccccc6F)nccc5[nH]4)c3n2)c1)C1CC1		CHEMBL4749957	=	EC50	nM	109.0	CHEMBL4226	Homo sapiens	EC50	uM	0.109
	22939996	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccccc6F)nccc5[nH]4)c3c2)c1)C1CCCC1		CHEMBL4757198	=	EC50	nM	158.0	CHEMBL4226	Homo sapiens	EC50	uM	0.158
	22939997	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccccc6F)nccc5[nH]4)c3c2)c1		CHEMBL4791233	=	EC50	nM	196.0	CHEMBL4226	Homo sapiens	EC50	uM	0.196
	22939998	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccccc6F)ccnc5[nH]4)c3c2)c1		CHEMBL4799290	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22939999	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccccc6F)cncc5[nH]4)c3c2)c1		CHEMBL4760804	=	EC50	nM	89.0	CHEMBL4226	Homo sapiens	EC50	uM	0.08900000000000001
	22940000	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2cc3c(-c4cc5c(-c6ccccc6F)ccnc5[nH]4)n[nH]c3cn2)c1		CHEMBL4792242	=	EC50	nM	2313.0	CHEMBL4226	Homo sapiens	EC50	uM	2.313
	22940001	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccccc6F)cncc5[nH]4)c3c2)c1		CHEMBL4750038	=	EC50	nM	107.0	CHEMBL4226	Homo sapiens	EC50	uM	0.107
	22940002	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccccc6F)cncc5[nH]4)c3n2)c1		CHEMBL4782086	=	EC50	nM	109.0	CHEMBL4226	Homo sapiens	EC50	uM	0.109
	22940003	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1ccccc1-c1nccc2[nH]c(-c3n[nH]c4cnc(-c5cncc(CN6CCCC6)c5)cc34)cc12		CHEMBL4756072	=	EC50	nM	222.0	CHEMBL4226	Homo sapiens	EC50	uM	0.222
	22940004	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1ccccc1-c1cncc2[nH]c(-c3n[nH]c4ncc(-c5cn[nH]c5)cc34)cc12		CHEMBL4763957	=	EC50	nM	99.0	CHEMBL4226	Homo sapiens	EC50	uM	0.099
	22940005	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1ccccc1-c1nccc2[nH]c(-c3n[nH]c4cnc(-c5cn[nH]c5)cc34)cc12		CHEMBL4762727	=	EC50	nM	785.0	CHEMBL4226	Homo sapiens	EC50	uM	0.785
	22940006	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1		CHEMBL4748515	=	EC50	nM	3.0	CHEMBL4226	Homo sapiens	EC50	uM	0.003
	22940007	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)ccnc5[nH]4)c3c2)c1		CHEMBL4778916	=	EC50	nM	90.0	CHEMBL4226	Homo sapiens	EC50	uM	0.09
	22940008	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2cc3c(-c4cc5c(-c6cccnc6)cncc5[nH]4)n[nH]c3cn2)c1		CHEMBL4758642	=	EC50	nM	468.0	CHEMBL4226	Homo sapiens	EC50	uM	0.46799999999999997
	22940009	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)ccnc5[nH]4)c3n2)c1		CHEMBL4757917	=	EC50	nM	9838.0	CHEMBL4226	Homo sapiens	EC50	uM	9.838
	22940010	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccncc1-c1cnc2[nH]nc(-c3cc4c(-c5cccnc5)cncc4[nH]3)c2c1		CHEMBL4798397	=	EC50	nM	107.0	CHEMBL4226	Homo sapiens	EC50	uM	0.107
	22940011	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccncc1-c1ccc2[nH]nc(-c3cc4c(-c5cccnc5)cncc4[nH]3)c2n1		CHEMBL4741420	=	EC50	nM	133.0	CHEMBL4226	Homo sapiens	EC50	uM	0.133
	22940012	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)nccc5[nH]4)c3c2)c1		CHEMBL4749420	=	EC50	nM	18.0	CHEMBL4226	Homo sapiens	EC50	uM	0.018000000000000002
	22940013	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cccnc6)cccc5[nH]4)c3c2)c1		CHEMBL4747342	=	EC50	nM	538.0	CHEMBL4226	Homo sapiens	EC50	uM	0.5379999999999999
	22940014	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1		CHEMBL4758034	=	EC50	nM	37.0	CHEMBL4226	Homo sapiens	EC50	uM	0.037000000000000005
	22940015	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2cc3c(-c4cc5c(-c6cccnc6)cccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4754964	=	EC50	nM	1905.0	CHEMBL4226	Homo sapiens	EC50	uM	1.905
	22940016	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCCC(=O)Nc1cncc(-c2cc3c(-c4cc5c(-c6cccnc6)ccnc5[nH]4)n[nH]c3cn2)c1		CHEMBL4741533	=	EC50	nM	9838.0	CHEMBL4226	Homo sapiens	EC50	uM	9.838
	22940017	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cccnc6)ccnc5[nH]4)c3c2)c1		CHEMBL4783658	=	EC50	nM	9838.0	CHEMBL4226	Homo sapiens	EC50	uM	9.838
	22940018	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)CC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1		CHEMBL4744328	=	EC50	nM	85.0	CHEMBL4226	Homo sapiens	EC50	uM	0.085
	22940019	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cc3c(-c4cc5c(-c6cccnc6)cccc5[nH]4)n[nH]c3cn2)c1)C1CC1		CHEMBL4782218	=	EC50	nM	537.0	CHEMBL4226	Homo sapiens	EC50	uM	0.537
	22940020	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cccnc6)cccc5[nH]4)c3c2)c1)C1CCC1		CHEMBL4755952	=	EC50	nM	151.0	CHEMBL4226	Homo sapiens	EC50	uM	0.151
	22940021	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1)C1CCCC1		CHEMBL4755941	=	EC50	nM	78.0	CHEMBL4226	Homo sapiens	EC50	uM	0.078
	22940022	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)nccc5[nH]4)c3c2)c1)c1ccccc1		CHEMBL4755598	=	EC50	nM	43.0	CHEMBL4226	Homo sapiens	EC50	uM	0.043
	22940023	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1)c1ccccc1		CHEMBL4786950	=	EC50	nM	71.0	CHEMBL4226	Homo sapiens	EC50	uM	0.071
	22940024	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)cccc5[nH]4)c3c2)c1		CHEMBL4754308	=	EC50	nM	962.0	CHEMBL4226	Homo sapiens	EC50	uM	0.9620000000000001
	22940025	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1		CHEMBL4794971	=	EC50	nM	330.0	CHEMBL4226	Homo sapiens	EC50	uM	0.33
	22940026	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)ccnc5[nH]4)c3c2)c1		CHEMBL4777044	=	EC50	nM	164.0	CHEMBL4226	Homo sapiens	EC50	uM	0.16399999999999998
	22940027	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cccnc6)ccnc5[nH]4)c3c2)c1		CHEMBL4745435	=	EC50	nM	292.0	CHEMBL4226	Homo sapiens	EC50	uM	0.292
	22940028	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2cc3c(-c4cc5c(-c6cccnc6)ccnc5[nH]4)n[nH]c3cn2)c1		CHEMBL4799685	=	EC50	nM	9838.0	CHEMBL4226	Homo sapiens	EC50	uM	9.838
	22940029	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)ccnc5[nH]4)c3n2)c1		CHEMBL4784177	=	EC50	nM	139.0	CHEMBL4226	Homo sapiens	EC50	uM	0.139
	22940030	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)ccnc5[nH]4)c3c2)c1		CHEMBL4785809	=	EC50	nM	443.0	CHEMBL4226	Homo sapiens	EC50	uM	0.44299999999999995
	22940031	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cccnc6)ccnc5[nH]4)c3c2)c1		CHEMBL4758482	=	EC50	nM	74.0	CHEMBL4226	Homo sapiens	EC50	uM	0.07400000000000001
	22940032	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2cc3c(-c4cc5c(-c6cccnc6)cncc5[nH]4)n[nH]c3cn2)c1		CHEMBL4750750	=	EC50	nM	214.0	CHEMBL4226	Homo sapiens	EC50	uM	0.214
	22940033	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)cccc5[nH]4)c3n2)c1		CHEMBL4743788	=	EC50	nM	102.0	CHEMBL4226	Homo sapiens	EC50	uM	0.102
	22940034	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccnc3[nH]c(-c4n[nH]c5cnc(-c6cncc(CN7CCCC7)c6)cc45)cc23)c1		CHEMBL4757688	=	EC50	nM	102.0	CHEMBL4226	Homo sapiens	EC50	uM	0.102
	22940035	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3ccc4[nH]nc(-c5cc6c(-c7cccnc7)ccnc6[nH]5)c4c3)c2)C1		CHEMBL4760685	=	EC50	nM	101.0	CHEMBL4226	Homo sapiens	EC50	uM	0.10099999999999999
	22940036	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3ccc4[nH]nc(-c5cc6c(-c7cccnc7)cncc6[nH]5)c4n3)c2)C1		CHEMBL4763204	=	EC50	nM	408.0	CHEMBL4226	Homo sapiens	EC50	uM	0.408
	22940037	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccnc3[nH]c(-c4n[nH]c5ncc(-c6cncc(CN7CCCCC7)c6)cc45)cc23)c1		CHEMBL4747481	=	EC50	nM	69.0	CHEMBL4226	Homo sapiens	EC50	uM	0.069
	22940038	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2cncc3[nH]c(-c4n[nH]c5ncc(-c6cncnc6)cc45)cc23)c1		CHEMBL4742941	=	EC50	nM	156.0	CHEMBL4226	Homo sapiens	EC50	uM	0.156
	22940039	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccnc3[nH]c(-c4n[nH]c5cnc(-c6cncnc6)cc45)cc23)c1		CHEMBL4781998	=	EC50	nM	9838.0	CHEMBL4226	Homo sapiens	EC50	uM	9.838
	22940040	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)cncc5[nH]4)c3c2)cn1		CHEMBL4746411	=	EC50	nM	100.0	CHEMBL4226	Homo sapiens	EC50	uM	0.1
	22940041	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccncc1-c1ccc2[nH]nc(-c3cc4c(-c5ccncc5)ccnc4[nH]3)c2n1		CHEMBL4776132	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940042	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccncc6)nccc5[nH]4)c3c2)c1		CHEMBL4747922	=	EC50	nM	113.0	CHEMBL4226	Homo sapiens	EC50	uM	0.113
	22940043	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccncc6)nccc5[nH]4)c3c2)c1		CHEMBL4757102	=	EC50	nM	50.0	CHEMBL4226	Homo sapiens	EC50	uM	0.05
	22940044	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccncc6)cncc5[nH]4)c3c2)c1		CHEMBL4741393	=	EC50	nM	69.0	CHEMBL4226	Homo sapiens	EC50	uM	0.069
	22940045	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccncc6)ccnc5[nH]4)c3c2)c1		CHEMBL4789703	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940046	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2cc3c(-c4cc5c(-c6ccncc6)cncc5[nH]4)n[nH]c3cn2)c1		CHEMBL4763601	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940047	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccncc6)ccnc5[nH]4)c3n2)c1		CHEMBL4744766	=	EC50	nM	63.0	CHEMBL4226	Homo sapiens	EC50	uM	0.063
	22940048	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccncc6)cncc5[nH]4)c3c2)c1		CHEMBL4761515	=	EC50	nM	460.0	CHEMBL4226	Homo sapiens	EC50	uM	0.46
	22940049	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccncc6)ccnc5[nH]4)c3c2)c1		CHEMBL4783896	=	EC50	nM	100.0	CHEMBL4226	Homo sapiens	EC50	uM	0.1
	22940050	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2cc3c(-c4cc5c(-c6ccncc6)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4787630	=	EC50	nM	389.0	CHEMBL4226	Homo sapiens	EC50	uM	0.389
	22940051	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCCC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccncc6)cncc5[nH]4)c3c2)c1		CHEMBL4792964	=	EC50	nM	201.0	CHEMBL4226	Homo sapiens	EC50	uM	0.201
	22940052	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccncc6)nccc5[nH]4)c3c2)c1		CHEMBL4780519	=	EC50	nM	132.0	CHEMBL4226	Homo sapiens	EC50	uM	0.132
	22940053	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccncc6)cncc5[nH]4)c3c2)c1		CHEMBL4760110	=	EC50	nM	29.0	CHEMBL4226	Homo sapiens	EC50	uM	0.028999999999999998
	22940054	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccncc6)cccc5[nH]4)c3c2)c1		CHEMBL4762259	=	EC50	nM	9914.0	CHEMBL4226	Homo sapiens	EC50	uM	9.914
	22940055	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccncc6)ccnc5[nH]4)c3c2)c1		CHEMBL4743802	=	EC50	nM	137.0	CHEMBL4226	Homo sapiens	EC50	uM	0.13699999999999998
	22940056	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)C(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccncc6)cncc5[nH]4)c3c2)c1		CHEMBL4763649	=	EC50	nM	62.0	CHEMBL4226	Homo sapiens	EC50	uM	0.062
	22940057	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)C(=O)Nc1cncc(-c2cc3c(-c4cc5c(-c6ccncc6)cncc5[nH]4)n[nH]c3cn2)c1		CHEMBL4743111	=	EC50	nM	92.0	CHEMBL4226	Homo sapiens	EC50	uM	0.092
	22940058	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(CC1CCNCC1)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccncc6)ccnc5[nH]4)c3c2)c1		CHEMBL4748329	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940059	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccncc6)cncc5[nH]4)c3c2)c1)C1CCC1		CHEMBL4750354	=	EC50	nM	69.0	CHEMBL4226	Homo sapiens	EC50	uM	0.069
	22940060	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccncc6)nccc5[nH]4)c3c2)c1)C1CCCC1		CHEMBL4786493	=	EC50	nM	30.0	CHEMBL4226	Homo sapiens	EC50	uM	0.03
	22940061	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cc(-c2ccnc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CNCC7CCCC7)c6)nc45)cc23)ccn1		CHEMBL4743335	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940062	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)c1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccncc6)cncc5[nH]4)c3c2)c1		CHEMBL4782038	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940063	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccncc6)cncc5[nH]4)c3c2)c1		CHEMBL4780076	=	EC50	nM	56.0	CHEMBL4226	Homo sapiens	EC50	uM	0.055999999999999994
	22940064	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2cc3c(-c4cc5c(-c6ccncc6)cncc5[nH]4)n[nH]c3cn2)c1		CHEMBL4759225	=	EC50	nM	188.0	CHEMBL4226	Homo sapiens	EC50	uM	0.188
	22940065	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2cc3c(-c4cc5c(-c6ccncc6)ccnc5[nH]4)n[nH]c3cn2)c1		CHEMBL4797314	=	EC50	nM	180.0	CHEMBL4226	Homo sapiens	EC50	uM	0.18
	22940066	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3cnc4[nH]nc(-c5cc6c(-c7ccncc7)cccc6[nH]5)c4c3)c2)C1		CHEMBL4753143	=	EC50	nM	895.0	CHEMBL4226	Homo sapiens	EC50	uM	0.895
	22940067	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3cnc4[nH]nc(-c5cc6c(-c7ccncc7)cncc6[nH]5)c4c3)c2)C1		CHEMBL4751489	=	EC50	nM	110.0	CHEMBL4226	Homo sapiens	EC50	uM	0.11
	22940068	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cc(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CN7CCCCC7)c6)nc45)cc23)ccn1		CHEMBL4788538	=	EC50	nM	306.0	CHEMBL4226	Homo sapiens	EC50	uM	0.306
	22940069	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cc(-c2ccnc3[nH]c(-c4n[nH]c5ccc(-c6cncc(OCCN7CCCC7)c6)nc45)cc23)ccn1		CHEMBL4759120	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940070	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cc(-c2ccnc3[nH]c(-c4n[nH]c5ccc(-c6cncnc6)cc45)cc23)ccn1		CHEMBL4750923	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940071	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccncc6)cncc5[nH]4)c3c2)n1C		CHEMBL4759093	=	EC50	nM	227.0	CHEMBL4226	Homo sapiens	EC50	uM	0.22699999999999998
	22940072	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccccn6)ccnc5[nH]4)c3c2)c1		CHEMBL4750609	=	EC50	nM	19.0	CHEMBL4226	Homo sapiens	EC50	uM	0.019
	22940073	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(CC1CCNCC1)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccccn6)cccc5[nH]4)c3n2)c1		CHEMBL4755473	=	EC50	nM	32.0	CHEMBL4226	Homo sapiens	EC50	uM	0.032
	22940074	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3ccc4[nH]nc(-c5cc6c(-c7ccccn7)cccc6[nH]5)c4n3)c2)C1		CHEMBL4747611	=	EC50	nM	142.0	CHEMBL4226	Homo sapiens	EC50	uM	0.142
	22940075	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccc3[nH]nc(-c4cc5cnccc5[nH]4)c3c2)c1		CHEMBL4759361	=	EC50	nM	15.0	CHEMBL4226	Homo sapiens	EC50	uM	0.015
	22940076	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2cnc3[nH]nc(-c4cc5cccnc5[nH]4)c3c2)c1		CHEMBL4761786	=	EC50	nM	351.0	CHEMBL4226	Homo sapiens	EC50	uM	0.35100000000000003
	22940077	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2cc3c(-c4cc5cnccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4747558	=	EC50	nM	88.0	CHEMBL4226	Homo sapiens	EC50	uM	0.08800000000000001
	22940078	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2cc3c(-c4cc5cccnc5[nH]4)n[nH]c3cn2)c1		CHEMBL4753920	=	EC50	nM	5488.0	CHEMBL4226	Homo sapiens	EC50	uM	5.4879999999999995
	22940079	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccc3[nH]nc(-c4cc5cccnc5[nH]4)c3n2)c1		CHEMBL4757131	=	EC50	nM	1360.0	CHEMBL4226	Homo sapiens	EC50	uM	1.36
	22940080	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccncc1-c1ccc2[nH]nc(-c3cc4ccncc4[nH]3)c2c1		CHEMBL4761131	=	EC50	nM	31.0	CHEMBL4226	Homo sapiens	EC50	uM	0.031
	22940081	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccncc1-c1cc2c(-c3cc4cnccc4[nH]3)n[nH]c2cn1		CHEMBL4799353	=	EC50	nM	61.0	CHEMBL4226	Homo sapiens	EC50	uM	0.061
	22940082	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2ccc3[nH]nc(-c4cc5cccnc5[nH]4)c3c2)c1		CHEMBL4755073	=	EC50	nM	73.0	CHEMBL4226	Homo sapiens	EC50	uM	0.073
	22940083	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5cnccc5[nH]4)c3c2)c1		CHEMBL4755477	=	EC50	nM	41.0	CHEMBL4226	Homo sapiens	EC50	uM	0.040999999999999995
	22940084	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2cc3c(-c4cc5cnccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4745415	=	EC50	nM	16.0	CHEMBL4226	Homo sapiens	EC50	uM	0.016
	22940085	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5cccnc5[nH]4)c3c2)c1		CHEMBL4758986	=	EC50	nM	344.0	CHEMBL4226	Homo sapiens	EC50	uM	0.344
	22940086	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCCC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5cnccc5[nH]4)c3c2)c1		CHEMBL4751155	=	EC50	nM	83.0	CHEMBL4226	Homo sapiens	EC50	uM	0.083
	22940087	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCCC(=O)Nc1cncc(-c2cc3c(-c4cc5cnccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4746788	=	EC50	nM	54.0	CHEMBL4226	Homo sapiens	EC50	uM	0.054000000000000006
	22940088	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2cc3c(-c4cc5cccnc5[nH]4)n[nH]c3cn2)c1		CHEMBL4754274	=	EC50	nM	6212.0	CHEMBL4226	Homo sapiens	EC50	uM	6.212000000000001
	22940089	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)CC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5cnccc5[nH]4)c3c2)c1		CHEMBL4752468	=	EC50	nM	47.0	CHEMBL4226	Homo sapiens	EC50	uM	0.047
	22940090	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)CC(=O)Nc1cncc(-c2cc3c(-c4cc5cnccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4746032	=	EC50	nM	56.0	CHEMBL4226	Homo sapiens	EC50	uM	0.055999999999999994
	22940091	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cc3c(-c4cc5cnccc5[nH]4)n[nH]c3cn2)c1)C1CC1		CHEMBL4757454	=	EC50	nM	88.0	CHEMBL4226	Homo sapiens	EC50	uM	0.08800000000000001
	22940092	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cc3c(-c4cc5cccnc5[nH]4)n[nH]c3cn2)c1)C1CC1		CHEMBL4740976	=	EC50	nM	9838.0	CHEMBL4226	Homo sapiens	EC50	uM	9.838
	22940093	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4cc5cnccc5[nH]4)c3c2)c1)C1CCC1		CHEMBL4797292	=	EC50	nM	19.0	CHEMBL4226	Homo sapiens	EC50	uM	0.019
	22940094	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4cc5cccnc5[nH]4)c3c2)c1)C1CCCC1		CHEMBL4776789	=	EC50	nM	365.0	CHEMBL4226	Homo sapiens	EC50	uM	0.365
	22940095	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4cc5ccncc5[nH]4)c3n2)c1)C1CCCC1		CHEMBL4741036	=	EC50	nM	147.0	CHEMBL4226	Homo sapiens	EC50	uM	0.147
	22940096	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4cc5cnccc5[nH]4)c3c2)c1)C1CCCCC1		CHEMBL4779458	=	EC50	nM	18.0	CHEMBL4226	Homo sapiens	EC50	uM	0.018000000000000002
	22940097	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4cc5cccnc5[nH]4)c3c2)c1)C1CCCCC1		CHEMBL4799905	=	EC50	nM	2971.0	CHEMBL4226	Homo sapiens	EC50	uM	2.971
	22940098	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cc3c(-c4cc5cnccc5[nH]4)n[nH]c3cn2)c1)C1CCCCC1		CHEMBL4756871	=	EC50	nM	62.0	CHEMBL4226	Homo sapiens	EC50	uM	0.062
	22940099	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Cc1ccccc1)Nc1cncc(-c2ccc3[nH]nc(-c4cc5cnccc5[nH]4)c3c2)c1		CHEMBL4740858	=	EC50	nM	180.0	CHEMBL4226	Homo sapiens	EC50	uM	0.18
	22940100	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4cc5cnccc5[nH]4)c3c2)c1)c1ccccc1		CHEMBL4751252	=	EC50	nM	46.0	CHEMBL4226	Homo sapiens	EC50	uM	0.046
	22940101	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4cc5cccnc5[nH]4)c3c2)c1)c1ccccc1		CHEMBL4758308	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940102	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cc3c(-c4cc5cnccc5[nH]4)n[nH]c3cn2)c1)c1ccccc1		CHEMBL4758596	=	EC50	nM	62.0	CHEMBL4226	Homo sapiens	EC50	uM	0.062
	22940103	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2ccc3[nH]nc(-c4cc5ccccc5[nH]4)c3c2)c1		CHEMBL4786094	=	EC50	nM	269.0	CHEMBL4226	Homo sapiens	EC50	uM	0.26899999999999996
	22940104	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2ccc3[nH]nc(-c4cc5cnccc5[nH]4)c3c2)c1		CHEMBL4753378	=	EC50	nM	49.0	CHEMBL4226	Homo sapiens	EC50	uM	0.049
	22940105	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2ccc3[nH]nc(-c4cc5cccnc5[nH]4)c3n2)c1		CHEMBL4797436	=	EC50	nM	562.0	CHEMBL4226	Homo sapiens	EC50	uM	0.562
	22940106	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)c1cncc(-c2cc3c(-c4cc5cnccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4744291	=	EC50	nM	538.0	CHEMBL4226	Homo sapiens	EC50	uM	0.5379999999999999
	22940107	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2ccc3[nH]nc(-c4cc5cnccc5[nH]4)c3n2)c1		CHEMBL4796832	=	EC50	nM	101.0	CHEMBL4226	Homo sapiens	EC50	uM	0.10099999999999999
	22940108	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2ccc3[nH]nc(-c4cc5cccnc5[nH]4)c3n2)c1		CHEMBL4789529	=	EC50	nM	566.0	CHEMBL4226	Homo sapiens	EC50	uM	0.5660000000000001
	22940109	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1ccc2[nH]c(-c3n[nH]c4ncc(-c5cncc(CN6CCCC6)c5)cc34)cc2c1		CHEMBL4793740	=	EC50	nM	362.0	CHEMBL4226	Homo sapiens	EC50	uM	0.36200000000000004
	22940110	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3cc4c(-c5cc6cccnc6[nH]5)n[nH]c4cn3)c2)C1		CHEMBL4784018	=	EC50	nM	203.0	CHEMBL4226	Homo sapiens	EC50	uM	0.203
	22940111	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3ccc4[nH]nc(-c5cc6cnccc6[nH]5)c4n3)c2)C1		CHEMBL4763390	=	EC50	nM	23.0	CHEMBL4226	Homo sapiens	EC50	uM	0.023
	22940112	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3ccc4[nH]nc(-c5cc6cccnc6[nH]5)c4n3)c2)C1		CHEMBL4792259	=	EC50	nM	370.0	CHEMBL4226	Homo sapiens	EC50	uM	0.37
	22940113	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cc2[nH]c(-c3n[nH]c4ccc(-c5cncc(CN6CCCCC6)c5)cc34)cc2cn1		CHEMBL4754457	=	EC50	nM	28.0	CHEMBL4226	Homo sapiens	EC50	uM	0.027999999999999997
	22940114	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cnc2cc(-c3n[nH]c4ccc(-c5cncc(CN6CCCCC6)c5)cc34)[nH]c2c1		CHEMBL4764806	=	EC50	nM	19.0	CHEMBL4226	Homo sapiens	EC50	uM	0.019
	22940115	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cnc2[nH]c(-c3n[nH]c4ccc(-c5cncc(CN6CCCCC6)c5)cc34)cc2c1		CHEMBL4777829	=	EC50	nM	85.0	CHEMBL4226	Homo sapiens	EC50	uM	0.085
	22940116	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cc2[nH]c(-c3n[nH]c4ncc(-c5cncc(CN6CCCCC6)c5)cc34)cc2cn1		CHEMBL4789272	=	EC50	nM	53.0	CHEMBL4226	Homo sapiens	EC50	uM	0.053
	22940117	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cc2cc(-c3n[nH]c4ccc(-c5cncc(OCCN6CCCC6)c5)cc34)[nH]c2cn1		CHEMBL4749742	=	EC50	nM	68.0	CHEMBL4226	Homo sapiens	EC50	uM	0.068
	22940118	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cnc2[nH]c(-c3n[nH]c4ccc(-c5cncc(OCCN6CCCC6)c5)cc34)cc2c1		CHEMBL4741593	=	EC50	nM	246.0	CHEMBL4226	Homo sapiens	EC50	uM	0.24600000000000002
	22940119	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2cnc3[nH]nc(-c4cc5cccnc5[nH]4)c3c2)cn1		CHEMBL4795309	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940120	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(N6CCCCC6)ccnc5[nH]4)c3c2)c1		CHEMBL4762016	=	EC50	nM	110.0	CHEMBL4226	Homo sapiens	EC50	uM	0.11
	22940121	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2cc3c(-c4cc5c(N6CCCCC6)cncc5[nH]4)n[nH]c3cn2)c1		CHEMBL4763741	=	EC50	nM	94.0	CHEMBL4226	Homo sapiens	EC50	uM	0.094
	22940122	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(N6CCCCC6)nccc5[nH]4)c3c2)c1		CHEMBL4776104	=	EC50	nM	52.0	CHEMBL4226	Homo sapiens	EC50	uM	0.052000000000000005
	22940123	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(N6CCCCC6)cccc5[nH]4)c3n2)c1		CHEMBL4762624	=	EC50	nM	2192.0	CHEMBL4226	Homo sapiens	EC50	uM	2.1919999999999997
	22940124	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(N6CCCCC6)nccc5[nH]4)c3n2)c1		CHEMBL4790903	=	EC50	nM	269.0	CHEMBL4226	Homo sapiens	EC50	uM	0.26899999999999996
	22940125	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(N6CCCCC6)nccc5[nH]4)c3c2)c1)C1CC1		CHEMBL4800596	=	EC50	nM	231.0	CHEMBL4226	Homo sapiens	EC50	uM	0.231
	22940126	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cc3c(-c4cc5c(N6CCCCC6)nccc5[nH]4)n[nH]c3cn2)c1)C1CCC1		CHEMBL4796975	=	EC50	nM	342.0	CHEMBL4226	Homo sapiens	EC50	uM	0.342
	22940127	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(CC1CCNCC1)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(N6CCCCC6)nccc5[nH]4)c3n2)c1		CHEMBL4795946	=	EC50	nM	48.0	CHEMBL4226	Homo sapiens	EC50	uM	0.048
	22940128	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(N6CCCCC6)nccc5[nH]4)c3c2)c1		CHEMBL4762357	=	EC50	nM	1277.0	CHEMBL4226	Homo sapiens	EC50	uM	1.2770000000000001
	22940129	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2ccc3[nH]nc(-c4cc5c(N6CCCCC6)cccc5[nH]4)c3c2)c1		CHEMBL4793215	=	EC50	nM	3662.0	CHEMBL4226	Homo sapiens	EC50	uM	3.662
	22940130	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2ccc3[nH]nc(-c4cc5c(N6CCCCC6)nccc5[nH]4)c3c2)c1		CHEMBL4740574	=	EC50	nM	293.0	CHEMBL4226	Homo sapiens	EC50	uM	0.293
	22940131	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1ncc(-c2ccc3[nH]nc(-c4cc5c(N6CCCCC6)cncc5[nH]4)c3c2)cc1CN1CCCC1		CHEMBL4798538	=	EC50	nM	64.0	CHEMBL4226	Homo sapiens	EC50	uM	0.064
	22940132	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3ccc4[nH]nc(-c5cc6c(N7CCCCC7)cccc6[nH]5)c4c3)c2)C1		CHEMBL4781079	=	EC50	nM	279.0	CHEMBL4226	Homo sapiens	EC50	uM	0.27899999999999997
	22940133	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3ccc4[nH]nc(-c5cc6c(N7CCCCC7)ccnc6[nH]5)c4n3)c2)C1		CHEMBL4780802	=	EC50	nM	166.0	CHEMBL4226	Homo sapiens	EC50	uM	0.166
	22940134	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cc2[nH]c(-c3n[nH]c4ccc(-c5cncc(CN6CCCCC6)c5)cc34)cc2c(N2CCCCC2)n1		CHEMBL4757427	=	EC50	nM	470.0	CHEMBL4226	Homo sapiens	EC50	uM	0.47
	22940135	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(N)c6)cc45)cc23)CC1		CHEMBL4797723	=	EC50	nM	40.0	CHEMBL4226	Homo sapiens	EC50	uM	0.04
	22940136	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2ccnc3[nH]c(-c4n[nH]c5ccc(-c6cncc(N)c6)cc45)cc23)CC1		CHEMBL4744948	=	EC50	nM	89.0	CHEMBL4226	Homo sapiens	EC50	uM	0.08900000000000001
	22940137	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]c5cnc(-c6cncc(N)c6)cc45)cc23)CC1		CHEMBL4741476	=	EC50	nM	1082.0	CHEMBL4226	Homo sapiens	EC50	uM	1.082
	22940138	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2cc3c(-c4cc5c(N6CCN(C)CC6)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4795743	=	EC50	nM	285.0	CHEMBL4226	Homo sapiens	EC50	uM	0.285
	22940139	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2cc3c(-c4cc5c(N6CCN(C)CC6)cccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4799857	=	EC50	nM	2039.0	CHEMBL4226	Homo sapiens	EC50	uM	2.039
	22940140	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(N6CCN(C)CC6)nccc5[nH]4)c3c2)c1		CHEMBL4740045	=	EC50	nM	569.0	CHEMBL4226	Homo sapiens	EC50	uM	0.569
	22940141	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(N6CCN(C)CC6)nccc5[nH]4)c3c2)c1		CHEMBL4797092	=	EC50	nM	800.0	CHEMBL4226	Homo sapiens	EC50	uM	0.8
	22940142	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(N6CCN(C)CC6)ccnc5[nH]4)c3n2)c1		CHEMBL4795751	=	EC50	nM	204.0	CHEMBL4226	Homo sapiens	EC50	uM	0.204
	22940143	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]c5cnc(-c6cncc(NC(=O)C(C)(C)C)c6)cc45)cc23)CC1		CHEMBL4757534	=	EC50	nM	137.0	CHEMBL4226	Homo sapiens	EC50	uM	0.13699999999999998
	22940144	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)CC(C)(C)C)c6)cc45)cc23)CC1		CHEMBL4756940	=	EC50	nM	145.0	CHEMBL4226	Homo sapiens	EC50	uM	0.145
	22940145	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2ccnc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)CC(C)(C)C)c6)nc45)cc23)CC1		CHEMBL4798097	=	EC50	nM	186.0	CHEMBL4226	Homo sapiens	EC50	uM	0.18600000000000003
	22940146	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]c5ncc(-c6cncc(NC(=O)C7CCCC7)c6)cc45)cc23)CC1		CHEMBL4782101	=	EC50	nM	741.0	CHEMBL4226	Homo sapiens	EC50	uM	0.741
	22940147	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)C7CCCCC7)c6)cc45)cc23)CC1		CHEMBL4790585	=	EC50	nM	2378.0	CHEMBL4226	Homo sapiens	EC50	uM	2.378
	22940148	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]c5cnc(-c6cncc(NC(=O)C7CCCCC7)c6)cc45)cc23)CC1		CHEMBL4749506	=	EC50	nM	303.0	CHEMBL4226	Homo sapiens	EC50	uM	0.303
	22940149	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)CC7CCNCC7)c6)cc45)cc23)CC1		CHEMBL4749220	=	EC50	nM	428.0	CHEMBL4226	Homo sapiens	EC50	uM	0.428
	22940150	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)CC7CCNCC7)c6)cc45)cc23)CC1		CHEMBL4776216	=	EC50	nM	303.0	CHEMBL4226	Homo sapiens	EC50	uM	0.303
	22940151	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)c7ccccc7)c6)cc45)cc23)CC1		CHEMBL4779082	=	EC50	nM	291.0	CHEMBL4226	Homo sapiens	EC50	uM	0.29100000000000004
	22940152	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]c5cnc(-c6cncc(NC(=O)c7ccccc7)c6)cc45)cc23)CC1		CHEMBL4777935	=	EC50	nM	302.0	CHEMBL4226	Homo sapiens	EC50	uM	0.302
	22940153	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2ccnc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)c7ccccc7)c6)nc45)cc23)CC1		CHEMBL4763400	=	EC50	nM	258.0	CHEMBL4226	Homo sapiens	EC50	uM	0.258
	22940154	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2ccnc3[nH]c(-c4n[nH]c5cnc(-c6cncc(CNCC7CCCC7)c6)cc45)cc23)CC1		CHEMBL4751483	=	EC50	nM	340.0	CHEMBL4226	Homo sapiens	EC50	uM	0.34
	22940155	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CNCc7ccccc7)c6)cc45)cc23)CC1		CHEMBL4785840	=	EC50	nM	142.0	CHEMBL4226	Homo sapiens	EC50	uM	0.142
	22940156	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2cc3c(-c4cc5c(N6CCN(C)CC6)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4748551	=	EC50	nM	1938.0	CHEMBL4226	Homo sapiens	EC50	uM	1.9380000000000002
	22940157	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CN7CCCC7)c6)cc45)cc23)CC1		CHEMBL4793656	=	EC50	nM	885.0	CHEMBL4226	Homo sapiens	EC50	uM	0.885
	22940158	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CN7CCCCC7)c6)cc45)cc23)CC1		CHEMBL4796190	=	EC50	nM	912.0	CHEMBL4226	Homo sapiens	EC50	uM	0.912
	22940159	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cccc3[nH]c(-c4n[nH]c5ncc(-c6cncc(CN7CCCCC7)c6)cc45)cc23)CC1		CHEMBL4787864	=	EC50	nM	973.0	CHEMBL4226	Homo sapiens	EC50	uM	0.973
	22940160	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]c5ncc(-c6cncc(CN7CCCCC7)c6)cc45)cc23)CC1		CHEMBL4748414	=	EC50	nM	1901.0	CHEMBL4226	Homo sapiens	EC50	uM	1.901
	22940161	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CN7CCCCC7)c6)nc45)cc23)CC1		CHEMBL4754230	=	EC50	nM	524.0	CHEMBL4226	Homo sapiens	EC50	uM	0.524
	22940162	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2ccnc3[nH]c(-c4n[nH]c5ncc(-c6cn[nH]c6)cc45)cc23)CC1		CHEMBL4747803	=	EC50	nM	678.0	CHEMBL4226	Homo sapiens	EC50	uM	0.6779999999999999
	22940163	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2ccnc3[nH]c(-c4n[nH]c5ccc(-c6cn[nH]c6)nc45)cc23)CC1		CHEMBL4751184	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940164	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccoc6)cncc5[nH]4)c3c2)c1		CHEMBL4790169	=	EC50	nM	42.0	CHEMBL4226	Homo sapiens	EC50	uM	0.042
	22940165	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccoc6)ccnc5[nH]4)c3c2)c1		CHEMBL4758657	=	EC50	nM	117.0	CHEMBL4226	Homo sapiens	EC50	uM	0.11699999999999999
	22940166	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(CC1CCNCC1)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccoc6)ccnc5[nH]4)c3n2)c1		CHEMBL4786287	=	EC50	nM	418.0	CHEMBL4226	Homo sapiens	EC50	uM	0.418
	22940167	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cc(-c2ccoc2)c2cc(-c3n[nH]c4ccc(-c5cncc(CNCC6CCCC6)c5)nc34)[nH]c2c1		CHEMBL4749966	=	EC50	nM	336.0	CHEMBL4226	Homo sapiens	EC50	uM	0.336
	22940168	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3cnc4[nH]nc(-c5cc6c(-c7ccoc7)cccc6[nH]5)c4c3)c2)C1		CHEMBL4760076	=	EC50	nM	104.0	CHEMBL4226	Homo sapiens	EC50	uM	0.10400000000000001
	22940169	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccoc6)nccc5[nH]4)c3c2)c1		CHEMBL4750641	=	EC50	nM	117.0	CHEMBL4226	Homo sapiens	EC50	uM	0.11699999999999999
	22940170	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1ncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccoc6)nccc5[nH]4)c3c2)cn1		CHEMBL4797627	=	EC50	nM	217.0	CHEMBL4226	Homo sapiens	EC50	uM	0.217
	22940171	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2cc3c(-c4cc5c(-c6cccs6)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4753467	=	EC50	nM	392.0	CHEMBL4226	Homo sapiens	EC50	uM	0.392
	22940172	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cccs6)nccc5[nH]4)c3c2)c1)C1CCC1		CHEMBL4754927	=	EC50	nM	60.0	CHEMBL4226	Homo sapiens	EC50	uM	0.06
	22940173	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1ccc(CNCc2cncc(-c3ccc4[nH]nc(-c5cc6c(-c7cccs7)cncc6[nH]5)c4c3)c2)cc1		CHEMBL4743209	=	EC50	nM	68.0	CHEMBL4226	Homo sapiens	EC50	uM	0.068
	22940174	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1csc(-c2nccc3[nH]c(-c4n[nH]c5cnc(-c6cncc(CN7CCCCC7)c6)cc45)cc23)c1		CHEMBL4741555	=	EC50	nM	140.0	CHEMBL4226	Homo sapiens	EC50	uM	0.14
	22940175	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1csc(-c2ccnc3[nH]c(-c4n[nH]c5ccc(-c6cncc(OC7CCNCC7)c6)nc45)cc23)c1		CHEMBL4742982	=	EC50	nM	1867.0	CHEMBL4226	Homo sapiens	EC50	uM	1.867
	22940176	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)CCNc1cc(F)cc(-c2cccc3[nH]c(-c4n[nH]c5cnc(-c6cncc(N)c6)cc45)cc23)c1		CHEMBL4759727	=	EC50	nM	50.0	CHEMBL4226	Homo sapiens	EC50	uM	0.05
	22940177	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCC(=O)Nc1cncc(-c2cc3c(-c4cc5c(-c6cc(F)cc(NCCN(C)C)c6)ccnc5[nH]4)n[nH]c3cn2)c1		CHEMBL4763521	=	EC50	nM	94.0	CHEMBL4226	Homo sapiens	EC50	uM	0.094
	22940178	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)CCNc1cc(F)cc(-c2cccc3[nH]c(-c4n[nH]c5cnc(-c6cncc(NC(=O)C(C)(C)C)c6)cc45)cc23)c1		CHEMBL4793616	=	EC50	nM	49.0	CHEMBL4226	Homo sapiens	EC50	uM	0.049
	22940179	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)CCNc1cc(F)cc(-c2cccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CN7CCCCC7)c6)nc45)cc23)c1		CHEMBL4780639	=	EC50	nM	49.0	CHEMBL4226	Homo sapiens	EC50	uM	0.049
	22940180	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)CCNc1cc(F)cc(-c2cccc3[nH]c(-c4n[nH]c5cnc(-c6cncc(O)c6)cc45)cc23)c1		CHEMBL4791991	=	EC50	nM	109.0	CHEMBL4226	Homo sapiens	EC50	uM	0.109
	22940181	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)CCNc1cc(F)cc(-c2cccc3[nH]c(-c4n[nH]c5ccc(-c6cncnc6)nc45)cc23)c1		CHEMBL4756681	=	EC50	nM	63.0	CHEMBL4226	Homo sapiens	EC50	uM	0.063
	22940182	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cc(F)cc(CNS(C)(=O)=O)c6)cncc5[nH]4)c3c2)c1		CHEMBL4753972	=	EC50	nM	216.0	CHEMBL4226	Homo sapiens	EC50	uM	0.21600000000000003
	22940183	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cc(F)cc(CNS(C)(=O)=O)c6)cncc5[nH]4)c3c2)c1		CHEMBL4796752	=	EC50	nM	39.0	CHEMBL4226	Homo sapiens	EC50	uM	0.039
	22940184	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cc(F)cc(CNS(C)(=O)=O)c6)cncc5[nH]4)c3c2)c1		CHEMBL4799161	=	EC50	nM	236.0	CHEMBL4226	Homo sapiens	EC50	uM	0.23600000000000002
	22940185	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2cc3c(-c4cc5c(-c6cc(F)cc(CNS(C)(=O)=O)c6)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4762665	=	EC50	nM	75.0	CHEMBL4226	Homo sapiens	EC50	uM	0.075
	22940186	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCCC(=O)Nc1cncc(-c2cc3c(-c4cc5c(-c6cc(F)cc(CNS(C)(=O)=O)c6)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4759630	=	EC50	nM	776.0	CHEMBL4226	Homo sapiens	EC50	uM	0.7759999999999999
	22940187	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cc(F)cc(CNS(C)(=O)=O)c6)nccc5[nH]4)c3c2)c1		CHEMBL4764899	=	EC50	nM	48.0	CHEMBL4226	Homo sapiens	EC50	uM	0.048
	22940188	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cc(F)cc(CNS(C)(=O)=O)c6)cncc5[nH]4)c3c2)c1		CHEMBL4744478	=	EC50	nM	81.0	CHEMBL4226	Homo sapiens	EC50	uM	0.081
	22940189	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2cc3c(-c4cc5c(-c6cc(F)cc(CNS(C)(=O)=O)c6)cncc5[nH]4)n[nH]c3cn2)c1		CHEMBL4761655	=	EC50	nM	198.0	CHEMBL4226	Homo sapiens	EC50	uM	0.198
	22940190	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cc(F)cc(CNS(C)(=O)=O)c6)nccc5[nH]4)c3n2)c1		CHEMBL4740181	=	EC50	nM	38.0	CHEMBL4226	Homo sapiens	EC50	uM	0.038
	22940191	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CS(=O)(=O)NCc1cc(F)cc(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)C7CC7)c6)nc45)cc23)c1		CHEMBL4795292	=	EC50	nM	140.0	CHEMBL4226	Homo sapiens	EC50	uM	0.14
	22940192	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CS(=O)(=O)NCc1cc(F)cc(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)C7CCC7)c6)cc45)cc23)c1		CHEMBL4785853	=	EC50	nM	66.0	CHEMBL4226	Homo sapiens	EC50	uM	0.066
	22940193	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CS(=O)(=O)NCc1cc(F)cc(-c2nccc3[nH]c(-c4n[nH]c5ncc(-c6cncc(NC(=O)C7CCC7)c6)cc45)cc23)c1		CHEMBL4754966	=	EC50	nM	59.0	CHEMBL4226	Homo sapiens	EC50	uM	0.059000000000000004
	22940194	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CS(=O)(=O)NCc1cc(F)cc(-c2cncc3[nH]c(-c4n[nH]c5cnc(-c6cncc(NC(=O)C7CCC7)c6)cc45)cc23)c1		CHEMBL4745159	=	EC50	nM	188.0	CHEMBL4226	Homo sapiens	EC50	uM	0.188
	22940195	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CS(=O)(=O)NCc1cc(F)cc(-c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)Cc7ccccc7)c6)nc45)cc23)c1		CHEMBL4760946	=	EC50	nM	151.0	CHEMBL4226	Homo sapiens	EC50	uM	0.151
	22940196	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cc(F)cc(CNS(C)(=O)=O)c6)cncc5[nH]4)c3c2)c1		CHEMBL4743076	=	EC50	nM	52.0	CHEMBL4226	Homo sapiens	EC50	uM	0.052000000000000005
	22940197	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cc(F)cc(CNS(C)(=O)=O)c6)nccc5[nH]4)c3c2)c1		CHEMBL4754837	=	EC50	nM	305.0	CHEMBL4226	Homo sapiens	EC50	uM	0.305
	22940198	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cc(F)cc(CNS(C)(=O)=O)c6)cncc5[nH]4)c3c2)c1		CHEMBL4788404	=	EC50	nM	51.0	CHEMBL4226	Homo sapiens	EC50	uM	0.051
	22940199	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CS(=O)(=O)NCc1cc(F)cc(-c2nccc3[nH]c(-c4n[nH]c5cnc(-c6cncc(CNCC7CCCC7)c6)cc45)cc23)c1		CHEMBL4793214	=	EC50	nM	471.0	CHEMBL4226	Homo sapiens	EC50	uM	0.47100000000000003
	22940200	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CS(=O)(=O)NCc1cc(F)cc(-c2cncc3[nH]c(-c4n[nH]c5ncc(-c6cncc(CN7CCCCC7)c6)cc45)cc23)c1		CHEMBL4755835	=	EC50	nM	53.0	CHEMBL4226	Homo sapiens	EC50	uM	0.053
	22940201	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CS(=O)(=O)NCc1cc(F)cc(-c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CN7CCCCC7)c6)nc45)cc23)c1		CHEMBL4782289	=	EC50	nM	79.0	CHEMBL4226	Homo sapiens	EC50	uM	0.079
	22940202	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CS(=O)(=O)NCc1cc(F)cc(-c2nccc3[nH]c(-c4n[nH]c5ncc(-c6cncc(OCc7ccccc7)c6)cc45)cc23)c1		CHEMBL4747076	=	EC50	nM	329.0	CHEMBL4226	Homo sapiens	EC50	uM	0.32899999999999996
	22940203	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CS(=O)(=O)NCc1cc(F)cc(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncnc6)nc45)cc23)c1		CHEMBL4765107	=	EC50	nM	58.0	CHEMBL4226	Homo sapiens	EC50	uM	0.057999999999999996
	22940204	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC#CC(=O)Nc1cc2cc(-c3cnn(C)c3)ccc2cn1		CHEMBL4789335	=	EC50	nM	123.0	CHEMBL4226	Homo sapiens	EC50	uM	0.12300000000000001
	22940205	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1ccc(C(=O)Nc2cc3cc(-c4cnn(C)c4)ccc3cn2)cc1		CHEMBL4755642	=	EC50	nM	41.0	CHEMBL4226	Homo sapiens	EC50	uM	0.040999999999999995
	22940206	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(Oc2ccc(C(=O)Nc3cc4cc(-c5cnn(C)c5)ccc4cn3)cc2)CC1		CHEMBL4748484	=	EC50	nM	14.0	CHEMBL4226	Homo sapiens	EC50	uM	0.013999999999999999
	22940207	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2ccc(C(=O)Nc3cc4cc(-c5cnn(C)c5)ccc4cn3)cn2)CC1		CHEMBL4800211	=	EC50	nM	36.0	CHEMBL4226	Homo sapiens	EC50	uM	0.036000000000000004
	22940208	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)CCNc1cc(C(=O)Nc2cc3cc(-c4cnn(C)c4)ccc3cn2)ccn1		CHEMBL4755182	=	EC50	nM	60.0	CHEMBL4226	Homo sapiens	EC50	uM	0.06
	22940209	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)CCOc1cc(C(=O)Nc2cc3cc(-c4cnn(C)c4)ccc3cn2)ccn1		CHEMBL4783105	=	EC50	nM	30.0	CHEMBL4226	Homo sapiens	EC50	uM	0.03
	22940210	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cc(C(=O)Nc3cc4cc(-c5cnn(C)c5)ccc4cn3)ccn2)CC1		CHEMBL4784318	=	EC50	nM	12.0	CHEMBL4226	Homo sapiens	EC50	uM	0.012
	22940211	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cc(C(=O)Nc3cc4cc(-c5cnn(C)c5)c(F)cc4cn3)ccn2)CC1		CHEMBL4778468	=	EC50	nM	21.0	CHEMBL4226	Homo sapiens	EC50	uM	0.021
	22940212	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cc(C(=O)Nc3cc4c(Cl)c(-c5cnn(C)c5)ccc4cn3)ccn2)CC1		CHEMBL4758035	=	EC50	nM	43.0	CHEMBL4226	Homo sapiens	EC50	uM	0.043
	22940213	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1cc(C(=O)Nc2cc3cc(-c4cnn(C)c4)ccc3cn2)cc(N2CCN(C)CC2)n1		CHEMBL4748781	=	EC50	nM	26.0	CHEMBL4226	Homo sapiens	EC50	uM	0.026000000000000002
	22940214	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2ccc3cnc(NC(=O)c4ccnc(N5CC6CC5CN6)c4)cc3c2)cn1		CHEMBL4791671	=	EC50	nM	26.0	CHEMBL4226	Homo sapiens	EC50	uM	0.026000000000000002
	22940215	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCCN(c2cc(C(=O)Nc3cc4cc(-c5cnn(C)c5)ccc4cn3)ccn2)CC1		CHEMBL4789887	=	EC50	nM	28.0	CHEMBL4226	Homo sapiens	EC50	uM	0.027999999999999997
	22940216	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cc(CC(=O)Nc3cc4cc(-c5cnn(C)c5)ccc4cn3)ccn2)CC1		CHEMBL4759886	=	EC50	nM	78.0	CHEMBL4226	Homo sapiens	EC50	uM	0.078
	22940217	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)C1CCN(c2cc(C(=O)Nc3cc4cc(-c5cnn(C)c5)ccc4cn3)ccn2)CC1		CHEMBL4741472	=	EC50	nM	9.0	CHEMBL4226	Homo sapiens	EC50	uM	0.009000000000000001
	22940218	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2ccc(C(=O)N3CCN(c4cc(C(=O)Nc5cc6cc(-c7cnn(C)c7)ccc6cn5)ccn4)CC3)cn2)CC1		CHEMBL4764269	=	EC50	nM	280.0	CHEMBL4226	Homo sapiens	EC50	uM	0.28
	22940219	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC2(CC1)CN(c1cc(C(=O)Nc3cc4cc(-c5cnn(C)c5)ccc4cn3)ccn1)C2		CHEMBL4748909	=	EC50	nM	16.0	CHEMBL4226	Homo sapiens	EC50	uM	0.016
	22940220	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(Nc2cc(C(=O)Nc3cc4cc(-c5cnn(C)c5)ccc4cn3)ccn2)CC1		CHEMBL4743755	=	EC50	nM	21.0	CHEMBL4226	Homo sapiens	EC50	uM	0.021
	22940221	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2ccc3cnc(NC(=O)c4ccnc(OC5CNC5)c4)cc3c2)cn1		CHEMBL4777508	=	EC50	nM	38.0	CHEMBL4226	Homo sapiens	EC50	uM	0.038
	22940222	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2ccc3cnc(NC(=O)c4ccc5c(c4)CNCC5)cc3c2)cn1		CHEMBL4745735	=	EC50	nM	39.0	CHEMBL4226	Homo sapiens	EC50	uM	0.039
	22940223	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2ccc3cnc(NC(=O)c4ccc5c(cnn5C)c4)cc3c2)cn1		CHEMBL4752070	=	EC50	nM	49.0	CHEMBL4226	Homo sapiens	EC50	uM	0.049
	22940224	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2ccc3cnc(NC(=O)c4cnc5ccccc5c4)cc3c2)cn1		CHEMBL4780800	=	EC50	nM	66.0	CHEMBL4226	Homo sapiens	EC50	uM	0.066
	22940225	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2ccc3cnc(NC(=O)c4ccc5cnccc5c4)cc3c2)cn1		CHEMBL4758126	=	EC50	nM	85.0	CHEMBL4226	Homo sapiens	EC50	uM	0.085
	22940226	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(n2cc(C(=O)Nc3cc4cc(-c5cnn(C)c5)ccc4cn3)cn2)CC1		CHEMBL4761662	=	EC50	nM	6.0	CHEMBL4226	Homo sapiens	EC50	uM	0.006
	22940227	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)OC(=O)N1CCC(n2cc(C(=O)Nc3cc4cc(-c5cnn(C)c5)ccc4cn3)cn2)CC1		CHEMBL4746707	=	EC50	nM	20.0	CHEMBL4226	Homo sapiens	EC50	uM	0.02
	22940228	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)N1CCC(c2nc(C(=O)Nc3cc4cc(-c5cnn(C)c5)ccc4cn3)co2)CC1		CHEMBL4762553	=	EC50	nM	20.0	CHEMBL4226	Homo sapiens	EC50	uM	0.02
	22940229	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)C1CN(c2ncc(C(=O)Nc3cc4cc(-c5cnn(C)c5)ccc4cn3)s2)C1		CHEMBL4762838	=	EC50	nM	37.0	CHEMBL4226	Homo sapiens	EC50	uM	0.037000000000000005
	22940230	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cc(C(=O)Nc3cc4cc(-c5cnn(C6CC6)c5)ccc4cn3)ccn2)CC1		CHEMBL4750631	=	EC50	nM	71.0	CHEMBL4226	Homo sapiens	EC50	uM	0.071
	22940231	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cc(C(=O)Nc3cc4cc(-c5cnn(C)c5N)ccc4cn3)ccn2)CC1		CHEMBL4793867	=	EC50	nM	34.0	CHEMBL4226	Homo sapiens	EC50	uM	0.034
	22940232	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1ncc(-c2ccc3cnc(NC(=O)c4ccc(OC(F)F)cc4)cc3c2)c1CO		CHEMBL4797187	=	EC50	nM	261.0	CHEMBL4226	Homo sapiens	EC50	uM	0.261
	22940233	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC2(CC1)CN(c1cc(C(=O)Nc3cc4cc(-c5cnn(C)c5CO)ccc4cn3)ccn1)C2		CHEMBL4762392	=	EC50	nM	44.0	CHEMBL4226	Homo sapiens	EC50	uM	0.044000000000000004
	22940234	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CO[C@H]1CC[C@H](C(=O)Nc2cc3cc(-c4cnn(C)c4CN4CCCCC4)ccc3cn2)CC1		CHEMBL4763084	=	EC50	nM	164.0	CHEMBL4226	Homo sapiens	EC50	uM	0.16399999999999998
	22940235	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1ncc(-c2ccc3cnc(NC(=O)[C@H]4CC[C@H](CO)CC4)cc3c2)c1CN1CCCCC1		CHEMBL4752464	=	EC50	nM	143.0	CHEMBL4226	Homo sapiens	EC50	uM	0.14300000000000002
	22940236	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1ncc(-c2ccc3cnc(NC(=O)C4CCN(C(=O)c5ccccc5)CC4)cc3c2)c1CN1CCCCC1		CHEMBL4751301	=	EC50	nM	318.0	CHEMBL4226	Homo sapiens	EC50	uM	0.318
	22940237	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1ncc(-c2ccc3cnc(NC(=O)c4cccc(CN5CCCC5)c4)cc3c2)c1CN1CCCCC1		CHEMBL4740518	=	EC50	nM	15.0	CHEMBL4226	Homo sapiens	EC50	uM	0.015
	22940238	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1ncc(-c2ccc3cnc(NC(=O)c4ccnc(N5CCOCC5)c4)cc3c2)c1CN1CCOCC1		CHEMBL4782826	=	EC50	nM	8.0	CHEMBL4226	Homo sapiens	EC50	uM	0.008
	22940239	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cc2cc(-c3cnn4c3CCNC4)ccc2cn1)c1ccc(OC(F)F)cc1		CHEMBL4794929	=	EC50	nM	200.0	CHEMBL4226	Homo sapiens	EC50	uM	0.2
	22940240	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)N1CCC(Oc2cc(C(=O)Nc3cc4cc(-c5cnn6c5CCNC6)ccc4cn3)ccn2)CC1		CHEMBL4762157	=	EC50	nM	26.0	CHEMBL4226	Homo sapiens	EC50	uM	0.026000000000000002
	22940241	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2ccc(C(=O)Nc3cc4cc(-c5cnn6c5CN(CCF)CC6)ccc4cn3)cn2)CC1		CHEMBL4747563	=	EC50	nM	81.0	CHEMBL4226	Homo sapiens	EC50	uM	0.081
	22940242	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CNC(=O)c1ccc(C(=O)Nc2cc3cc(-c4cn(C)nn4)ccc3cn2)cn1		CHEMBL4790614	=	EC50	nM	56.0	CHEMBL4226	Homo sapiens	EC50	uM	0.055999999999999994
	22940243	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCc2cc(C(=O)Nc3cc4cc(-c5cn(C)nn5)ccc4cn3)ccc2C1		CHEMBL4777663	=	EC50	nM	48.0	CHEMBL4226	Homo sapiens	EC50	uM	0.048
	22940244	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)N1CCC(n2cc(C(=O)Nc3cc4cc(-c5cn(C)nn5)ccc4cn3)cn2)CC1		CHEMBL4795948	=	EC50	nM	19.0	CHEMBL4226	Homo sapiens	EC50	uM	0.019
	22940245	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cncc1-c1ccc2cnc(NC(=O)c3ccc(F)cc3)cc2c1		CHEMBL4783628	=	EC50	nM	33.0	CHEMBL4226	Homo sapiens	EC50	uM	0.033
	22940246	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cncc1-c1ccc2cnc(NC(=O)c3ccnc(N4CC(N)C4)c3)cc2c1		CHEMBL4780597	=	EC50	nM	11.0	CHEMBL4226	Homo sapiens	EC50	uM	0.011000000000000001
	22940247	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cncc1-c1ccc2cnc(NC(=O)c3ccnc(N4CCN(C5CC5)CC4)c3)cc2c1		CHEMBL4758853	=	EC50	nM	18.0	CHEMBL4226	Homo sapiens	EC50	uM	0.018000000000000002
	22940248	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1Cc2ccc(C(=O)Nc3cc4cc(-c5cncn5C)ccc4cn3)cc2C1		CHEMBL4786449	=	EC50	nM	27.0	CHEMBL4226	Homo sapiens	EC50	uM	0.027000000000000003
	22940249	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1nnc(C(=O)Nc2cc3cc(-c4cncn4C)ccc3cn2)s1		CHEMBL4787749	=	EC50	nM	177.0	CHEMBL4226	Homo sapiens	EC50	uM	0.177
	22940250	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)n1cc(C(=O)Nc2cc3cc(-c4cncn4C)ccc3cn2)cn1		CHEMBL4755579	=	EC50	nM	13.0	CHEMBL4226	Homo sapiens	EC50	uM	0.013000000000000001
	22940251	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)n1cc(C(=O)Nc2cc3cc(-c4cncn4C(C)C)ccc3cn2)cn1		CHEMBL4754087	=	EC50	nM	23.0	CHEMBL4226	Homo sapiens	EC50	uM	0.023
	22940252	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ncc(-c2ccc3cnc(NC(=O)C4(F)CC4)cc3c2)n1C		CHEMBL4752888	=	EC50	nM	678.0	CHEMBL4226	Homo sapiens	EC50	uM	0.6779999999999999
	22940253	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ncc(-c2ccc3cnc(NC(=O)c4ccc(OC(C)C)cc4)cc3c2)n1C		CHEMBL4791186	=	EC50	nM	70.0	CHEMBL4226	Homo sapiens	EC50	uM	0.07
	22940254	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ncc(C(=O)Nc2cc3cc(-c4cnc(C)n4C)ccc3cn2)s1		CHEMBL4800296	=	EC50	nM	31.0	CHEMBL4226	Homo sapiens	EC50	uM	0.031
	22940255	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	NC1CN(c2cc(C(=O)Nc3cc4cc(-c5cnco5)ccc4cn3)ccn2)C1		CHEMBL4741620	=	EC50	nM	40.0	CHEMBL4226	Homo sapiens	EC50	uM	0.04
	22940256	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cc(C(=O)Nc3cc4cc(-c5cncs5)ccc4cn3)ccn2)CC1		CHEMBL4744439	=	EC50	nM	20.0	CHEMBL4226	Homo sapiens	EC50	uM	0.02
	22940257	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cc2cc(-c3cncs3)ccc2cn1)c1ccc2c(c1)CNCC2		CHEMBL4760089	=	EC50	nM	43.0	CHEMBL4226	Homo sapiens	EC50	uM	0.043
	22940258	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cc(C(=O)Nc3cc4cc(-c5cnc(N)s5)ccc4cn3)ccn2)CC1		CHEMBL4747892	=	EC50	nM	22.0	CHEMBL4226	Homo sapiens	EC50	uM	0.022000000000000002
	22940259	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1nnc(-c2ccc3cnc(NC(=O)c4ccnc(C5=CCN(C)CC5)c4)cc3c2)s1		CHEMBL4799760	=	EC50	nM	14.0	CHEMBL4226	Homo sapiens	EC50	uM	0.013999999999999999
	22940260	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1nnc(-c2ccc3cnc(NC(=O)c4ccnc(N(C)C5CCN(C)CC5)c4)cc3c2)s1		CHEMBL4788867	=	EC50	nM	19.0	CHEMBL4226	Homo sapiens	EC50	uM	0.019
	22940261	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cc(C(=O)Nc3cc4cc(-c5ccc(N)nc5)ccc4cn3)ccn2)CC1		CHEMBL4782831	=	EC50	nM	42.0	CHEMBL4226	Homo sapiens	EC50	uM	0.042
	22940262	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cc2cc(-c3cncc(CN4CCC(O)CC4)c3)ccc2cn1)c1ccc(F)cc1		CHEMBL4781707	=	EC50	nM	94.0	CHEMBL4226	Homo sapiens	EC50	uM	0.094
	22940263	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3cnc(NC(=O)C4CCN(CCF)CC4)cc3c2)n1		CHEMBL4751376	=	EC50	nM	52.0	CHEMBL4226	Homo sapiens	EC50	uM	0.052000000000000005
	22940264	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3cnc(NC(=O)c4cccc(C5CCN(C)CC5)c4)cc3c2)n1		CHEMBL4797241	=	EC50	nM	11.0	CHEMBL4226	Homo sapiens	EC50	uM	0.011000000000000001
	22940265	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cc2cc(-c3cncc(NC4CCNCC4)n3)ccc2cn1)C1CC(F)(F)C1		CHEMBL4761487	=	EC50	nM	78.0	CHEMBL4226	Homo sapiens	EC50	uM	0.078
	22940266	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cc2cc(-c3cncc(NC4CCNCC4)n3)ccc2cn1)C1CCCCC1		CHEMBL4763112	=	EC50	nM	59.0	CHEMBL4226	Homo sapiens	EC50	uM	0.059000000000000004
	22940267	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cc2cc(-c3cncc(NCC4(F)CNC4)n3)ccc2cn1)C1CC1		CHEMBL4777070	=	EC50	nM	18.0	CHEMBL4226	Homo sapiens	EC50	uM	0.018000000000000002
	22940268	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cc2cc(-c3cncc(N[C@H]4CCNC[C@@H]4F)n3)ccc2cn1)C1CC1		CHEMBL4780537	=	EC50	nM	11.0	CHEMBL4226	Homo sapiens	EC50	uM	0.011000000000000001
	22940269	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(n2cc(C(=O)Nc3cc4cc(-c5cncc6[nH]ccc56)ccc4cn3)cn2)CC1		CHEMBL4746469	=	EC50	nM	7.0	CHEMBL4226	Homo sapiens	EC50	uM	0.006999999999999999
	22940270	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(n2cc(C(=O)Nc3cc4cc(-c5cnc6cc[nH]c6c5)ccc4cn3)cn2)CC1		CHEMBL4745584	=	EC50	nM	9.0	CHEMBL4226	Homo sapiens	EC50	uM	0.009000000000000001
	22940271	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cc(C(=O)Nc3cc4nc(-c5cnn(C)c5)ccc4cn3)ccn2)CC1		CHEMBL4743920	=	EC50	nM	60.0	CHEMBL4226	Homo sapiens	EC50	uM	0.06
	22940272	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cc(C(=O)Nc3ncc4ccc(-c5cnn(C)c5)cc4n3)ccn2)CC1		CHEMBL4778580	=	EC50	nM	135.0	CHEMBL4226	Homo sapiens	EC50	uM	0.135
	22940273	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2ccc3cnc(NC(=O)c4ccc5nccnc5c4)cc3n2)cn1		CHEMBL4794127	=	EC50	nM	141.0	CHEMBL4226	Homo sapiens	EC50	uM	0.141
	22940274	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)OC(=O)N1CCC(n2cc(C(=O)Nc3cc4cc(-c5cnn(C)c5)ncc4cn3)cn2)CC1		CHEMBL4790835	=	EC50	nM	61.0	CHEMBL4226	Homo sapiens	EC50	uM	0.061
	22940275	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC2(CC1)CN(c1cc(C(=O)Nc3cc4cc(-c5cnn(C)c5CN5CCCCC5)cnc4cn3)ccn1)C2		CHEMBL4779822	=	EC50	nM	31.0	CHEMBL4226	Homo sapiens	EC50	uM	0.031
	22940276	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ncc(C(=O)Nc2cc3nc(-c4cnc(C)n4C)ccc3cn2)s1		CHEMBL4790079	=	EC50	nM	31.0	CHEMBL4226	Homo sapiens	EC50	uM	0.031
	22940277	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CC=C(c2cc(C(=O)Nc3cc4cc(-c5cncc(NC(C)(C)C)n5)cnc4cn3)ccn2)CC1		CHEMBL4800068	=	EC50	nM	12.0	CHEMBL4226	Homo sapiens	EC50	uM	0.012
	22940278	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cc2cc(-c3cncc(NC4CCNCC4)n3)ncc2cn1)C1CCOCC1		CHEMBL4794913	=	EC50	nM	133.0	CHEMBL4226	Homo sapiens	EC50	uM	0.133
	22940279	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)n1cc(C(=O)Nc2cc3cc(-c4cncc(NC5CCN(C)CC5)n4)ncc3cn2)cn1		CHEMBL4785775	=	EC50	nM	97.0	CHEMBL4226	Homo sapiens	EC50	uM	0.09699999999999999
	22940280	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cc2cc(-c3cncc(NCC4(F)CNC4)n3)ncc2cn1)C1CC1		CHEMBL4741309	=	EC50	nM	53.0	CHEMBL4226	Homo sapiens	EC50	uM	0.053
	22940281	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(n2cc(C(=O)Nc3ncc4ccc(-c5cncc6[nH]ccc56)cc4n3)cn2)CC1		CHEMBL4748839	=	EC50	nM	19.0	CHEMBL4226	Homo sapiens	EC50	uM	0.019
	22940282	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCCCN(C)c2nccc3[nH]c(nc23)-c2c[nH]c3ccc(cc23)-c2cncc(c2)C1		CHEMBL4741101	=	EC50	nM	12.0	CHEMBL4226	Homo sapiens	EC50	uM	0.012
	22940283	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cc2cc(c1)-c1cncc3[nH]c(nc13)-c1n[nH]c3ccc(cc13)-c1cncc(c1)CNC2		CHEMBL4793171	=	EC50	nM	12.0	CHEMBL4226	Homo sapiens	EC50	uM	0.012
	22940284	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C1CCc2cccc(c2)-c2cncc3[nH]c(nc23)-c2n[nH]c3ccc(cc23)-c2cncc(c2)N1		CHEMBL4753134	=	EC50	nM	29.0	CHEMBL4226	Homo sapiens	EC50	uM	0.028999999999999998
	22940285	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C1COc2cccc(c2)-c2cncc3[nH]c(nc23)-c2n[nH]c3ccc(cc23)-c2cncc(c2)N1		CHEMBL4800405	=	EC50	nM	16.0	CHEMBL4226	Homo sapiens	EC50	uM	0.016
	22940286	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCCn2cc(nn2)-c2nccc3[nH]c(nc23)-c2n[nH]c3ccc(cc23)-c2cncc(c2)C1		CHEMBL4791855	=	EC50	nM	26.0	CHEMBL4226	Homo sapiens	EC50	uM	0.026000000000000002
	22940287	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C1CCc2cccc(c2)-c2cncc(c2)NC(=O)c2n[nH]c3ccc(cc23)-c2cncc(c2)CN1		CHEMBL4784103	=	EC50	nM	36.0	CHEMBL4226	Homo sapiens	EC50	uM	0.036000000000000004
	22940288	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cc(Nc3ncc4c(-c5ccc6ncccc6c5)c[nH]c4n3)ccn2)CC1		CHEMBL4798969	=	EC50	nM	10.0	CHEMBL4226	Homo sapiens	EC50	uM	0.01
	22940289	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CNc1nc(NCc2ncccn2)c2c(-c3ccc4ncccc4c3)c[nH]c2n1		CHEMBL4797564	=	EC50	nM	26.0	CHEMBL4226	Homo sapiens	EC50	uM	0.026000000000000002
	22940290	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1cccc(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cnccn6)nc45)nc23)c1		CHEMBL4764942	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940291	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Cc1ccccc1)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccncc6)ccnc5[nH]4)c3n2)c1		CHEMBL4740879	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940292	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cccc(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)C7CCCCC7)c6)nc45)nc23)c1		CHEMBL4753453	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940293	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1ccc(-c2cccc3[nH]c(-c4n[nH]c5ccc(-c6cncnc6)nc45)nc23)cc1		CHEMBL4795145	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940294	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cccc5[nH]4)c3n2)c1)C1CC1		CHEMBL4758567	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940295	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccccn6)ccnc5[nH]4)c3n2)c1)c1ccccc1		CHEMBL4778724	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940296	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccs6)cccc5[nH]4)c3n2)c1)C1CC1		CHEMBL4763191	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940297	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCCCC6)ccnc5[nH]4)c3n2)c1		CHEMBL4757442	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940298	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cccc(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cn[nH]c6)nc45)nc23)c1		CHEMBL4794216	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940299	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1ccc(-c2cccc3[nH]c(-c4n[nH]c5ncc(-c6cncc(CN7CCCCC7)c6)cc45)cc23)cc1		CHEMBL4749743	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940300	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)CCNc1cc(F)cc(-c2cccc3[nH]c(-c4n[nH]c5ncc(-c6ccncc6)cc45)cc23)c1		CHEMBL4787213	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940301	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cc3c(-c4cc5c(-c6cccc(F)c6)ccnc5[nH]4)n[nH]c3cn2)c1)C1CC1		CHEMBL4753128	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940302	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cc2cc(-c3cncs3)ccc2cn1)C1(F)CCCCC1		CHEMBL4792722	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940303	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CC2CCC(C1)N2C(=O)Nc1cc2cc(-c3cnn(C)c3)ccc2cn1		CHEMBL4740450	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940304	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(C(=O)Nc2cc3cc(-c4cnsc4)cnc3cn2)CC1		CHEMBL4749519	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940305	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cc2cc(-c3cnco3)cnc2cn1)[C@H]1CC[C@H](CO)CC1		CHEMBL4761669	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940306	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cc2cc(-c3cnco3)cnc2cn1)C1CCNCC1		CHEMBL4764466	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22940307	CHEMBL4739819	Inhibition of recombinant CLK3 (unknown origin) using Ser/Thr 18 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(F)(F)CN1CCC(C(=O)Nc2cc3cc(-c4cnco4)cnc3cn2)CC1		CHEMBL4752797	>	EC50	nM	10000.0	CHEMBL4226	Homo sapiens	EC50	uM	10.0
	22952802	CHEMBL4766739	Inhibition of recombinant full length human CLK3 assessed as residual activity at 10 uM using ERMRPRKRQGSVRRRV as substrate incubated 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	79.0	CHEMBL4226	Homo sapiens	Activity	%	79.0
	23122273	CHEMBL4804717	Inhibition of CLK3 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	1500.0	CHEMBL4226	Homo sapiens	IC50	uM	1.5
	23122274	CHEMBL4804717	Inhibition of CLK3 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	23300.0	CHEMBL4226	Homo sapiens	IC50	uM	23.3
	23122275	CHEMBL4804717	Inhibition of CLK3 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	40000.0	CHEMBL4226	Homo sapiens	IC50	uM	40.0
	23122276	CHEMBL4804718	Inhibition of CLK3 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL4226	Homo sapiens	INH	%	0.0
	23122277	CHEMBL4804718	Inhibition of CLK3 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL4226	Homo sapiens	INH	%	0.0
	23122278	CHEMBL4804718	Inhibition of CLK3 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	35.0	CHEMBL4226	Homo sapiens	INH	%	35.0
	23122501	CHEMBL4804852	Inhibition of human CLK3 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	65.0	CHEMBL4226	Homo sapiens	Activity	%	65.0
	23123196	CHEMBL4805440	Inhibition of human CLK3 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	91.0	CHEMBL4226	Homo sapiens	Activity	%	91.0
	23123694	CHEMBL4805938	Inhibition of DNA-tagged human CLK3 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL4226	Homo sapiens	Activity	%	100.0
	23124482	CHEMBL4806457	Inhibition of human CLK3 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL4226	Homo sapiens	Activity	%	100.0
	23124483	CHEMBL4806457	Inhibition of human CLK3 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	95.0	CHEMBL4226	Homo sapiens	Activity	%	95.0
	23127981	CHEMBL4807802	Inhibition of CLK3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL4226	Homo sapiens	Activity	%	75.0
	23127982	CHEMBL4807802	Inhibition of CLK3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL4226	Homo sapiens	Activity	%	75.0
	23127983	CHEMBL4807802	Inhibition of CLK3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL4226	Homo sapiens	Activity	%	75.0
	23152040	CHEMBL4810638	Inhibition of wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	CN(C)c1nccc(-c2cnn3ncccc23)n1		CHEMBL4848254	=	Activity	%	54.0	CHEMBL4226	Homo sapiens	Activity	%	54.0
	23152041	CHEMBL4810638	Inhibition of wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	CN(c1nccc(-c2cnn3ncccc23)n1)C1CC1		CHEMBL4848696	=	Activity	%	96.0	CHEMBL4226	Homo sapiens	Activity	%	96.0
	23152042	CHEMBL4810638	Inhibition of wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	c1cnn2ncc(-c3ccnc(N4CCC45COC5)n3)c2c1		CHEMBL4845809	=	Activity	%	54.0	CHEMBL4226	Homo sapiens	Activity	%	54.0
	23152043	CHEMBL4810638	Inhibition of wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	CC1CCCN1c1nccc(-c2cnn3ncccc23)n1		CHEMBL4859912	=	Activity	%	100.0	CHEMBL4226	Homo sapiens	Activity	%	100.0
	23152044	CHEMBL4810638	Inhibition of wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	C[C@H]1CCN(c2nccc(-c3cnn4ncccc34)n2)C1		CHEMBL4853444	=	Activity	%	88.0	CHEMBL4226	Homo sapiens	Activity	%	88.0
	23152045	CHEMBL4810638	Inhibition of wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	C[C@@H]1CCN(c2nccc(-c3cnn4ncccc34)n2)C1		CHEMBL4870121	=	Activity	%	73.0	CHEMBL4226	Homo sapiens	Activity	%	73.0
	23152046	CHEMBL4810638	Inhibition of wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	F[C@@H]1CCN(c2nccc(-c3cnn4ncccc34)n2)C1		CHEMBL4852944	=	Activity	%	96.0	CHEMBL4226	Homo sapiens	Activity	%	96.0
	23152047	CHEMBL4810638	Inhibition of wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	N[C@H]1CCN(c2nccc(-c3cnn4ncccc34)n2)C1		CHEMBL4877372	=	Activity	%	95.0	CHEMBL4226	Homo sapiens	Activity	%	95.0
	23152048	CHEMBL4810638	Inhibition of wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	N[C@@H]1CCN(c2nccc(-c3cnn4ncccc34)n2)C1		CHEMBL4876980	=	Activity	%	89.0	CHEMBL4226	Homo sapiens	Activity	%	89.0
	23152049	CHEMBL4810638	Inhibition of wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	Cc1cnn2ncc(-c3ccnc(N(C)C)n3)c2c1		CHEMBL4851717	=	Activity	%	76.0	CHEMBL4226	Homo sapiens	Activity	%	76.0
	23152050	CHEMBL4810638	Inhibition of wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	COc1ccnn2ncc(-c3ccnc(N(C)C)n3)c12		CHEMBL4874923	=	Activity	%	83.0	CHEMBL4226	Homo sapiens	Activity	%	83.0
	23152051	CHEMBL4810638	Inhibition of wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	CN(C)c1nccc(-c2cnc3ncccn23)n1		CHEMBL4872408	=	Activity	%	56.0	CHEMBL4226	Homo sapiens	Activity	%	56.0
	23152052	CHEMBL4810638	Inhibition of wild-type human full length CLK3 (M1 to R490 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	CN(C)c1ncc(F)c(-c2cnn3ncccc23)n1		CHEMBL4861396	=	Activity	%	84.0	CHEMBL4226	Homo sapiens	Activity	%	84.0
	23178411	CHEMBL4815944	Inhibition of recombinant full length human CLK3 using ERMRPRKRQGSVR as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	COc1ccc(CNC(=O)c2cnc3ccc(-c4ccc5ncccc5c4)cn23)cc1		CHEMBL4853178	>	IC50	nM	10000.0	CHEMBL4226	Homo sapiens	IC50	nM	10000.0
Not Active	23317336	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	73.0	CHEMBL4226	Homo sapiens	% Control	%	73.0
Not Active	23317804	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23318474	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	75.0	CHEMBL4226	Homo sapiens	% Control	%	75.0
Not Active	23318954	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23319593	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23320066	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23320744	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23321212	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	85.0	CHEMBL4226	Homo sapiens	% Control	%	85.0
Not Active	23321842	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	97.0	CHEMBL4226	Homo sapiens	% Control	%	97.0
Not Active	23322310	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	93.0	CHEMBL4226	Homo sapiens	% Control	%	93.0
Not Active	23322999	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23323467	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23323980	CHEMBL4880599	CLK3 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	-1.0	CHEMBL4226	Homo sapiens	% inhibition	%	-1.0
Not Active	23324321	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23324956	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23325424	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	91.0	CHEMBL4226	Homo sapiens	% Control	%	91.0
Not Active	23326071	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	83.0	CHEMBL4226	Homo sapiens	% Control	%	83.0
Not Active	23326539	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	72.0	CHEMBL4226	Homo sapiens	% Control	%	72.0
Not Active	23327239	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	86.0	CHEMBL4226	Homo sapiens	% Control	%	86.0
Not Active	23327707	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23328294	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23328762	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23329306	CHEMBL4881013	CLK3(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	111.0	CHEMBL4226	Homo sapiens	% residual kinase activity	%	111.0
Not Active	23329708	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23330176	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	94.0	CHEMBL4226	Homo sapiens	% Control	%	94.0
Not Active	23330932	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23331400	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23331987	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	87.7	CHEMBL4226	Homo sapiens	% Control	%	87.7
Not Active	23332455	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23333171	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23333810	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23334278	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23335257	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	91.0	CHEMBL4226	Homo sapiens	% Control	%	91.0
Not Active	23335725	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	91.0	CHEMBL4226	Homo sapiens	% Control	%	91.0
Not Active	23336352	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	78.0	CHEMBL4226	Homo sapiens	% Control	%	78.0
Not Active	23336820	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	90.0	CHEMBL4226	Homo sapiens	% Control	%	90.0
Not Active	23337550	CHEMBL4881921	CLK3 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	95.5	CHEMBL4226	Homo sapiens	% Ctrl	%	95.5
Not Active	23337901	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23338369	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23338981	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23339449	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23340086	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	86.0	CHEMBL4226	Homo sapiens	% Control	%	86.0
Not Active	23340554	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	99.0	CHEMBL4226	Homo sapiens	% Control	%	99.0
Not Active	23341211	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23341679	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23342295	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	91.0	CHEMBL4226	Homo sapiens	% Control	%	91.0
Not Active	23342763	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23343393	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	83.0	CHEMBL4226	Homo sapiens	% Control	%	83.0
Not Active	23343861	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	95.0	CHEMBL4226	Homo sapiens	% Control	%	95.0
Not Active	23344499	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23345072	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23345540	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	93.0	CHEMBL4226	Homo sapiens	% Control	%	93.0
Not Active	23346117	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23346586	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	76.0	CHEMBL4226	Homo sapiens	% Control	%	76.0
Not Active	23347195	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	82.2	CHEMBL4226	Homo sapiens	% Control	%	82.2
Not Active	23347677	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23348256	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23348724	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	92.0	CHEMBL4226	Homo sapiens	% Control	%	92.0
Not Active	23349311	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	86.0	CHEMBL4226	Homo sapiens	% Control	%	86.0
Not Active	23349929	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	83.0	CHEMBL4226	Homo sapiens	% Control	%	83.0
Not Active	23350397	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	95.0	CHEMBL4226	Homo sapiens	% Control	%	95.0
Not Active	23351002	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	97.0	CHEMBL4226	Homo sapiens	% Control	%	97.0
Not Active	23351470	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23352000	CHEMBL4882692	CLK3 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	8.925	CHEMBL4226	Homo sapiens	% Inhibition	%	8.9252
Not Active	23352494	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	94.0	CHEMBL4226	Homo sapiens	% Control	%	94.0
Not Active	23352962	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	98.0	CHEMBL4226	Homo sapiens	% Control	%	98.0
Not Active	23353844	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23354312	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23355044	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23355512	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23356148	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23356616	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23357225	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23357872	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23358340	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23358926	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23359524	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23359992	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23360577	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	88.0	CHEMBL4226	Homo sapiens	% Control	%	88.0
Not Active	23361045	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	74.0	CHEMBL4226	Homo sapiens	% Control	%	74.0
Not Active	23361618	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	76.0	CHEMBL4226	Homo sapiens	% Control	%	76.0
Not Active	23362154	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	94.0	CHEMBL4226	Homo sapiens	% Control	%	94.0
Not Active	23362622	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	85.0	CHEMBL4226	Homo sapiens	% Control	%	85.0
Active	23363192	CHEMBL4883212	CLK3 Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	88.72	CHEMBL4226	Homo sapiens	% inhibition	%	88.72415000000001
Not Active	23363193	CHEMBL4883212	CLK3 Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	38.33	CHEMBL4226	Homo sapiens	% inhibition	%	38.3339
Active	23363332	CHEMBL4883199	In vitro kinase assay (CLK3)	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		IC50	nM	110.0	CHEMBL4226	Homo sapiens	IC50	nM	110.0
Not Active	23364264	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	90.0	CHEMBL4226	Homo sapiens	% Control	%	90.0
Not Active	23364732	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23365471	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	86.0	CHEMBL4226	Homo sapiens	% Control	%	86.0
Not Active	23366014	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23366604	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	95.0	CHEMBL4226	Homo sapiens	% Control	%	95.0
Not Active	23367072	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23367522	CHEMBL4883875	CLK3 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	88.0	CHEMBL4226	Homo sapiens	% Residual activity with Skepinone-L	%	88.0
Not Active	23367950	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	88.0	CHEMBL4226	Homo sapiens	% Control	%	88.0
Not Active	23368418	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	82.0	CHEMBL4226	Homo sapiens	% Control	%	82.0
Not Active	23369017	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23369485	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23370028	CHEMBL4884272	CLK3(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	109.0	CHEMBL4226	Homo sapiens	% residual kinase activity	%	109.0
Not Active	23370453	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23370921	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	94.0	CHEMBL4226	Homo sapiens	% Control	%	94.0
Not Active	23371730	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23372198	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	85.0	CHEMBL4226	Homo sapiens	% Control	%	85.0
	23372703	CHEMBL4884668	CLK3(CLK3LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL4226	Homo sapiens	pIC50		6.0
	23373112	CHEMBL4884959	CLK3(CLK3LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL4226	Homo sapiens	pIC50		6.0
	23373473	CHEMBL4885250	CLK3(CLK3LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL4226	Homo sapiens	pIC50		6.0
Not Active	23374946	CHEMBL4885940	CLK3 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	10.0	CHEMBL4226	Homo sapiens	% Inhibition	%	10.0
Not Active	23375625	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23376093	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	96.0	CHEMBL4226	Homo sapiens	% Control	%	96.0
Not Active	23376670	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	96.0	CHEMBL4226	Homo sapiens	% Control	%	96.0
Not Active	23377140	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	97.0	CHEMBL4226	Homo sapiens	% Control	%	97.0
Not Active	23377998	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	83.0	CHEMBL4226	Homo sapiens	% Control	%	83.0
Not Active	23378466	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	84.0	CHEMBL4226	Homo sapiens	% Control	%	84.0
Not Active	23379633	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23380101	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	99.0	CHEMBL4226	Homo sapiens	% Control	%	99.0
Not Active	23380795	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	99.0	CHEMBL4226	Homo sapiens	% Control	%	99.0
Not Active	23381443	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	96.0	CHEMBL4226	Homo sapiens	% Control	%	96.0
Not Active	23381911	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL4226	Homo sapiens	% Control	%	100.0
Not Active	23382535	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	97.0	CHEMBL4226	Homo sapiens	% Control	%	97.0
Active	23383003	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	12.0	CHEMBL4226	Homo sapiens	% Control	%	12.0
Not Active	23383741	CHEMBL4887387	CLK3 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	102.0	CHEMBL4226	Homo sapiens	% Ctrl	%	102.0
Not Active	23384235	CHEMBL4887830	CLK3(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	2.84	CHEMBL4226	Homo sapiens	% inhibition	%	2.84
Not Active	23384918	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	87.0	CHEMBL4226	Homo sapiens	% Control	%	87.0
Not Active	23385385	CHEMBL4879642	KinomeScan assay: inhibition of CLK3	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	87.0	CHEMBL4226	Homo sapiens	% Control	%	87.0
